Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AC092143.1		ENSG00000198211			16	89919165-89936092	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"testis: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SK-MEL-30: 19.0"									"CAB011512, HPA043640, HPA046280"	Uncertain		Uncertain	"Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB011512: AB_444319, HPA043640: AB_2678594, HPA046280: AB_2679612"					"unprognostic (2.90e-4)"				"unprognostic (6.87e-2)"									0.4	0.2	0.2	0.1	0.8	0.3	0.1	0.4	0.7	1.0	0.5	0.6	0.0	0.1	1.2	0.9	1.0	0.7	1.5	1.8	0.2	0.4	0.1	1.3	0.4	0.1	0.9	0.4	4.0	0.2	0.1	0.7	1.4	2.0	2.6	0.1	0.3	0.1	0.1	0.6	5.1	0.4	0.5	2.8	0.6	0.1	10.9	0.2	0.0	0.3	0.0	0.1	1.0	5.1	0.1	0.5	0.5	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.1	0.4	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.3	0.2	0.8	0.4	0.7	0.2	0.4	0.9	0.4	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADAMTS18	ADAMTS21	ENSG00000140873	"ADAM metallopeptidase with thrombospondin type 1 motif 18"	Q8TE60	16	77247813-77435114	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"adipose tissue: 16.1;brain: 31.9;placenta: 27.6"	"Group enriched"	"Detected in some"	6	"Muller glia cells: 16.4;Rod photoreceptor cells: 8.0"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in all"	5	"cerebellum: 31.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 13.2;HUVEC TERT2: 8.9;SuSa: 12.5;U-87 MG: 5.5"	"Region enriched"	"Detected in single"	5	"cerebellum: 3.7"	"Not detected"	"Not detected"			HPA044326	Uncertain		Approved	"Midbody,Mitotic spindle"	"Secreted to extracellular matrix"	Yes	NA			"Midbody, Mitotic spindle"		"HPA044326: AB_10961006"	"unprognostic (1.10e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.17e-4)"	"unprognostic (1.77e-5)"	"unprognostic (2.17e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.47e-4)"	16.1	0.6	1.1	0.8	5.1	0.4	3.2	31.9	3.3	2.2	0.4	8.2	0.0	0.5	1.6	0.4	0.5	0.7	1.1	0.4	2.0	1.3	0.5	0.3	0.5	0.5	1.8	1.4	0.5	0.8	0.4	1.4	27.6	6.4	1.0	0.4	0.2	2.1	0.5	1.0	0.4	0.4	1.2	3.7	0.3	0.3	0.7	2.4	0.0	0.4	0.0	0.3	0.8	0.4	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	12.5	0.0	0.5	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.1	5.1	31.9	3.3	2.0	1.3	1.8	1.4	6.4	2.4	0.0	0.0	0.0	0.1	0.1	0.4	0.5	0.0	0.0	0.0	1.8	2.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.0	0.0
APPL1	APPL	ENSG00000157500	"Adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1"	Q9UKG1	3	57227737-57273468	"Disease related genes, Predicted intracellular proteins"	"Cell cycle"		"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"naive B-cell: 20.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011138, HPA073477"	Approved		Uncertain	"Mitotic spindle,Centrosome"		Yes	No		28000	"Mitotic spindle, Centrosome"		"HPA011138: AB_1844959, HPA073477: AB_2797272"	"unprognostic (1.39e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.36e-2)"	"unprognostic (9.05e-3)"	"unprognostic (5.55e-2)"	"prognostic favorable (7.26e-5)"	"unprognostic (3.99e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.55e-1)"	18.3	14.0	20.9	15.3	17.9	13.7	22.5	25.2	23.7	18.5	15.7	12.8	16.8	12.6	19.2	14.5	21.0	16.0	13.2	23.7	15.8	15.4	17.0	14.3	15.3	24.3	15.4	18.8	24.0	38.2	28.4	20.4	14.1	18.8	15.7	14.4	11.0	18.0	22.2	40.5	19.9	14.5	20.5	16.7	15.0	16.3	10.5	15.7	20.9	20.0	15.2	18.9	17.7	20.8	20.7	12.0	2.5	3.9	4.7	3.5	1.7	14.9	6.5	6.4	23.2	11.0	15.5	13.5	7.9	4.9	8.0	9.2	7.6	9.0	24.3	3.3	12.2	12.6	3.0	17.1	13.7	13.8	18.3	7.6	13.7	10.4	8.0	11.9	30.4	10.1	11.4	12.5	10.2	11.1	16.1	12.7	15.3	4.6	15.3	9.0	5.1	23.9	7.5	10.0	10.6	11.2	0.8	26.0	13.0	14.1	8.4	6.5	13.8	10.9	16.4	10.4	9.0	8.0	19.8	12.0	13.3	9.4	19.3	15.3	14.1	20.6	17.1	14.4	14.7	8.6	1.6	3.9	2.5	2.6	3.0	3.5	11.3	2.8	2.4	7.2	20.7	2.6	1.9	1.0	4.7	2.5	12.0	1.1	1.7	20.9	17.9	25.2	23.7	15.8	15.4	15.4	18.8	18.8	15.7	47.6	39.2	44.5	41.0	47.1	39.5	88.3	45.9	20.1	55.7	40.1	29.5	40.0	49.7	52.3	22.7	58.0	26.9	0.0	52.6	38.3	45.7	34.4	22.0	37.6	46.6	49.3	43.8	35.6	50.8	15.5	67.6	54.0	18.6	85.6	35.9	55.2	46.8	11.5	71.5	43.7	52.2	51.8	38.7	40.0	39.4	60.9	23.5	30.5	44.7	23.4
B3GNT7	beta3GnT7	ENSG00000156966	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7"	Q8NFL0	2	231395543-231401164	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 93.7;intestine: 41.2"	"Cell type enhanced"	"Detected in many"	12	"Intestinal endocrine cells: 99.1;Mucus-secreting cells: 119.1;Undifferentiated cells: 275.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 19.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 15.0;HEL: 11.8;THP-1: 10.5;WM-115: 18.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA013881, HPA035625, HPA035626"	Enhanced		Approved	"Golgi apparatus,Mitotic spindle,Cytosol"	"Intracellular and membrane"	NA	NA		2100000	"Golgi apparatus"	"Mitotic spindle, Cytosol"	"HPA013881: , HPA035625: AB_10601118, HPA035626: AB_2674707"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.17e-2)"	"unprognostic (7.77e-2)"	"unprognostic (4.27e-3)"	"unprognostic (6.96e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (6.00e-4)"	"unprognostic (3.57e-1)"	3.0	10.3	5.3	2.3	4.9	5.5	1.9	0.9	3.2	1.2	28.0	3.8	0.8	12.2	1.6	3.5	1.9	3.6	93.7	26.8	4.2	4.4	1.4	1.3	17.7	1.8	4.0	2.0	13.0	18.9	6.7	8.9	10.7	3.2	1.6	35.5	2.0	4.0	2.3	0.4	2.4	41.2	1.1	1.9	6.7	17.1	1.6	2.2	1.2	4.2	1.7	3.9	1.2	0.6	7.1	4.2	0.4	0.3	19.9	2.0	0.5	0.5	2.1	0.2	0.4	0.1	0.2	0.8	0.2	0.8	0.1	0.1	1.0	15.0	1.7	4.6	0.2	0.1	3.9	0.2	0.0	0.1	0.2	0.4	11.8	0.3	0.7	0.1	0.1	0.6	0.1	1.1	0.1	0.2	0.8	0.2	0.3	0.3	0.3	0.1	0.6	0.1	0.5	4.9	5.8	2.6	0.2	0.0	0.2	0.5	1.3	0.4	0.6	0.2	1.3	0.5	5.7	0.5	10.5	0.2	0.3	0.3	0.2	0.1	1.8	0.6	0.5	0.3	0.1	18.2	0.3	0.0	0.4	2.0	0.3	0.4	7.1	0.0	0.2	4.2	5.1	0.1	0.5	0.1	19.9	0.3	2.1	0.1	0.5	5.3	4.9	0.9	3.2	4.2	4.4	4.0	2.0	3.2	2.2	38.7	24.6	2.2	1.2	2.1	0.2	0.8	84.1	75.0	33.0	1.8	2.0	0.4	0.0	13.5	0.3	0.7	75.7	0.0	73.7	52.0	2.2	11.2	9.2	0.0	9.0	0.0	99.1	3.7	7.0	0.9	1.4	13.6	3.3	4.6	119.1	0.5	58.2	46.0	7.8	0.1	1.6	0.0	1.4	0.7	1.3	2.4	1.7	6.9	275.6	13.2
BIRC6	BRUCE	ENSG00000115760	"Baculoviral IAP repeat containing 6"	Q9NR09	2	32357028-32618899	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 180.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074409, HPA074738"	Approved		Supported	"Golgi apparatus,Vesicles,Mitotic spindle"		Yes	No			"Golgi apparatus, Vesicles"	"Mitotic spindle"	"HPA074409: , HPA074738: AB_2686710"	"unprognostic (3.38e-2)"	"unprognostic (8.13e-3)"	"unprognostic (8.88e-2)"	"unprognostic (7.06e-3)"	"unprognostic (6.69e-3)"	"unprognostic (9.01e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.49e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.61e-1)"	"unprognostic (7.32e-2)"	"unprognostic (3.37e-1)"	15.0	16.7	10.3	20.7	14.4	18.4	16.1	21.9	13.7	16.2	13.0	15.3	15.6	8.7	17.2	13.9	13.2	13.1	11.7	11.4	9.8	7.3	14.1	14.8	12.5	16.1	13.9	11.8	23.6	24.8	32.5	17.4	14.1	14.8	11.3	13.6	11.5	14.7	17.1	20.9	14.9	16.0	12.5	13.3	16.1	13.9	13.0	14.4	23.1	21.5	9.2	17.2	16.2	12.0	3.8	2.8	10.6	2.4	2.3	3.4	0.7	15.3	12.8	11.9	5.1	9.4	13.4	7.2	6.8	9.6	8.4	8.0	8.8	3.6	16.4	5.4	12.7	9.6	7.1	16.7	10.1	10.4	13.2	7.6	22.3	8.1	7.3	5.2	20.6	7.9	8.9	4.9	13.1	11.7	6.8	12.4	3.7	18.1	7.1	7.7	5.9	10.3	4.8	8.0	5.8	7.6	10.5	19.3	5.6	6.1	15.8	8.9	13.6	13.4	7.0	6.2	9.5	4.6	7.4	19.4	8.8	9.9	5.9	10.4	9.5	13.3	22.0	6.4	10.2	5.7	10.6	1.6	0.9	2.7	1.2	3.4	1.7	2.1	2.3	1.3	3.8	2.3	2.6	2.7	2.3	2.4	2.8	1.6	0.7	10.3	14.4	21.9	13.7	9.8	7.3	13.9	11.8	14.8	14.4	29.8	26.2	37.9	25.6	40.9	59.4	42.2	30.6	10.7	35.2	34.9	180.6	28.6	1.7	22.3	35.8	45.7	44.5	0.0	26.8	18.3	30.5	38.3	29.9	44.3	26.3	65.2	31.2	46.1	58.6	13.7	42.0	32.8	21.9	31.5	36.3	39.9	28.2	25.9	55.5	19.2	89.9	38.8	42.4	52.0	44.5	47.9	31.8	56.8	37.0	38.9
C1orf123	FLJ20580	ENSG00000162384	"Chromosome 1 open reading frame 123"	Q9NWV4	1	53214099-53220617	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043835	Uncertain		Approved	"Vesicles,Mitotic spindle,Cytosol"		Yes	No		380000	Cytosol	"Vesicles, Mitotic spindle"	"HPA043835: AB_10796797"	"unprognostic (1.09e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.55e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.27e-1)"	"unprognostic (5.52e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.05e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (6.31e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.43e-1)"	32.6	21.4	27.8	19.1	29.4	12.9	26.3	16.4	25.4	29.2	33.2	25.0	22.7	15.4	34.0	28.9	25.7	32.2	22.7	28.8	24.3	22.3	26.9	29.3	20.3	18.3	24.7	26.3	33.5	17.5	21.0	20.1	22.5	23.7	31.7	24.7	24.0	16.6	33.5	44.4	14.3	16.9	48.4	22.5	18.4	23.4	26.0	23.8	18.9	26.0	18.0	19.4	28.9	26.0	25.5	38.4	31.5	39.1	30.5	36.5	26.4	11.7	12.8	16.9	15.4	39.3	50.5	15.0	17.7	18.9	18.0	19.5	10.9	10.2	18.3	14.9	21.4	17.5	4.7	10.4	17.4	21.9	23.5	17.7	18.6	9.9	16.3	38.8	21.4	12.3	32.7	19.0	19.2	20.4	27.3	29.3	22.7	19.2	5.1	22.5	19.8	26.2	20.1	28.2	14.5	20.4	19.2	21.5	14.4	20.8	12.0	14.3	13.8	16.7	15.4	16.7	28.7	11.0	21.9	18.3	20.9	12.3	14.4	17.2	7.5	10.8	20.6	16.8	21.4	16.0	28.3	32.1	31.5	30.4	39.1	27.7	25.5	30.2	31.7	38.4	23.6	33.7	33.4	13.0	30.5	31.8	25.9	36.5	26.4	27.8	29.4	16.4	25.4	24.3	22.3	24.7	26.3	23.7	23.8	11.9	22.3	30.6	23.2	14.7	32.1	41.2	20.4	42.8	25.0	36.6	2.0	51.1	86.2	35.5	86.3	45.6	23.9	0.0	31.5	63.6	57.4	21.8	30.1	40.4	58.2	17.5	27.0	35.6	28.2	159.2	74.5	32.0	33.7	43.3	31.3	44.6	30.1	36.6	92.6	79.1	28.3	64.7	60.5	49.3	36.1	13.7	39.0	20.8	32.6	18.0
CAMSAP1	"DKFZp434F195, FLJ31228"	ENSG00000130559	"Calmodulin regulated spectrin associated protein 1"	Q5T5Y3	9	135808487-135907228	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Cone photoreceptor cells: 320.0;Rod photoreceptor cells: 218.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020527, HPA024161"	Approved		Supported	"Mitotic spindle,Cytosol"		Yes	No			"Mitotic spindle, Cytosol"		"HPA020527: , HPA024161: AB_1845967"	"unprognostic (3.18e-3)"	"unprognostic (4.16e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.16e-2)"	"prognostic favorable (3.09e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.66e-3)"	8.0	8.6	12.4	6.5	15.7	10.5	8.3	23.9	21.7	7.6	6.3	14.3	7.2	4.1	9.5	6.9	22.0	9.8	6.5	9.2	11.2	10.8	5.2	4.8	8.2	6.6	10.4	9.9	13.5	9.5	8.9	9.4	6.5	12.2	8.0	4.7	24.2	7.3	8.6	32.7	10.4	4.3	8.6	10.3	6.2	6.2	20.8	9.2	10.0	5.7	14.4	11.4	7.6	10.0	2.4	1.1	3.8	1.6	1.0	2.1	1.2	9.3	13.7	22.7	16.0	5.3	4.6	11.1	7.5	6.3	8.2	6.3	12.0	8.2	4.3	10.9	9.5	10.6	19.1	11.9	8.2	6.3	14.6	6.6	6.2	15.4	6.0	8.1	10.8	9.4	6.2	10.4	10.5	14.5	7.9	9.2	9.6	12.8	9.4	10.7	16.6	10.0	6.7	13.0	11.2	10.0	19.7	18.9	10.5	8.3	11.5	24.8	24.4	9.7	7.1	10.5	7.8	9.9	9.0	11.3	15.7	12.4	11.5	12.8	4.7	8.8	11.8	10.2	7.4	9.0	3.8	1.5	0.3	1.1	1.6	2.1	2.4	1.8	1.7	0.9	0.5	1.3	1.9	0.5	1.0	1.3	1.1	1.4	1.2	12.4	15.7	23.9	21.5	11.2	10.8	10.4	9.9	12.2	9.2	6.0	3.8	6.0	12.6	20.1	32.5	12.2	5.1	16.0	15.9	3.5	320.0	10.0	0.0	10.2	8.6	7.9	3.0	23.3	7.6	3.1	5.4	12.1	5.8	7.3	9.4	15.9	12.1	4.9	9.2	13.6	5.5	8.9	11.8	10.0	3.8	16.5	12.6	3.5	5.6	3.8	218.3	12.9	9.0	16.3	32.4	27.7	4.7	3.2	3.8	24.1
CCDC7	"BIOT2, C10orf68, FLJ13031, FLJ32762"	ENSG00000216937	"Coiled-coil domain containing 7"	Q96M83	10	32446140-32882874	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 65.5"	"Group enriched"	"Detected in many"	8	"Early spermatids: 397.3;Late spermatids: 669.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA075536			Approved	"Nucleoli,Mitotic spindle,Cytosol"		Yes	No			Nucleoli	"Mitotic spindle, Cytosol"	"HPA075536: AB_2686755"	"unprognostic (3.43e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.75e-3)"	"unprognostic (2.65e-5)"	"unprognostic (6.95e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.95e-5)"	"unprognostic (7.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	2.1	2.1	3.2	3.8	3.6	2.8	2.2	4.8	3.6	2.3	2.1	4.2	4.3	2.0	3.4	5.1	2.0	1.7	1.9	2.3	2.6	1.9	1.9	1.7	2.0	2.8	4.2	1.5	2.7	2.3	2.1	8.5	1.8	3.0	2.1	2.3	1.8	2.0	3.2	2.0	2.0	1.8	2.1	5.4	2.0	2.0	65.5	3.2	3.4	2.7	0.3	2.2	2.3	2.3	2.4	1.7	0.1	0.6	2.9	5.9	0.5	2.6	2.9	0.8	3.6	2.5	1.9	1.3	2.3	0.9	0.8	2.5	0.6	3.8	1.9	1.2	1.6	2.3	1.3	1.4	1.4	3.2	6.8	0.3	1.1	2.0	0.7	4.3	1.1	1.9	1.8	0.7	1.7	0.7	1.6	1.0	3.0	1.5	6.7	3.3	0.4	0.8	0.6	0.7	1.4	2.8	1.6	3.7	0.3	2.4	0.6	1.9	1.9	0.4	0.5	1.6	1.1	1.9	1.5	3.9	2.0	2.4	2.6	1.3	2.1	1.4	2.0	2.6	7.5	1.1	0.0	0.6	0.1	3.4	0.3	3.3	2.4	5.3	2.9	0.3	1.2	5.9	3.9	0.1	2.9	0.3	1.7	3.5	0.5	3.2	3.6	4.8	3.6	2.6	1.9	4.2	1.5	3.0	3.2	6.0	7.5	0.8	1.0	1.6	8.6	6.7	0.0	1.4	4.5	1.8	3.9	0.6	1.7	3.1	397.3	2.3	1.4	0.0	3.0	1.0	1.2	0.8	11.6	0.0	1.6	0.0	2.9	0.0	0.0	669.2	8.9	2.3	1.7	1.0	2.0	2.7	2.3	0.0	6.7	0.6	25.0	12.9	1.0	70.9	6.1	1.0	0.1	1.5	1.7	0.6
CDC25B		ENSG00000101224	"Cell division cycle 25B"	P30305	20	3786772-3806121	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 4.5;NK-cells: 9.3;T-cells: 15.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038892, HPA038893, HPA075215"	Enhanced		Uncertain	"Vesicles,Mitotic spindle"		Yes	Yes			Vesicles	"Mitotic spindle"	"HPA038892: AB_2676258, HPA038893: AB_2676259, HPA075215: "	"unprognostic (4.69e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.93e-2)"	"prognostic unfavorable (4.76e-4)"	"unprognostic (1.13e-1)"	"unprognostic (4.23e-1)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (1.31e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.03e-2)"	"prognostic unfavorable (2.94e-13)"	"unprognostic (1.15e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.94e-1)"	"unprognostic (9.46e-2)"	12.1	8.7	15.1	27.7	23.3	26.0	28.8	49.6	21.1	13.0	14.7	12.8	4.6	14.9	17.0	10.3	11.7	13.0	18.6	7.5	15.7	12.5	13.3	11.0	33.0	42.8	21.9	12.5	17.3	5.7	7.5	21.0	30.3	13.8	11.0	12.0	7.7	7.4	10.2	6.2	19.8	16.8	14.8	14.7	24.5	14.1	6.3	22.3	33.3	18.7	20.8	31.6	15.3	16.3	4.5	1.3	1.5	1.8	9.3	15.5	5.9	29.0	62.7	8.4	13.9	10.3	10.1	4.2	14.4	21.6	24.1	18.0	10.9	42.1	20.3	6.2	14.7	59.6	42.5	11.3	23.9	11.4	7.8	12.2	10.9	20.1	13.1	41.2	8.4	5.6	9.9	19.2	22.3	26.4	8.2	13.3	10.2	7.0	53.5	14.2	23.3	26.3	12.3	6.2	19.9	26.8	13.8	23.8	14.5	16.4	2.7	6.0	13.1	34.1	32.6	16.7	7.5	11.0	4.4	11.0	12.9	15.7	23.4	19.0	13.1	20.6	8.2	6.6	8.3	12.4	1.5	1.4	0.0	13.6	1.8	12.7	3.5	13.6	13.7	1.3	4.5	11.4	13.2	0.1	9.3	0.9	0.7	15.5	5.9	15.1	23.3	49.6	21.1	15.7	12.5	21.9	12.5	13.8	22.3	8.9	23.7	9.0	5.5	10.0	13.9	6.8	7.6	0.0	3.4	7.0	2.0	5.3	0.0	7.8	0.5	24.0	3.8	23.3	4.2	14.2	13.6	4.7	1.1	11.6	24.4	3.2	7.5	12.9	11.6	1.0	6.6	10.6	16.9	5.4	7.9	8.3	10.4	2.9	8.5	9.4	2.4	0.0	11.3	1.0	11.5	9.8	3.0	25.4	3.5	3.4
CDC6	CDC18L	ENSG00000094804	"Cell division cycle 6"	Q99741	17	40287633-40304657	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"		"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.0"	"Cell type enhanced"	"Detected in many"	8	"Erythroid cells: 23.3;Extravillous trophoblasts: 27.7;Spermatogonia: 23.0;Syncytiotrophoblasts: 14.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 6.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 6.2;NK-cells: 2.2;T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 86.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA050114, HPA065070"	Approved		Approved	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	Yes			"Nucleoplasm, Cytosol"	"Cytokinetic bridge, Mitotic spindle"	"HPA050114: AB_2681021, HPA065070: AB_2732729"	"unprognostic (1.29e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.97e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (5.96e-8)"	"unprognostic (2.31e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (5.47e-2)"	"unprognostic (3.00e-15)"	"unprognostic (1.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.95e-3)"	"unprognostic (3.88e-2)"	1.8	2.9	3.1	10.8	2.6	16.8	1.5	2.3	6.0	2.7	5.8	0.8	2.7	5.3	1.9	1.6	9.0	1.3	5.4	1.6	1.9	1.4	1.8	5.1	2.8	10.6	1.0	1.5	1.5	3.6	1.1	1.2	9.4	0.8	1.4	5.6	0.2	3.2	4.1	0.9	2.3	7.9	2.4	1.6	7.7	2.7	14.8	1.2	30.0	1.3	5.0	10.1	4.1	3.0	0.7	6.2	0.2	0.3	2.2	3.4	1.2	25.4	17.6	21.3	15.1	1.1	2.3	19.5	27.8	8.3	24.4	29.5	20.0	11.4	20.6	17.4	5.9	14.1	37.1	18.4	12.6	24.3	10.9	14.5	16.7	21.0	17.9	0.7	22.8	10.3	0.6	0.9	28.2	16.9	2.6	7.3	14.2	30.5	19.3	11.8	13.3	33.1	5.5	17.5	15.1	6.5	24.4	51.9	19.4	4.0	28.7	14.6	13.1	25.3	86.7	8.6	17.4	17.6	19.8	6.1	17.6	25.2	28.8	32.9	8.1	17.5	39.7	15.2	15.1	19.2	0.1	0.3	0.0	1.3	0.0	0.9	0.7	1.2	2.1	1.4	0.7	0.9	2.1	0.2	2.2	0.0	6.2	3.4	1.2	3.1	2.6	2.3	6.0	1.9	1.4	1.0	1.5	0.8	1.2	0.0	1.3	2.2	1.1	3.8	0.0	0.6	0.0	0.0	1.2	0.0	0.0	12.0	0.0	1.2	1.4	0.5	1.1	23.3	0.6	27.7	2.4	1.1	0.0	0.9	6.8	0.0	0.0	1.8	1.3	0.2	2.6	1.3	0.0	0.0	1.7	0.3	1.2	2.9	0.7	0.2	0.3	12.9	1.0	11.4	23.0	1.4	14.0	2.5	4.6	2.0
CDC7	"CDC7L1, HsCdc7, Hsk1, huCdc7"	ENSG00000097046	"Cell division cycle 7"	O00311	1	91500893-91525764	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 28.3;Spermatocytes: 28.4;Spermatogonia: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002669, HPA035831"	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	No			Nucleoplasm	"Cytokinetic bridge, Mitotic spindle"	"CAB002669: , HPA035831: AB_2674807"	"unprognostic (6.84e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.64e-2)"	"unprognostic (7.02e-3)"	"unprognostic (5.57e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (3.15e-6)"	"unprognostic (6.52e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.89e-15)"	"unprognostic (9.44e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.39e-2)"	2.5	3.7	5.7	7.6	8.9	15.4	4.3	19.4	10.3	2.5	4.2	1.4	0.9	4.2	2.8	2.6	4.7	1.7	2.6	1.9	6.8	5.2	3.6	2.3	5.1	11.7	4.0	4.7	3.7	2.4	2.2	12.3	7.9	5.2	2.7	6.8	2.3	2.5	2.3	1.0	6.8	4.9	3.3	5.9	15.1	2.6	21.2	4.7	18.7	2.5	4.5	12.0	4.2	3.0	1.6	3.5	0.1	1.6	2.4	6.5	2.1	14.2	4.2	27.6	7.8	0.6	3.7	8.8	5.4	4.3	10.7	11.7	8.9	5.1	9.9	7.6	3.4	9.3	6.2	18.1	6.1	14.8	16.4	15.5	15.0	12.2	4.1	1.0	16.3	5.5	1.9	1.8	9.8	5.6	1.9	4.1	13.9	19.8	14.5	7.3	5.2	14.0	14.6	22.9	7.8	10.1	17.3	22.9	6.3	4.6	10.7	21.9	8.6	17.1	4.7	9.6	7.1	4.4	8.0	3.4	12.1	10.7	9.4	8.1	5.3	6.7	26.5	4.3	15.9	4.4	0.0	1.6	0.0	5.9	1.2	5.2	1.5	4.5	5.6	3.5	1.6	2.5	5.1	0.1	2.4	0.3	2.1	6.5	2.1	5.7	8.9	19.4	10.3	6.8	5.2	4.0	4.7	5.2	4.7	0.0	0.6	2.2	1.1	5.3	7.6	1.3	0.0	1.4	1.2	1.8	0.0	5.3	3.3	1.1	28.3	2.8	0.2	0.0	2.2	5.1	4.6	0.7	4.6	0.0	2.2	3.2	0.0	3.1	1.8	12.9	0.9	1.0	3.3	1.0	1.3	1.3	1.0	1.1	0.7	0.1	4.7	6.5	3.1	28.4	20.6	3.1	1.8	5.1	2.9	0.9
CEP170	"FAM68A, KAB, KIAA0470"	ENSG00000143702	"Centrosomal protein 170"	Q5SW79	1	243124428-243255348	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.7"	"Group enriched"	"Detected in many"	37	"Early spermatids: 1512.0;Late spermatids: 3749.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 51.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042151, HPA045597, HPA045787"	Uncertain		Enhanced	"Mitotic spindle,Centrosome,Cytosol"		Yes	No			Centrosome	"Mitotic spindle, Cytosol"	"HPA042151: AB_2677876, HPA045597: AB_2732522, HPA045787: AB_2679453"	"unprognostic (2.97e-1)"	"unprognostic (2.49e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.83e-5)"	"unprognostic (8.05e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.09e-2)"	"unprognostic (3.52e-2)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (1.30e-9)"	"unprognostic (2.21e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.49e-3)"	"unprognostic (9.62e-3)"	9.5	6.1	13.7	10.8	13.2	36.5	6.8	27.7	23.2	7.4	5.4	11.4	3.1	3.1	9.1	5.2	5.5	6.4	11.1	8.6	12.8	11.2	3.8	6.7	8.4	7.3	19.3	13.7	13.3	2.8	2.8	10.8	9.8	20.2	5.0	4.2	3.3	4.2	5.5	9.3	4.2	4.7	7.4	25.8	7.8	4.2	53.7	18.0	11.6	14.4	3.3	8.9	8.6	6.6	9.4	8.4	12.3	10.1	2.8	4.7	2.1	6.0	5.1	13.2	11.1	8.2	15.9	2.9	16.1	9.6	12.1	11.5	3.2	5.9	4.5	9.9	13.7	4.1	3.0	11.3	6.9	17.3	10.0	6.5	4.7	4.8	2.2	7.1	8.2	8.8	10.0	1.9	38.6	16.9	27.7	28.2	2.7	11.3	4.7	15.3	1.3	5.0	4.4	16.6	1.2	14.5	9.0	9.4	1.5	2.5	1.0	19.1	25.7	8.2	0.7	7.7	10.8	2.8	11.2	31.1	22.6	6.7	12.1	18.5	4.6	5.9	9.0	12.0	7.5	51.9	3.5	8.3	7.6	1.9	10.0	2.7	3.6	3.8	1.6	8.4	9.4	4.7	2.7	12.3	2.8	10.1	5.5	2.9	2.1	13.7	13.2	27.7	15.8	12.8	11.2	19.3	13.7	20.2	18.0	17.9	16.6	13.7	4.2	13.5	41.1	19.0	7.6	25.4	11.4	12.2	5.9	3.1	0.0	18.9	1512.0	31.0	0.7	0.0	6.1	6.7	26.8	3.3	22.0	6.8	31.5	42.9	10.4	18.4	34.9	3749.4	40.9	70.8	21.9	31.5	1.9	11.4	19.1	0.0	33.2	2.1	18.3	25.8	15.7	71.0	23.8	10.0	1.6	7.0	1.6	3.1
CEP95	"CCDC45, DKFZp667E1824"	ENSG00000258890	"Centrosomal protein 95"	Q96GE4	17	64506588-64542461	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 86.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023654, HPA052426, HPA052428, HPA061371"	Approved		Approved	"Nucleoplasm,Vesicles,Mitotic spindle,Centrosome"		Yes	No			Nucleoplasm	"Vesicles, Mitotic spindle, Centrosome"	"HPA023654: AB_2072077, HPA052426: AB_2681827, HPA052428: AB_2681829, HPA061371: AB_2684495"	"unprognostic (1.28e-2)"	"unprognostic (9.12e-2)"	"unprognostic (3.66e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.30e-2)"	"prognostic favorable (5.78e-4)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (6.57e-3)"	"unprognostic (7.88e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-3)"	13.0	8.6	10.9	17.1	13.1	37.9	15.5	27.9	15.6	16.7	14.2	16.2	11.6	11.9	26.5	16.6	10.7	17.1	12.3	10.6	11.5	7.8	14.1	11.7	13.0	20.7	13.6	7.9	27.3	15.5	11.8	20.4	8.5	13.0	15.2	13.5	15.6	13.8	19.8	14.6	21.7	14.2	15.0	17.4	13.2	13.3	16.9	13.9	26.4	21.0	8.6	14.7	14.3	14.0	5.9	3.7	2.2	3.6	2.1	10.8	2.4	9.9	6.3	12.9	11.1	3.4	8.9	13.0	5.1	5.2	6.3	9.6	7.6	5.7	15.9	3.3	7.1	6.3	12.6	11.1	9.7	13.1	4.2	8.5	14.1	12.2	14.6	11.5	15.3	7.6	10.1	10.2	7.0	15.7	8.4	5.3	16.6	16.2	11.6	6.9	11.6	19.4	9.8	8.0	10.2	7.9	14.0	23.5	11.8	7.4	15.9	8.2	14.8	6.9	10.2	13.1	20.2	11.2	10.3	7.9	14.5	11.3	6.6	6.9	11.9	9.5	16.9	6.2	11.8	8.8	2.2	3.6	2.2	4.5	2.9	10.8	4.5	5.2	4.5	3.4	5.9	8.0	5.4	1.4	2.1	3.4	3.7	4.2	2.4	10.9	13.1	27.9	15.6	11.5	7.8	13.6	7.9	13.0	13.9	38.7	22.9	11.5	23.2	14.3	26.0	16.7	12.7	65.6	39.8	3.5	43.2	7.8	6.6	16.8	45.2	9.8	15.1	0.0	10.2	9.0	11.5	13.9	27.8	6.6	7.4	17.5	7.5	12.3	9.5	14.2	19.2	10.4	11.8	15.4	12.4	22.7	11.6	11.5	20.1	5.0	86.8	12.9	15.0	30.7	28.8	17.8	5.5	19.7	17.0	19.0
CKAP2L	"FLJ40629, radmis"	ENSG00000169607	"Cytoskeleton associated protein 2 like"	Q8IYA6	2	112736607-112764677	"Disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.4;lymphoid tissue: 38.3"	"Group enriched"	"Detected in many"	4	"Extravillous trophoblasts: 8.9;Spermatocytes: 31.7;Spermatogonia: 32.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA039407, HPA040057, HPA070737"	Uncertain		Supported	"Mitotic spindle,Cytosol"		Yes	Yes			"Mitotic spindle"	Cytosol	"HPA039407: AB_10794091, HPA040057: AB_10794871, HPA070737: AB_2686303"	"unprognostic (2.29e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-1)"	"unprognostic (5.59e-2)"	"unprognostic (5.75e-5)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.91e-1)"	"unprognostic (9.57e-6)"	"unprognostic (2.42e-1)"	"unprognostic (0.00e+0)"	"unprognostic (7.37e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.49e-2)"	1.5	0.7	0.6	9.2	0.6	13.4	1.3	0.7	0.6	0.6	1.8	0.0	0.3	1.5	0.5	1.4	3.8	0.7	0.1	2.3	0.6	0.5	0.7	0.7	1.2	5.3	0.6	0.2	0.6	0.6	0.0	0.5	3.2	0.2	0.6	2.4	0.0	1.0	0.0	0.6	1.5	2.4	0.9	0.6	2.2	0.9	9.0	0.1	38.3	0.6	5.9	6.0	0.9	0.7	1.0	0.8	1.8	0.7	1.6	1.8	0.4	20.1	4.0	15.9	7.2	0.9	1.5	3.2	16.7	13.9	17.4	16.6	3.8	5.9	13.8	6.9	6.5	21.7	7.8	9.1	8.8	29.3	19.2	4.0	23.0	5.6	3.2	0.0	10.8	13.8	0.4	0.8	21.8	12.4	4.5	7.9	10.1	6.1	20.2	14.1	2.9	13.1	4.1	6.8	8.6	13.2	9.5	16.7	3.6	2.9	7.9	8.8	5.5	6.8	5.6	5.8	6.2	5.5	5.0	5.6	19.3	15.0	15.3	12.2	4.3	8.4	11.8	8.3	7.8	30.2	0.8	0.5	0.7	0.5	0.7	0.4	0.9	1.2	1.1	0.5	1.0	0.5	0.7	1.8	1.6	0.7	0.8	1.8	0.4	0.6	0.6	0.7	0.6	0.6	0.5	0.6	0.2	0.2	0.1	3.0	1.1	0.8	1.6	3.0	0.0	0.4	2.5	0.0	0.0	0.0	0.0	1.0	0.0	0.5	1.5	0.0	0.0	0.0	0.3	8.9	0.4	0.3	0.0	0.0	5.4	0.0	0.0	1.8	2.1	0.8	0.0	1.4	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	31.7	32.2	1.5	0.8	1.5	1.0	0.9
CLTC	"CLTCL2, Hc"	ENSG00000141367	"Clathrin heavy chain"	Q00610	17	59619689-59696956	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Cell cycle, Cell division, Mitosis"		"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB010389, CAB011571, CAB017155, HPA059143"	Approved		Enhanced	"Vesicles,Endosomes,Lysosomes,Mitotic spindle,Cytosol"		Yes	No		51000000	"Vesicles, Endosomes, Lysosomes"	"Mitotic spindle, Cytosol"	"CAB010389: AB_2083184, CAB011571: AB_2083165, CAB017155: , HPA059143: AB_2683924"	"unprognostic (1.56e-1)"	"prognostic unfavorable (7.35e-4)"	"prognostic favorable (7.65e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.23e-3)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.02e-4)"	39.5	45.7	47.4	35.1	57.6	30.7	57.9	59.1	83.6	38.1	45.0	25.1	47.7	27.9	38.7	52.3	32.1	30.9	34.1	39.9	47.1	53.7	48.6	46.0	46.5	60.7	53.9	59.3	29.8	23.3	96.1	30.0	51.5	57.0	38.9	48.9	22.7	28.6	54.4	44.2	30.5	27.7	45.8	47.8	28.0	34.2	29.4	28.8	28.0	43.7	26.6	31.2	37.1	40.6	10.0	24.6	13.9	24.6	12.3	15.6	13.1	47.4	71.8	35.4	35.0	59.8	48.8	40.5	51.0	53.8	45.7	47.8	44.0	29.2	33.0	58.6	72.4	50.6	31.3	52.8	42.4	61.1	35.5	28.4	54.1	45.4	68.2	45.7	37.0	31.3	46.1	26.0	69.5	44.8	36.0	50.5	16.9	53.9	46.8	71.2	84.6	21.9	11.0	30.5	43.4	41.9	19.5	59.3	40.0	51.2	67.3	31.8	37.8	31.6	20.7	30.2	47.8	49.2	23.3	64.5	83.9	50.1	40.0	52.2	36.8	51.7	30.5	61.5	25.1	51.2	10.5	20.9	13.9	12.7	24.6	15.6	10.0	11.7	13.7	24.6	9.1	10.0	11.0	13.4	12.3	20.7	16.1	14.5	13.1	47.4	57.6	59.1	83.6	47.1	53.7	53.9	59.3	57.0	28.8	92.3	94.7	38.0	37.2	56.7	86.7	68.8	86.6	72.3	81.9	73.3	56.9	86.9	23.2	67.8	20.6	66.0	118.0	93.5	84.2	40.6	77.3	84.0	65.9	162.9	151.0	81.0	115.9	156.5	173.7	53.1	68.4	90.2	50.6	62.3	109.9	47.7	89.2	73.7	88.1	105.0	55.3	77.6	61.2	51.7	37.2	69.4	90.3	33.1	108.8	72.3
CRYBB3	CRYB3	ENSG00000100053	"Crystallin beta B3"	P26998	22	25199850-25207363	"Disease related genes, Predicted intracellular proteins"		"Eye lens protein"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	21	"granulocytes: 4.6;Muller glia cells: 3.5;Proximal tubular cells: 9.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.7;HEK 293: 3.7;HeLa: 4.5;hTERT-HME1: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055840	Supported		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA055840: AB_2682939"	"unprognostic (1.36e-2)"	"unprognostic (6.27e-4)"	"unprognostic (6.30e-3)"	"unprognostic (5.34e-2)"	"unprognostic (8.76e-2)"	"unprognostic (3.15e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.15e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.20e-3)"	0.6	1.2	0.6	0.6	0.6	0.0	1.5	0.6	0.6	0.9	1.3	0.6	0.6	0.6	0.6	0.6	1.4	0.8	0.7	0.8	0.6	0.2	4.5	4.7	0.6	0.6	0.6	0.6	0.6	0.6	0.0	0.7	0.6	0.6	1.8	0.9	4.1	2.4	0.8	1.4	1.9	1.5	0.6	0.6	0.6	1.1	0.6	0.6	0.6	3.1	0.6	0.6	0.6	1.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.7	0.6	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.2	0.4	0.0	1.0	0.0	0.5	3.7	2.3	1.6	0.0	0.0	3.7	0.0	4.5	2.6	0.2	0.0	0.2	0.0	1.9	1.1	3.2	0.7	0.7	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.4	2.8	0.1	0.2	0.1	0.3	0.5	0.6	0.4	0.4	0.5	0.0	0.9	0.2	0.0	0.5	0.0	1.8	1.5	0.3	0.0	0.7	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	0.6	0.6	0.2	0.6	0.6	0.6	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.2	1.1	0.0	0.2	0.0	0.0	0.2	4.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	9.8	0.3	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1
CXCR2	"CD182, CMKAR2, IL8RB"	ENSG00000180871	"C-X-C motif chemokine receptor 2"	P25025	2	218125289-218137253	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"blood: 216.1"	"Cell type enhanced"	"Detected in some"	21	"Alveolar cells type 2: 17.5;Club cells: 3.4;granulocytes: 5.8;Kupffer cells: 5.0;Macrophages: 4.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	59	"neutrophil: 216.1"	"Lineage enriched"	"Detected in many"	109	"granulocytes: 216.1"	"Group enriched"	"Detected in some"	11	"BEWO: 12.4;HL-60: 6.9;HMC-1: 14.4;THP-1: 13.1;U-937: 12.9"	"Low region specificity"	"Detected in single"							"CAB016268, HPA031999, HPA032017"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle"		NA	NA			"Plasma membrane"	"Nucleoplasm, Microtubules, Mitotic spindle"	"CAB016268: AB_626893, HPA031999: AB_2674105, HPA032017: AB_2674112"	"unprognostic (4.89e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.23e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.48e-2)"	9.3	0.9	1.3	25.6	1.5	4.0	0.6	1.2	1.3	5.2	0.6	0.5	2.5	0.0	0.8	1.1	18.1	3.3	5.2	4.3	1.5	0.6	0.7	4.6	16.7	40.5	6.6	0.0	1.2	1.7	0.0	0.7	4.5	1.7	1.9	0.3	1.8	3.3	2.6	0.6	3.0	0.7	1.4	4.1	30.6	1.0	1.1	0.7	0.6	0.6	4.8	10.1	5.4	6.4	0.0	1.6	216.1	1.9	0.4	1.9	1.0	0.0	0.0	0.1	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.9	14.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	1.1	0.2	0.0	0.0	0.3	0.0	1.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.5	0.0	13.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	12.9	0.0	3.6	1.9	3.2	1.9	0.5	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.7	216.1	0.4	0.2	1.6	0.0	1.0	1.3	1.5	1.2	1.3	1.5	0.6	6.6	0.0	1.7	0.7	0.0	17.5	0.0	0.9	0.0	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.2	5.8	0.0	1.6	0.0	0.0	0.0	5.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.0	0.0	1.8
DCDC2	"DCDC2A, DFNB66, KIAA1154, NPHP19, RU2"	ENSG00000146038	"Doublecortin domain containing 2"	Q9UHG0	6	24171756-24358052	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Neurogenesis"		"Ciliopathy, Deafness, Disease mutation, Nephronophthisis, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 37.0;kidney: 46.4;pancreas: 22.7"	"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 61.1;Ciliated cells: 60.2;Collecting duct cells: 75.0;Distal tubular cells: 48.0;Ductal cells: 106.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 20.2;EFO-21: 14.1;Hep G2: 22.9;RPTEC TERT1: 74.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA031582, HPA031583, HPA031584"	Enhanced		Enhanced	"Microtubules,Mitotic spindle,Centriolar satellite,Cytosol"		NA	NA			"Mitotic spindle, Cytosol"	"Microtubules, Centriolar satellite"	"HPA031582: AB_10600901, HPA031583: AB_2673944, HPA031584: AB_2673945"	"unprognostic (8.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.99e-2)"	0.1	0.9	1.1	0.2	1.5	0.0	3.5	0.3	0.9	1.6	0.3	0.2	1.0	0.3	3.4	37.0	0.2	5.8	7.7	0.2	1.3	1.7	46.4	1.8	3.9	0.0	0.6	0.5	2.1	22.7	7.6	4.3	1.7	1.8	1.5	0.3	2.8	0.9	3.7	0.5	0.2	0.2	0.4	0.5	0.1	1.1	3.7	0.2	0.2	8.4	0.0	0.2	1.0	0.1	1.2	0.5	1.3	0.4	1.0	0.5	0.2	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	22.9	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.4	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.2	0.0	1.5	0.1	0.0	0.4	0.0	0.0	3.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.2	0.4	0.3	0.5	0.2	0.2	0.5	0.5	0.3	0.3	1.2	0.4	0.4	1.3	1.0	0.2	0.5	0.2	0.2	1.1	1.5	0.3	0.9	1.3	1.7	0.6	0.5	1.8	0.2	17.9	11.8	0.0	0.6	0.1	0.0	0.3	61.1	60.2	10.3	75.0	0.0	0.3	48.0	106.8	23.9	0.0	0.0	0.0	7.2	0.0	0.3	1.1	0.0	1.0	0.5	0.0	3.5	0.0	0.0	11.0	0.3	0.0	0.0	3.6	3.4	1.9	20.8	2.9	0.4	39.0	0.0	0.0	0.3	7.7	2.2	0.1	0.1	0.0	1.2	0.5
DCTN1		ENSG00000204843	"Dynactin subunit 1"	Q14203	2	74361154-74392087	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"		"Amyotrophic lateral sclerosis, Cancer-related genes, Neurodegeneration, Neuropathy, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009108, HPA034635, HPA071875"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	No		220000	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB009108: AB_2090601, HPA034635: AB_2674256, HPA071875: "	"unprognostic (1.14e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.33e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.11e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (2.34e-7)"	"unprognostic (5.41e-2)"	"unprognostic (3.11e-1)"	"unprognostic (7.86e-3)"	"unprognostic (1.12e-3)"	20.7	21.1	36.0	13.7	54.6	11.1	14.0	45.9	70.9	23.5	17.1	37.8	8.9	11.8	18.5	9.8	22.9	19.7	15.1	37.7	39.5	35.8	13.5	10.0	18.9	10.9	37.7	40.3	21.9	15.2	70.2	21.6	17.2	54.6	16.5	14.0	13.2	23.5	21.7	39.5	19.9	13.7	26.5	32.2	12.4	16.0	25.5	26.7	9.4	17.0	9.5	12.8	17.2	18.0	11.6	12.1	12.9	15.8	9.8	16.7	15.5	19.1	22.5	21.1	22.0	38.8	29.0	17.1	30.9	32.3	39.5	28.2	29.9	14.8	26.4	12.7	64.2	21.8	19.2	25.8	39.3	30.2	32.9	26.0	27.4	18.1	25.1	30.0	14.9	34.0	34.7	19.2	42.9	25.6	27.1	33.7	24.2	11.8	18.9	29.7	16.4	27.1	15.5	22.8	23.5	24.0	24.4	37.2	18.9	21.9	11.9	26.1	23.1	17.3	20.8	18.6	19.2	13.4	10.9	25.5	36.0	26.1	15.4	23.0	11.7	9.3	24.0	33.7	24.4	25.2	7.3	11.4	12.9	16.7	14.2	13.5	11.6	9.5	12.4	12.1	8.6	6.8	7.5	9.8	9.8	15.8	9.6	8.1	15.5	36.0	54.6	45.9	70.9	39.5	35.8	37.7	40.3	54.6	26.7	29.8	20.1	9.7	8.2	9.0	26.0	50.1	12.7	12.0	15.9	27.9	23.6	24.7	16.6	19.4	5.8	25.5	38.3	23.3	17.1	23.3	20.8	9.2	28.8	17.0	24.6	85.8	16.0	25.8	15.9	3.9	41.4	16.7	15.1	27.9	26.4	15.6	21.6	24.6	48.8	16.1	43.6	19.4	27.1	28.4	35.7	10.3	21.1	13.8	20.7	9.5
DHRSX	"DHRS5X, DHRS5Y, DHRSXY, DHRSY, SDR46C1, SDR7C6"	ENSG00000169084	"Dehydrogenase/reductase X-linked"	Q8N5I4	X	2219516-2502805	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 89.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA003035, HPA075955"	Approved		Uncertain	"Mitotic spindle,Cytosol"	"Secreted to blood"	NA	NA			Cytosol	"Mitotic spindle"	"HPA003035: AB_1080631, HPA075955: "	"unprognostic (7.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.95e-2)"	"unprognostic (4.65e-3)"	"unprognostic (8.87e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.59e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.69e-2)"	7.3	9.5	21.5	3.1	26.7	2.9	55.7	21.5	25.3	32.1	7.3	1.2	1.2	4.6	25.1	6.4	3.2	7.5	6.7	37.8	23.7	3.4	34.6	18.9	5.8	3.2	21.8	16.9	25.0	15.2	5.5	24.2	32.7	28.3	7.7	6.5	1.2	10.8	5.7	6.3	4.9	6.5	5.3	26.5	5.9	8.6	3.4	23.6	1.2	8.1	1.2	2.7	6.1	27.4	12.2	18.3	30.0	21.1	8.7	9.1	10.0	4.5	20.9	14.1	6.5	17.6	11.1	10.6	10.4	17.7	8.0	10.8	15.6	9.9	7.3	13.4	12.3	18.7	2.2	9.7	8.4	5.7	13.4	15.1	7.0	11.0	11.6	20.3	3.8	5.7	13.6	10.4	6.9	6.9	13.6	6.3	8.1	7.7	3.6	12.8	5.2	13.9	5.3	3.4	6.1	5.8	5.4	7.4	2.0	8.6	11.2	13.4	13.4	9.9	11.8	7.7	9.0	5.1	6.0	8.5	8.8	2.1	4.9	6.1	4.2	0.0	18.8	5.8	5.0	3.9	6.5	21.1	17.1	8.4	15.7	8.9	12.2	7.6	7.0	18.3	10.6	7.2	6.0	30.0	8.7	9.5	14.8	9.1	10.0	21.5	26.7	21.5	25.3	23.7	3.4	21.8	16.9	28.3	23.6	17.9	9.4	13.4	20.7	9.4	8.8	20.9	25.5	6.7	5.7	24.4	9.8	36.6	11.6	44.5	0.4	12.8	31.3	0.0	70.9	36.4	20.8	43.3	18.4	46.5	34.3	3.2	18.5	11.6	15.9	1.8	22.5	27.2	11.8	47.7	19.0	8.0	61.5	28.1	23.7	35.4	5.9	19.4	14.4	9.7	17.2	5.6	89.7	13.4	22.6	17.1
EPB41	"4.1R, EL1"	ENSG00000159023	"Erythrocyte membrane protein band 4.1"	P11171	1	28887091-29120046	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"	"Actin-binding, Calmodulin-binding"	"Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 59.7"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 129.6;Erythroid cells: 116.8;Rod photoreceptor cells: 166.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 59.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 39.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	11	"cerebellum: 375.3"	"HPA028076, HPA028096, HPA028412, HPA028414"	Supported		Supported	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	No		3400000	"Plasma membrane, Cell Junctions"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA028076: AB_2672476, HPA028096: , HPA028412: AB_2672592, HPA028414: AB_10601366"	"unprognostic (2.16e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (5.00e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (5.01e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	9.2	9.6	3.3	19.4	10.2	28.0	9.6	59.7	11.6	8.2	12.4	2.0	9.8	9.3	10.5	5.7	10.8	5.5	7.9	7.5	3.3	4.8	10.0	13.2	11.0	25.4	3.9	3.0	12.3	10.4	9.1	9.0	8.7	10.3	8.3	12.5	14.6	10.1	10.8	15.0	8.9	14.6	9.2	5.8	13.5	14.0	7.9	6.9	42.2	8.1	8.8	19.8	11.3	12.4	9.9	3.0	30.1	2.1	5.7	15.9	7.7	7.4	1.8	18.6	8.8	1.5	0.2	6.2	1.9	2.8	2.3	2.9	4.9	9.0	13.8	5.0	2.5	3.8	3.4	23.2	1.8	2.5	24.8	7.1	39.5	5.6	8.0	2.9	13.4	26.4	0.5	5.4	2.2	4.0	5.7	4.1	22.1	37.2	11.0	0.0	2.5	21.7	8.8	19.5	12.3	2.9	33.4	8.2	19.8	2.2	9.5	25.1	18.6	5.8	5.5	12.6	6.6	4.2	5.2	0.4	0.1	3.9	3.6	3.8	16.5	21.4	24.7	3.5	13.8	2.1	17.2	2.1	12.6	8.5	0.7	9.6	9.9	12.4	9.3	2.4	9.3	14.8	8.9	30.1	5.7	0.8	3.0	15.9	7.7	3.3	10.2	59.7	11.6	3.3	4.8	3.9	3.0	10.3	6.9	17.9	64.9	30.6	6.3	9.3	105.3	20.1	30.6	22.7	21.6	15.7	129.6	2.3	14.9	15.8	13.9	14.5	25.2	116.8	16.1	3.2	3.3	11.2	23.1	28.8	6.5	20.6	40.0	20.3	22.1	13.3	2.0	11.5	0.0	11.8	25.9	13.2	25.6	22.4	2.1	10.5	166.4	12.9	4.7	8.6	53.0	14.6	3.4	42.8	28.3	11.5
FAM83D	"C20orf129, CHICA, dJ616B8.3"	ENSG00000101447	"Family with sequence similarity 83 member D"	Q9H4H8	20	38926312-38953106	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 39.0;smooth muscle: 69.8"	"Cell type enhanced"	"Detected in many"	22	"Erythroid cells: 23.3;Extravillous trophoblasts: 36.2;Syncytiotrophoblasts: 127.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 1.6;NK-cells: 2.4;T-cells: 4.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA049333, HPA060854"			Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	Yes			"Mitotic spindle"	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA049333: AB_2680717, HPA060854: "	"unprognostic (7.90e-3)"	"unprognostic (4.34e-2)"	"unprognostic (6.41e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (5.44e-6)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.73e-5)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.81e-14)"	"unprognostic (2.57e-3)"	"unprognostic (5.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.87e-2)"	0.5	0.5	0.5	4.9	0.8	7.9	0.7	0.4	1.2	1.7	29.6	0.4	0.7	3.4	0.8	1.5	39.0	0.2	5.6	1.5	0.5	0.1	2.2	1.4	2.6	1.5	0.3	0.5	0.7	0.2	0.0	0.3	2.2	0.7	7.6	3.6	1.2	3.1	1.0	0.4	4.1	16.2	69.8	0.4	1.0	22.8	3.8	0.2	9.2	0.5	8.6	17.9	24.5	6.4	1.6	0.1	0.0	0.4	2.4	4.6	1.2	31.5	19.5	15.4	12.9	1.7	2.0	27.7	14.2	8.9	28.2	17.3	29.8	14.5	8.0	14.1	9.3	21.9	27.2	21.1	24.4	26.5	2.6	8.3	9.3	15.0	21.4	1.4	4.1	4.9	1.0	1.2	16.2	9.4	3.4	15.4	3.6	8.2	11.6	16.0	17.0	6.3	6.0	12.8	18.4	24.9	6.1	28.5	4.4	8.1	8.1	7.1	11.9	41.5	34.7	6.1	15.0	21.7	4.2	7.3	18.7	23.0	21.2	31.3	3.5	5.4	8.3	8.4	6.1	13.7	0.0	0.0	0.0	0.7	0.4	2.3	1.6	2.4	2.7	0.1	1.6	2.7	3.4	0.0	2.4	0.1	0.0	4.6	1.2	0.5	0.8	0.4	1.2	0.5	0.1	0.3	0.5	0.7	0.2	0.0	2.2	0.0	5.2	2.1	0.0	0.8	0.0	1.4	1.2	0.0	0.0	2.6	0.0	0.0	0.4	0.5	2.6	23.3	0.0	36.2	0.9	0.7	0.0	5.4	4.0	0.0	1.7	1.8	2.1	0.6	0.3	0.4	0.0	0.0	2.2	0.0	0.1	3.7	0.0	4.3	0.0	19.4	2.1	11.1	14.5	1.6	127.6	2.2	2.5	4.3
FKBPL	"DIR1, NG7, WISp39"	ENSG00000204315	"FK506 binding protein like"	Q9UIM3	6	32128707-32130291	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA043478, HPA060158"	Approved		Approved	"Nucleoplasm,Mitotic spindle"		Yes	No			Nucleoplasm	"Mitotic spindle"	"HPA043478: AB_2678500, HPA060158: AB_2684213"	"unprognostic (1.80e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.67e-2)"	"unprognostic (8.22e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (8.46e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.96e-2)"	"unprognostic (5.79e-2)"	"unprognostic (7.32e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.13e-1)"	3.6	5.6	4.1	2.7	4.7	4.6	7.1	12.1	6.2	4.4	4.5	3.9	8.9	6.0	4.1	8.7	12.7	7.0	4.5	6.0	4.1	3.5	5.9	6.7	4.5	7.7	7.1	2.4	7.0	13.2	6.2	5.0	6.9	5.8	3.8	4.9	3.7	8.0	3.6	5.1	11.5	4.4	5.1	3.6	7.8	6.6	7.6	6.8	10.5	11.6	2.8	6.8	4.7	6.3	3.4	3.7	8.3	4.8	3.3	4.6	1.5	0.0	2.0	4.4	11.9	6.6	4.7	3.8	2.9	3.3	5.5	5.3	9.5	4.0	3.3	3.4	5.1	7.4	2.2	6.2	5.7	3.8	5.9	7.6	0.0	6.6	5.3	3.7	0.0	3.6	4.6	5.8	10.7	6.7	4.1	5.8	8.7	11.1	8.3	5.6	3.2	3.6	4.1	3.3	8.6	1.7	3.0	5.8	7.3	5.7	0.7	8.5	2.0	2.9	5.3	6.4	2.3	9.2	6.4	2.5	8.0	6.6	4.1	7.0	4.4	7.7	3.0	3.1	5.4	4.9	4.9	3.4	2.3	4.6	4.8	4.4	2.8	2.6	3.3	3.7	3.4	3.0	2.9	8.3	3.3	2.5	2.9	1.1	1.5	4.1	4.7	12.1	6.2	4.1	3.5	7.1	2.4	5.8	6.8	6.0	5.1	4.7	3.2	10.0	2.9	2.0	5.1	0.0	4.5	1.8	0.0	8.3	5.0	6.7	2.2	4.5	8.1	0.0	5.9	10.6	7.4	3.3	2.3	2.8	4.5	9.5	5.8	3.7	3.2	4.0	2.6	4.4	6.8	4.6	4.9	6.4	5.4	3.7	3.2	7.7	4.0	0.0	6.2	8.9	8.3	8.9	11.8	6.5	5.0	4.1
GPRIN2	"KIAA0514, MGC15171"	ENSG00000204175	"G protein regulated inducer of neurite outgrowth 2"	O60269	10	46549044-46555530	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 8.9;lung: 10.5;skin 1: 13.8"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 17.9;Exocrine glandular cells: 18.0;Mucus-secreting cells: 22.0"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 9.8;A549: 28.4;SiHa: 5.3;SK-BR-3: 15.7"	"Low region specificity"	"Detected in many"							"HPA038129, HPA070760"	Approved		Approved	"Plasma membrane,Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			"Plasma membrane, Microtubules"	"Cytokinetic bridge, Mitotic spindle"	"HPA038129: AB_2675846, HPA070760: "	"unprognostic (1.00e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (8.60e-8)"	"unprognostic (5.77e-2)"	"prognostic favorable (3.47e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.67e-3)"	0.0	0.0	0.0	0.6	0.2	0.0	1.1	6.5	0.0	0.2	5.7			6.6	0.0	0.0	2.8	0.1	0.0	0.0	0.0	5.2	1.7	0.0	10.5	0.0	1.2		0.0	4.1	0.0	3.0	0.0		1.6	4.0		4.2	1.5	0.0	13.8	8.9	0.0	0.2	0.0	5.1	1.3			2.3		0.3	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	28.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.3	0.0	1.0	1.1	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.2	0.0	0.0	0.0	0.0	1.5	0.4	0.7	0.1	5.3	15.7	0.0	1.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											17.9	3.0	0.0	2.4	1.4	0.4	0.1	5.1	2.7	1.2	3.5	0.0	0.0	0.0	11.6	7.9	0.0	12.8	0.0	18.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	6.3	0.0	0.0	12.9	0.3	0.0	0.0	0.0	22.0	0.0	9.1	10.5	0.4	2.4	0.0	0.0	0.0	0.5	0.4	5.4	0.0	0.0	6.3	1.1
HAUS3	"C4orf15, dgt3, IT1, MGC4701"	ENSG00000214367	"HAUS augmin like complex subunit 3"	Q68CZ6	4	2227464-2242164	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040649, HPA048190"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle,Mitochondria"		Yes	No			"Microtubules, Mitochondria"	"Cytokinetic bridge, Mitotic spindle"	"HPA040649: AB_2677060, HPA048190: AB_2680308"	"unprognostic (4.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.30e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.57e-3)"	"unprognostic (7.63e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.79e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.40e-2)"	"prognostic favorable (4.78e-5)"	11.7	10.8	15.5	10.9	14.7	44.4	11.5	26.3	14.3	8.6	9.5	10.0	8.6	9.6	11.0	9.1	10.3	8.8	6.9	6.3	11.8	5.9	7.8	8.8	11.1	15.0	11.7	11.0	10.8	13.6	7.3	18.9	10.3	10.5	10.7	8.8	6.0	10.8	8.5	9.0	10.4	11.2	9.6	14.5	15.2	10.5	12.5	13.7	20.7	9.8	4.3	13.0	9.3	9.6	11.0	8.6	14.9	7.8	12.2	15.6	7.6	9.8	5.0	14.5	14.2	6.9	9.6	14.2	15.7	6.9	14.3	13.2	8.7	12.7	18.5	6.7	6.0	17.8	9.1	11.6	7.9	18.3	7.0	7.7	11.0	11.7	7.1	5.5	11.5	12.5	5.5	10.6	12.9	6.5	7.5	11.6	8.8	21.0	22.4	14.4	5.1	16.7	20.0	12.3	9.0	12.0	13.3	12.9	11.1	7.2	7.0	17.9	9.9	9.7	7.1	9.0	12.3	15.4	7.6	8.1	17.8	9.6	10.8	16.6	11.3	11.3	17.2	9.5	17.3	13.4	10.1	5.5	14.9	10.9	7.4	14.4	7.7	11.5	12.2	5.0	11.0	13.4	12.1	6.4	12.2	7.8	8.6	15.6	7.6	15.5	14.7	26.3	14.3	11.8	5.9	11.7	11.0	10.5	13.7	3.0	4.5	4.2	4.8	11.2	11.1	4.6	10.2	4.0	12.5	3.5	11.8	6.4	1.7	6.3	9.9	6.7	3.0	0.0	4.9	9.5	7.8	4.5	12.7	3.0	6.2	23.8	6.9	6.2	4.1	4.9	9.2	8.7	11.8	8.2	5.3	6.9	4.4	0.0	8.1	2.6	11.6	0.0	6.7	20.1	15.1	6.8	4.2	20.2	5.2	2.6
HEPACAM2	FLJ38683	ENSG00000188175	"HEPACAM family member 2"	A8MVW5	7	93188586-93226524	"Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 43.4;kidney: 24.5;pituitary gland: 16.1"	"Group enriched"	"Detected in some"	23	"Intestinal endocrine cells: 209.3;Mucus-secreting cells: 364.1;Paneth cells: 298.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	37	"SCLC-21H: 63.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA012381			Supported	"Nucleoplasm,Vesicles,Mitotic spindle"		Yes	NA		89000	"Vesicles, Mitotic spindle"	Nucleoplasm	"HPA012381: AB_1853037"	"unprognostic (2.01e-3)"	"unprognostic (6.05e-2)"	"prognostic favorable (9.73e-5)"	"unprognostic (1.33e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.48e-2)"	"unprognostic (8.40e-3)"	"unprognostic (7.61e-2)"	"unprognostic (8.68e-2)"	"unprognostic (5.37e-3)"	"unprognostic (4.93e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.34e-2)"	0.1	0.2	0.2	8.5	0.2	0.6	3.4	0.1	0.1	0.1	29.4	0.1	5.3	11.8	0.1	0.4	0.2	0.1	0.8	0.3	0.2	0.2	24.5	0.2	0.4	0.1	0.2	0.1	0.1	5.5	0.0	16.1	0.4	0.2	0.7	38.9	0.1	4.1	1.2	0.1	0.1	43.4	0.4	0.2	0.2	4.0	1.4	0.1	0.3	0.1	0.1	2.1	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.1	0.1	0.2	0.2	0.2	0.1	0.2	0.1	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	8.3	0.0	2.1	0.0	6.7	0.0	0.0	0.0	0.0	1.2	4.6	0.0	0.0	0.0	209.3	0.0	0.0	1.9	0.0	0.0	6.8	0.0	364.1	0.0	0.0	298.7	0.0	0.0	0.0	0.0	0.0	4.5	0.7	0.1	0.1	0.0	12.4	0.0
HIGD1B	"CLST11240, CLST11240-15"	ENSG00000131097	"HIG1 hypoxia inducible domain family member 1B"	Q9P298	17	44846353-44850480	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"placenta: 61.8"	"Group enriched"	"Detected in some"	32	"Sertoli cells: 750.3;Smooth muscle cells: 198.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA079501			Uncertain	"Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			"Microtubules, Cytokinetic bridge, Mitotic spindle"		"HPA079501: "	"unprognostic (6.85e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.80e-3)"	"unprognostic (2.07e-1)"	"unprognostic (8.46e-2)"	"unprognostic (2.37e-2)"	"unprognostic (4.98e-3)"	"unprognostic (3.61e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.98e-1)"	"unprognostic (6.19e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.23e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.52e-2)"	6.4	0.7	12.4	0.7	18.2	0.6	3.2	4.5	9.7	5.7	1.9	3.6	0.4	1.5	6.4	7.6	2.5	3.1	7.1	11.0	12.4	10.1	2.6	0.6	21.6	1.7	15.8	6.8	2.0	2.0	2.5	0.3	61.8	8.7	3.6	1.0	0.7	1.3	4.4	7.9	1.3	1.3	7.3	6.2	0.4	1.5	1.2	8.9	0.1	3.4	1.8	1.1	3.0	1.6	1.1	3.3	4.6	2.9	1.9	3.5	1.1	0.5	1.8	0.0	2.0	0.0	0.0	1.8	1.7	0.0	0.0	0.0	1.0	0.6	1.7	0.5	0.0	0.1	0.7	0.0	0.0	0.0	1.4	2.0	0.4	2.1	1.3	0.0	2.6	3.7	0.0	0.0	0.0	0.0	0.6	0.0	2.6	2.1	1.5	0.0	0.7	1.9	2.0	1.3	0.7	1.0	2.2	1.2	2.5	0.0	1.3	2.2	1.0	0.6	0.0	0.3	0.1	0.9	1.1	0.0	1.8	0.6	1.2	1.4	1.3	3.9	2.0	1.6	3.1	2.2	4.6	1.9	0.7	3.5	2.9	1.3	0.7	2.3	2.6	3.3	1.1	2.5	2.3	0.0	1.9	0.3	0.9	2.0	1.1	12.4	18.2	4.5	9.7	12.4	10.1	15.8	6.8	8.7	8.9	0.0	0.3	0.0	0.5	3.1	0.4	3.9	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.1	14.7	0.0	0.0	0.0	0.2	2.0	0.3	0.0	0.0	0.6	1.6	0.0	1.3	0.0	0.0	0.3	0.6	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	1.5	750.3	198.1	0.0	0.2	2.0	0.2	0.0	0.0	0.7
HNF4G	NR2A2	ENSG00000164749	"Hepatocyte nuclear factor 4 gamma"	Q14541	8	75407914-75566843	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 139.6"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 53.6;Mucus-secreting cells: 31.7;Paneth cells: 41.9;Undifferentiated cells: 25.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"gdT-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"A549: 4.5;CAPAN-2: 16.8;Karpas-707: 4.7;OE19: 10.3;PC-3: 5.1;THP-1: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005438, HPA010610"	Enhanced		Enhanced	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		NA	NA			Nucleoplasm	"Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA005438: AB_1850822, HPA010610: AB_2668318"	"unprognostic (2.09e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.44e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.47e-2)"	0.2	0.2	0.5	5.0	0.5	0.0	0.3	0.3	0.3	0.6	56.2	0.1	0.3	35.9	0.4	1.1	0.4	0.3	12.6	0.2	0.3	0.3	6.1	12.1	0.4	0.0	0.4	0.2	0.2	10.9	0.0	0.2	0.0	0.3	0.6	6.9	0.2	0.4	0.6	0.2	0.2	139.6	0.2	0.3	0.2	2.6	0.9	0.1	0.1	0.2	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.1	4.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.3	16.8	0.0	2.4	0.0	2.0	0.0	2.1	0.0	0.0	0.0	1.9	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.3	0.3	10.3	5.1	0.0	0.0	0.3	2.9	0.1	0.3	1.7	0.3	0.1	0.0	0.2	0.3	5.6	0.0	0.3	0.1	0.1	0.0	1.2	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.3	0.3	0.3	0.4	0.2	0.3	0.1	0.0	0.6	0.5	0.6	0.0	0.0	0.2	17.8	9.4	1.2	3.5	0.0	0.0	5.0	2.2	1.7	0.0	53.6	0.0	3.7	0.0	0.0	1.1	0.0	9.0	0.0	0.0	15.6	0.0	0.0	4.5	0.0	0.0	0.0	0.0	31.7	0.0	5.6	41.9	0.0	13.6	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	25.9	2.8
IL17RB	"CRL4, EVI27, IL17BR, IL17RH1"	ENSG00000056736	"Interleukin 17 receptor B"	Q9NRM6	3	53846580-53865800	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 63.0;liver: 26.6"	"Group enriched"	"Detected in many"	4	"Intestinal endocrine cells: 28.0;Proximal tubular cells: 57.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 11.1;Hep G2: 32.2;OE19: 25.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002837, HPA005482"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitotic spindle,Centriolar satellite"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Plasma membrane"	"Mitotic spindle, Centriolar satellite"	"HPA002837: , HPA005482: AB_1234567"	"unprognostic (1.85e-3)"	"unprognostic (4.22e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.62e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.41e-2)"	"unprognostic (4.75e-2)"	"unprognostic (4.27e-2)"	"prognostic favorable (6.61e-4)"	"unprognostic (8.10e-2)"	"unprognostic (6.97e-2)"	"unprognostic (5.29e-1)"	"unprognostic (7.15e-3)"	1.1	2.1	13.4	2.2	12.2	0.9	9.2	15.1	14.7	17.1	5.8	6.8	0.0	5.1	5.0	1.3	1.9	3.2	2.4	2.5	17.1	7.4	63.0	26.6	3.5	2.3	11.9	6.4	1.8	5.3	1.4	3.9	1.2	11.2	2.5	6.1	1.9	4.1	1.0	1.4	2.3	5.1	1.2	11.3	1.4	3.4	2.5	15.2	0.0	2.9	0.0	1.0	1.7	1.0	0.9	1.1	4.1	0.6	0.5	3.1	0.5	0.8	1.7	2.5	1.9	0.0	0.0	4.0	1.7	0.0	0.0	0.0	11.1	0.8	2.5	0.6	0.5	0.9	0.4	6.8	0.0	0.0	0.9	1.9	3.3	3.4	32.2	0.0	3.0	1.8	0.0	0.0	0.0	0.0	2.2	0.0	0.9	2.6	1.2	0.0	2.2	0.5	1.2	6.8	25.2	1.4	0.9	1.0	2.9	0.7	2.9	3.6	2.1	5.6	1.3	1.0	1.9	5.2	1.1	1.3	1.7	1.9	1.5	2.1	2.6	2.9	1.6	1.5	1.8	0.9	4.1	0.6	0.2	1.0	0.6	0.6	0.5	2.1	0.6	0.2	0.9	0.8	0.9	0.3	0.5	0.2	1.1	3.1	0.5	13.4	12.2	15.1	14.7	17.1	7.4	11.9	6.4	11.2	15.2	0.0	2.6	0.0	2.0	0.2	0.0	3.4	10.2	0.0	2.3	0.0	0.0	0.3	8.3	3.7	0.8	0.0	1.3	0.0	1.3	0.9	0.2	6.7	2.3	8.9	0.1	0.0	28.0	0.6	0.0	0.0	1.1	0.8	0.0	0.0	4.3	4.5	2.7	2.0	0.4	57.9	0.0	0.0	0.6	0.4	1.3	0.1	0.3	0.0	6.6	0.5
IQCB1	"KIAA0036, NPHP5, SLSN5"	ENSG00000173226	"IQ motif containing B1"	Q15051	3	121769763-121835079	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Calmodulin-binding	"Ciliopathy, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 111.8;Spermatogonia: 63.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 48.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042028	Approved	Approved	Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			"Microtubules, Cytokinetic bridge, Mitotic spindle"		"HPA042028: AB_2677806"	"unprognostic (3.82e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (2.16e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (3.08e-5)"	"prognostic favorable (3.67e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.50e-3)"	"unprognostic (2.59e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.75e-3)"	11.5	10.8	9.9	25.1	12.6	16.6	21.9	14.7	16.8	14.4	11.8	8.8	16.9	11.0	14.7	19.4	13.1	15.9	11.5	10.4	10.1	10.1	10.6	9.0	15.0	20.6	12.5	14.5	19.8	22.7	13.9	20.7	12.1	12.4	16.2	15.6	10.9	14.4	30.2	11.4	14.2	14.0	14.6	11.4	19.3	11.2	40.1	12.5	16.2	11.4	9.5	23.0	16.7	14.1	18.9	7.6	8.9	10.4	8.6	10.0	4.9	14.0	3.8	18.8	21.1	3.0	4.6	22.1	6.7	4.1	7.6	9.2	12.9	6.8	28.4	9.4	3.8	11.7	10.8	11.5	5.4	11.4	5.5	9.3	18.8	7.5	10.6	7.8	23.3	5.7	2.9	10.4	5.2	11.7	3.9	5.7	12.2	11.2	10.6	8.4	7.1	15.2	16.5	15.8	8.4	6.9	15.1	8.9	9.0	4.4	6.3	10.0	8.1	6.5	4.6	11.6	6.4	4.1	18.3	4.8	7.2	8.7	3.5	8.7	25.7	16.3	48.3	6.9	10.7	6.5	2.5	5.2	8.9	6.3	9.9	9.0	18.9	8.3	7.6	7.6	17.5	10.0	6.3	2.1	8.6	10.4	7.2	8.7	4.9	9.9	12.6	14.7	16.8	10.1	10.1	12.5	14.5	12.4	12.5	6.0	15.9	17.1	15.3	16.8	14.7	7.7	15.3	62.9	27.3	10.4	25.5	23.4	3.3	8.8	2.8	9.0	5.9	0.0	11.3	6.9	13.9	12.8	8.1	5.6	9.1	12.7	6.9	6.2	10.0	5.3	14.4	10.5	13.5	17.2	8.9	11.8	10.6	9.1	12.7	5.8	27.3	12.9	11.7	111.8	63.7	18.1	11.8	13.3	12.6	14.8
KATNBL1	"C15orf29, FLJ22557"	ENSG00000134152	"Katanin regulatory subunit B1 like 1"	Q9H079	15	34140674-34210096	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 75.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 46.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 46.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062573	Approved		Supported	"Nucleoplasm,Midbody,Cleavage furrow,Mitotic spindle"		Yes	No			"Midbody, Mitotic spindle"	"Nucleoplasm, Cleavage furrow"	"HPA062573: AB_2684796"	"unprognostic (5.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.94e-3)"	"unprognostic (8.00e-3)"	"prognostic unfavorable (4.60e-5)"	"unprognostic (2.71e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.43e-1)"	13.2	7.9	16.2	14.0	22.6	9.1	22.7	16.7	26.0	11.7	12.2	10.7	10.5	9.6	13.5	12.5	28.8	10.9	10.2	9.0	11.2	9.0	9.1	10.9	20.2	10.7	13.8	10.3	10.9	14.3	8.7	10.4	75.0	15.0	11.9	13.6	8.9	10.5	9.0	7.4	19.7	9.4	16.1	17.8	12.0	11.0	11.0	12.8	7.5	8.3	8.6	12.3	10.2	19.1	9.1	10.2	46.0	6.8	4.3	8.9	4.5	17.7	15.6	24.9	16.6	20.2	20.2	18.5	24.2	14.7	19.4	19.4	8.8	9.9	8.7	15.9	15.7	27.4	23.5	12.1	13.9	23.0	17.8	6.5	15.3	16.5	10.4	14.0	16.0	16.7	12.0	20.5	13.1	26.0	20.2	34.7	22.4	16.3	18.3	26.4	8.7	10.0	13.2	18.2	22.9	12.4	15.5	15.1	8.1	17.9	24.0	14.1	12.6	14.8	10.9	7.1	25.8	13.5	19.2	19.9	26.4	13.6	23.4	19.1	11.4	15.3	17.9	23.7	17.5	19.6	16.5	6.8	10.3	7.0	6.3	8.9	8.5	7.7	7.2	7.4	9.1	8.6	7.6	46.0	4.3	4.0	10.2	6.3	4.5	16.2	22.6	16.7	26.0	11.2	9.0	13.8	10.3	15.0	12.8	35.7	25.1	24.1	50.0	36.7	53.1	11.8	28.1	44.2	34.2	24.4	49.1	52.9	28.2	51.7	63.2	41.9	19.0	0.0	47.3	69.4	32.9	72.1	42.8	18.4	34.4	63.5	23.0	32.5	28.5	42.2	29.4	37.7	30.4	56.9	30.5	52.5	80.0	38.6	31.1	34.2	40.0	58.2	43.0	37.0	44.8	47.4	150.1	31.6	35.9	104.3
KDF1	"C1orf172, FLJ34633, RP11-344H11.3"	ENSG00000175707	"Keratinocyte differentiation factor 1"	Q8NAX2	1	26949562-26960406	"Disease related genes, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 8.6"	"Group enriched"	"Detected in many"	36	"B-cells: 3.7;T-cells: 8.6"	"Cell line enhanced"	"Detected in some"		"A-431: 13.3;BEWO: 11.7;CAPAN-2: 12.5;HaCaT: 11.8;HBEC3-KT: 16.2;hTCEpi: 21.3;OE19: 20.5;SK-BR-3: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028639, HPA068312"	Uncertain		Supported	"Nucleoplasm,Cell Junctions,Mitotic spindle"		NA	NA			"Cell Junctions"	"Nucleoplasm, Mitotic spindle"	"HPA028639: AB_10599191, HPA068312: AB_2685972"	"unprognostic (2.58e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.45e-2)"	"unprognostic (9.09e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.91e-1)"	"prognostic favorable (3.04e-13)"	"unprognostic (1.38e-3)"	"unprognostic (7.83e-2)"	"unprognostic (8.03e-2)"	"prognostic favorable (4.40e-4)"	0.2	1.1	0.6	3.8	0.7	0.0	7.9	1.5	3.6	2.9	11.9	0.4	13.6	9.3	1.0	17.3	16.1	5.5	4.2	0.5	0.8	0.1	7.9	3.5	7.5	6.7	0.2	0.6	1.0	23.8	6.6	9.0	12.4	0.8	6.0	5.1	2.0	14.3	11.5	0.2	13.3	12.5	0.2	0.2	1.0	7.7	5.8	0.5	1.6	14.5	7.2	8.6	5.2	6.0	3.7	0.1	0.0	0.0	0.0	8.6	2.4	13.3	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	6.6	12.5	0.0	0.5	0.0	0.0	11.8	0.0	16.2	0.0	0.0	0.2	0.0	0.0	2.3	0.1	0.0	0.0	0.0	21.3	0.0	1.7	0.0	0.0	0.0	0.7	0.0	0.0	7.9	0.0	0.0	0.9	20.5	0.1	0.0	0.0	1.9	2.9	6.3	8.2	0.0	0.1	13.9	0.0	1.5	9.0	0.2	0.1	0.0	0.0	0.0	0.0	1.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	4.5	3.5	5.9	4.2	0.1	3.7	8.6	5.1	0.0	0.0	0.0	0.0	0.3	2.4	0.6	0.7	1.5	3.6	0.8	0.1	0.2	0.6	0.8	0.5	11.9	9.1	0.5	10.7	0.0	0.4	0.3	12.7	9.4	4.5	14.0	0.0	28.2	21.6	24.5	0.3	0.1	17.1	0.0	20.6	20.1	0.8	11.8	0.0	2.9	2.4	0.0	7.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	14.1	1.0	18.2	22.9	0.0	7.3	2.1	0.0	0.2	5.8	7.0	0.0	24.8	1.5	17.2	16.2
KIF11	"Eg5, HKSP, KNSL1, TRIP5"	ENSG00000138160	"Kinesin family member 11"	P52732	10	92593286-92655395	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 74.2"	"Group enriched"	"Detected in many"	4	"Early spermatids: 9.6;Erythroid cells: 23.3;Extravillous trophoblasts: 11.2;Hofbauer cells: 6.7;Spermatocytes: 24.7;Spermatogonia: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA006916, HPA010093, HPA010568, CAB017617"	Enhanced		Supported	"Mitotic spindle,Cytosol"		Yes	Yes			Cytosol	"Mitotic spindle"	"CAB017617: AB_2131098, HPA006916: AB_1848033, HPA010093: AB_2668281, HPA010568: AB_1848034"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (8.19e-7)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (6.59e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.35e-3)"	"unprognostic (7.23e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.01e-1)"	2.3	1.6	1.0	20.2	2.6	14.3	1.6	0.7	1.5	2.4	4.6	0.7	0.5	3.7	1.4	1.9	11.5	0.8	2.6	2.0	1.1	1.2	1.1	1.1	2.8	12.1	1.0	1.0	1.1	1.1	0.5	0.7	3.1	1.4	1.0	5.4	0.5	2.7	0.2	0.6	4.2	4.4	1.6	1.8	5.2	2.7	10.5	1.1	74.2	1.2	7.5	13.4	2.2	3.8	2.4	0.9	2.5	1.2	3.5	3.9	1.0	31.0	13.9	31.4	29.2	2.3	3.5	7.8	22.4	19.6	24.9	24.8	12.1	20.6	34.4	11.5	10.4	10.6	22.5	22.4	11.4	29.3	20.5	12.9	21.5	13.3	12.7	0.4	34.6	20.1	1.1	1.0	19.2	18.0	5.8	15.4	14.4	15.2	40.2	18.8	12.4	29.4	19.5	12.5	12.6	9.6	31.7	31.1	12.1	6.5	9.1	9.6	13.8	17.5	7.9	9.1	11.2	21.5	11.1	8.7	11.4	16.4	11.6	29.4	11.2	17.3	35.4	9.2	25.0	15.4	2.5	0.5	0.5	0.4	1.2	1.1	2.4	1.4	1.9	0.9	1.0	0.5	0.7	1.4	3.5	0.4	0.4	3.9	1.0	1.0	2.6	0.7	1.5	1.1	1.2	1.0	1.0	1.4	1.1	0.0	1.3	0.8	0.8	2.6	1.3	1.4	0.0	4.0	3.4	1.8	0.0	1.5	1.7	0.4	9.6	0.3	0.4	23.3	0.6	11.2	1.6	0.8	0.0	0.0	6.7	0.0	0.0	2.5	2.5	3.9	0.9	2.6	0.0	1.0	1.9	0.8	0.3	0.0	0.7	0.5	0.4	0.0	1.2	24.7	25.8	2.9	1.3	3.8	2.9	0.9
KIF21B	"DKFZP434J212, KIAA0449"	ENSG00000116852	"Kinesin family member 21B"	O75037	1	200969390-201023700	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.3;brain: 20.4"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 21.3;Cone photoreceptor cells: 55.0;Late spermatids: 57.7;Muller glia cells: 22.6;Rod photoreceptor cells: 23.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 15.7;HMC-1: 16.8;JURKAT: 31.6;Karpas-707: 19.8;RPMI-8226: 16.8;U-266/70: 36.2;U-266/84: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027249, HPA027274"	Approved		Approved	"Plasma membrane,Mitotic spindle,Cytosol"		Yes	No			"Plasma membrane"	"Mitotic spindle, Cytosol"	"HPA027249: AB_10602241, HPA027274: AB_1852483"	"unprognostic (3.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.41e-4)"	"unprognostic (5.98e-3)"	"unprognostic (2.64e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.81e-4)"	2.2	1.6	19.8	10.0	12.9	34.3	1.5	3.7	20.4	1.5	2.8	6.0	1.0	2.7	1.4	1.0	1.5	1.4	2.9	1.5	15.1	12.5	1.4	1.7	4.3	15.7	8.3	12.7	1.4	1.5	11.3	0.9	1.6	7.1	1.2	2.6	8.6	2.1	1.7	0.9	1.3	6.1	1.5	4.3	11.5	3.2	11.1	4.9	10.8	1.2	0.0	9.1	3.7	1.1	0.9	0.2	8.0	0.5	2.4	1.7	0.6	0.5	0.5	4.7	0.2	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.3	0.1	15.7	0.2	0.0	1.4	0.1	0.4	0.1	0.1	0.7	0.1	3.7	0.1	0.0	0.4	11.4	16.8	0.3	1.6	0.1	0.3	0.0	0.6	31.6	1.7	19.8	0.0	0.0	9.1	4.1	2.0	1.5	0.0	3.2	0.0	16.8	0.1	0.0	3.2	0.4	0.2	0.2	0.2	0.8	0.0	3.4	1.1	0.0	1.4	0.0	0.1	36.2	16.7	7.8	1.6	4.9	0.1	8.0	0.1	1.0	1.6	0.4	1.7	0.9	1.2	1.7	0.1	0.7	1.0	1.1	2.0	2.4	0.5	0.2	1.0	0.6	19.8	12.9	3.7	20.0	15.1	12.5	8.3	12.7	7.1	4.9	0.0	6.7	6.1	0.2	0.9	21.3	1.2	0.0	0.0	0.0	1.8	55.0	0.0	0.0	0.6	20.0	1.8	0.0	0.0	1.4	0.1	0.9	0.3	5.8	0.0	1.4	1.6	0.0	0.6	3.8	57.7	0.9	2.5	0.0	2.8	1.1	22.6	1.7	0.0	0.0	0.0	23.6	6.5	1.2	1.4	2.5	0.9	0.0	11.7	0.7	1.8
KIF23	"KNSL5, MKLP-1, MKLP1"	ENSG00000137807	"Kinesin family member 23"	Q02241	15	69414246-69448427	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 41.8;testis: 20.4"	"Cell type enhanced"	"Detected in many"	12	"Extravillous trophoblasts: 31.4;Spermatocytes: 47.9;Spermatogonia: 18.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"eosinophil: 7.7"	"Group enriched"	"Detected in many"	12	"granulocytes: 7.7;monocytes: 2.2;T-cells: 2.1"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB010414, HPA045208, HPA068831"	Uncertain		Enhanced	"Nucleoplasm,Midbody ring,Mitotic spindle"		Yes	Yes			Nucleoplasm	"Midbody ring, Mitotic spindle"	"CAB010414: AB_631959, HPA045208: AB_2679254, HPA068831: AB_2686045"	"unprognostic (1.29e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (8.62e-4)"	"unprognostic (1.86e-1)"	"unprognostic (7.99e-3)"	"prognostic unfavorable (3.18e-5)"	"unprognostic (1.43e-3)"	"unprognostic (4.25e-3)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (3.69e-5)"	"unprognostic (5.85e-3)"	"unprognostic (0.00e+0)"	"unprognostic (1.15e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.17e-2)"	1.8	2.6	1.8	12.7	1.3	16.3	3.2	0.3	0.9	2.2	3.3	0.3	1.4	3.5	3.3	1.2	8.8	1.8	2.4	2.2	0.7	0.5	4.9	0.8	2.5	6.7	0.9	0.5	1.6	0.9	0.0	0.3	10.8	1.3	1.9	4.3	0.6	2.1	0.9	0.3	3.0	3.9	3.4	1.4	4.5	3.1	20.4	0.2	41.8	0.6	6.3	8.8	1.8	3.3	0.3	0.1	7.7	2.2	0.1	2.1	0.6	25.2	22.0	16.3	15.6	1.0	1.9	9.9	27.7	15.0	40.2	31.3	13.3	19.8	14.8	8.4	14.3	21.4	29.2	33.6	10.3	40.9	13.7	15.7	13.9	20.6	8.2	0.6	14.3	12.9	0.9	1.1	19.2	16.2	5.1	13.6	12.0	9.2	18.5	25.2	11.1	8.0	7.7	20.2	9.4	8.8	9.1	36.3	8.2	10.6	13.1	8.3	6.9	32.2	14.2	12.1	21.4	13.5	6.5	8.8	24.3	32.4	16.8	40.7	7.2	19.5	13.3	8.6	19.3	21.4	0.0	2.2	7.7	0.0	1.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.1	1.0	0.1	2.1	0.6	1.8	1.3	0.3	0.9	0.7	0.5	0.9	0.5	1.3	0.2	0.0	0.3	0.0	2.6	1.6	0.2	0.8	7.6	1.4	6.8	7.0	2.0	5.9	3.3	1.8	6.3	0.1	1.1	0.0	0.0	31.4	3.1	0.5	2.3	0.0	6.8	0.0	1.7	6.2	3.2	3.2	0.9	2.9	0.0	10.0	2.2	0.1	0.4	0.0	1.8	0.5	0.0	6.5	2.3	47.9	18.3	0.9	2.1	0.8	2.3	1.0
KIF2B		ENSG00000141200	"Kinesin family member 2B"	Q8N4N8	17	53822901-53825213	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	261	"testis: 103.6"	"Group enriched"	"Detected in some"	82	"Early spermatids: 638.1;Late spermatids: 419.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023081, HPA023103, HPA024795"	Uncertain		Supported	"Nucleoli,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Microtubules, Cytokinetic bridge, Mitotic spindle"	Nucleoli	"HPA023081: AB_10600082, HPA023103: AB_10611254, HPA024795: AB_10602197"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	103.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	638.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	419.7	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	6.5	0.0	4.2	2.0	0.0	0.0	0.0	0.0	0.0
KIF5A	"D12S1889, MY050, NKHC, SPG10"	ENSG00000155980	"Kinesin family member 5A"	Q12840	12	57549998-57586632	"Disease related genes, Predicted intracellular proteins"		"Motor protein"	"Amyotrophic lateral sclerosis, Disease mutation, Epilepsy, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"brain: 138.6"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 36.9;Horizontal cells: 25.4;Late spermatids: 11.4;Spermatogonia: 9.3"	"Cancer enriched"	"Detected in some"	5	"glioma: 26.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.4;naive CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"T-cells: 2.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.4;K-562: 8.6;NTERA-2: 10.6;SCLC-21H: 21.8;U-87 MG: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004469, HPA073448"	Enhanced		Approved	"Nucleoplasm,Mitotic spindle,Cytosol"		Yes	No			"Nucleoplasm, Cytosol"	"Mitotic spindle"	"HPA004469: AB_1079212, HPA073448: AB_2686601"	"unprognostic (7.94e-2)"	"unprognostic (4.95e-3)"	"unprognostic (3.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (7.12e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.22e-5)"	"unprognostic (2.82e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.52e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (7.61e-2)"	"unprognostic (2.26e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.51e-1)"	1.8	7.6	85.4	3.0	47.6	1.9	1.9	15.2	138.6	2.1	2.8	4.0	0.0	2.4	3.4	2.1	1.9	2.0	1.9	1.7	52.4	18.3	2.0	1.7	1.8	1.8	12.9	43.6	1.8	2.3	6.0	2.5	1.7	21.6	1.9	2.8	0.6	2.0	2.0	1.7	1.7	3.0	2.8	9.0	1.8	2.1	4.4	12.9	0.0	2.8	0.0	1.8	1.8	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	3.8	3.3	0.0	0.0	0.1	0.2	0.7	1.3	1.7	0.0	0.0	1.6	0.0	0.7	0.6	0.1	2.0	0.0	1.0	20.4	1.5	0.1	0.1	1.6	0.6	0.0	0.1	0.2	0.1	1.0	0.0	0.0	0.2	1.8	8.6	4.5	0.0	0.0	0.3	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	21.8	4.9	0.0	0.2	0.0	0.6	0.4	0.0	0.0	0.0	2.4	0.0	0.9	2.9	3.5	0.3	8.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.4	0.8	0.0	0.0	0.8	2.0	0.0	0.0	0.0	0.0	0.3	0.0	85.4	47.6	15.2	112.0	52.4	18.3	12.9	43.6	21.6	12.9	0.0	0.0	0.0	0.1	0.0	36.9	1.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	25.4	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	5.8	0.2	0.0	0.4	0.0	8.7	0.0	0.9	2.3	9.3	0.1	0.0	0.0	0.0	0.0
KLHL22	"FLJ14360, KELCHL"	ENSG00000099910	"Kelch like family member 22"	Q53GT1	22	20441519-20495883	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040766			Supported	"Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	No			"Vesicles, Microtubules, Cytokinetic bridge, Mitotic spindle"		"HPA040766: AB_2732488"	"unprognostic (4.15e-1)"	"unprognostic (9.34e-3)"	"unprognostic (5.37e-2)"	"prognostic favorable (4.88e-6)"	"unprognostic (1.17e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.20e-1)"	"unprognostic (8.99e-2)"	"prognostic favorable (3.85e-6)"	"unprognostic (3.94e-2)"	"prognostic favorable (1.34e-8)"	"unprognostic (3.94e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.08e-2)"	10.8	12.4	15.2	11.2	17.8	8.6	9.6	26.9	24.0	15.4	10.7	11.8	13.1	6.5	17.8	15.7	8.5	15.1	15.9	11.2	14.2	14.9	13.7	9.0	11.1	13.1	11.5	16.3	19.8	16.3	20.7	14.7	13.2	10.9	16.6	9.2	17.0	11.3	16.2	16.3	9.9	8.0	19.0	7.8	12.5	9.9	8.3	9.6	5.0	18.5	6.8	17.1	11.1	12.3	7.1	12.9	15.1	6.6	13.7	16.0	5.1	9.0	8.9	20.1	16.7	17.2	19.8	5.0	11.6	19.2	11.9	13.1	4.6	3.4	6.0	3.9	20.4	9.2	11.6	13.9	5.2	10.6	12.3	7.5	5.7	8.7	4.5	15.8	1.4	6.7	15.3	7.9	10.3	7.3	14.7	16.5	4.9	16.7	6.4	11.5	14.2	1.2	8.5	3.5	7.1	6.4	12.5	7.4	0.3	6.9	11.0	10.9	11.3	12.0	9.3	8.4	7.3	8.2	5.0	7.3	14.4	6.9	9.7	4.8	3.6	3.7	4.5	7.6	5.6	9.3	5.4	3.6	15.1	7.3	5.1	5.7	7.1	9.3	6.6	12.9	6.1	7.3	7.3	8.7	13.7	6.6	4.9	16.0	5.1	15.2	17.8	26.9	24.0	14.2	14.9	11.5	16.3	10.9	9.6	0.0	3.0	3.7	2.7	1.4	10.8	4.1	10.2	4.0	3.4	8.7	3.9	13.9	3.3	7.6	0.2	3.0	2.1	0.0	2.2	5.8	5.5	3.4	4.7	5.0	6.9	12.7	2.9	4.3	4.3	1.3	11.2	3.4	1.7	1.8	4.8	12.8	5.3	3.2	18.7	7.3	5.9	6.5	4.7	6.2	7.7	1.3	11.2	6.9	3.5	1.3
KLHL6	FLJ00029	ENSG00000172578	"Kelch like family member 6"	Q8WZ60	3	183487531-183555689	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 43.2"	"Cell type enhanced"	"Detected in many"	12	"B-cells: 16.2;Ciliated cells: 18.7;granulocytes: 47.6;Hofbauer cells: 22.0;Kupffer cells: 16.7;Macrophages: 17.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 15.4;HEL: 9.8;HMC-1: 10.3;U-266/70: 31.6;U-266/84: 16.4;U-698: 46.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024512	Uncertain		Approved	"Plasma membrane,Microtubules,Mitotic spindle,Centriolar satellite"		Yes	NA			"Centriolar satellite"	"Plasma membrane, Microtubules, Mitotic spindle"	"HPA024512: AB_2131015"	"unprognostic (8.46e-2)"	"unprognostic (3.67e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.03e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (9.62e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (1.81e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.73e-2)"	4.4	1.2	1.4	43.2	3.3	2.9	2.2	0.5	1.8	1.7	4.1	2.4	0.5	2.3	1.1	0.3	1.7	4.2	2.3	1.9	1.8	1.3	1.4	1.4	8.0	23.8	4.4	0.0	0.7	0.8	0.2	1.0	1.8	2.8	1.4	2.2	0.8	4.6	0.6	0.7	0.8	9.9	0.7	8.8	15.1	3.5	0.7	2.3	21.4	1.6	0.5	34.5	2.8	2.7	4.4	5.2	13.3	3.3	2.8	4.8	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	9.8	0.0	0.0	0.0	2.6	10.3	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.1	7.0	0.0	0.0	3.2	1.5	0.0	0.0	0.0	5.4	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.9	0.0	0.0	0.0	0.0	31.6	16.4	46.4	0.0	2.9	0.0	7.1	3.3	13.3	0.8	2.7	0.9	4.4	3.0	1.3	2.3	3.3	3.6	2.2	3.1	2.8	3.0	5.2	4.8	2.7	1.4	3.3	0.5	1.8	1.8	1.3	4.4	0.0	2.8	2.3	6.0	9.2	16.2	1.5	1.0	0.6	3.2	0.0	18.7	9.1	0.0	2.0	0.2	0.0	0.0	1.5	2.9	0.0	0.0	0.0	0.2	1.1	1.1	47.6	0.0	22.0	0.0	0.0	1.8	16.7	0.0	0.3	17.0	8.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.4	0.5	0.5	10.8	0.0	1.0
KNSTRN	"C15orf23, FLJ14502, kinastrin, SKAP, TRAF4AF1"	ENSG00000128944	"Kinetochore localized astrin/SPAG5 binding protein"	Q9Y448	15	40382721-40394246	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 26.2;lymphoid tissue: 18.4;testis: 40.1;thyroid gland: 59.8"	"Group enriched"	"Detected in many"	4	"Early spermatids: 321.9;Late spermatids: 423.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA042027	Enhanced		Enhanced	"Plasma membrane,Mitotic spindle,Centriolar satellite"		Yes	Yes			"Mitotic spindle, Centriolar satellite"	"Plasma membrane"	"HPA042027: AB_10797378"	"unprognostic (2.35e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.23e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.47e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (3.43e-5)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (7.88e-9)"	"unprognostic (1.70e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.52e-2)"	5.5	4.4	6.7	5.5	6.3	7.3	9.0	8.1	7.0	3.3	4.5	4.0	8.0	5.3	3.9	7.8	6.2	3.4	2.5	4.1	6.0	5.3	4.2	7.0	4.1	8.0	4.6	7.1	3.4	3.5	6.0	4.2	7.4	6.8	4.4	6.3	2.5	6.4	5.0	7.5	4.2	4.1	5.9	4.3	4.8	6.2	40.1	4.5	18.4	59.8	6.0	9.1	3.8	3.7	5.9	11.0	10.0	26.2	5.5	5.5	4.0	31.2	14.7	29.4	19.2	6.5	10.1	15.3	21.7	16.9	44.9	39.7	31.5	13.8	12.1	11.1	14.6	35.8	36.2	31.3	20.1	40.7	21.5	15.3	35.9	33.0	19.8	6.1	19.2	18.8	5.2	11.6	22.6	22.7	11.0	25.1	30.5	25.8	21.0	37.7	15.8	16.6	15.5	18.5	26.8	22.4	17.1	22.1	14.0	15.6	13.0	28.7	19.9	18.1	20.0	4.8	18.6	20.9	13.8	12.9	21.7	22.2	22.1	30.0	18.0	29.1	21.8	13.4	25.8	17.7	4.8	10.3	10.0	4.8	14.5	4.4	5.9	3.6	4.4	11.0	5.4	3.5	3.6	5.9	5.5	26.2	7.5	5.5	4.0	6.7	6.3	8.1	7.0	6.0	5.3	4.6	7.1	6.8	4.5	8.9	0.6	0.8	3.1	1.9	7.8	4.7	2.5	9.4	5.7	0.0	7.9	14.3	3.3	9.5	321.9	1.7	1.6	46.7	8.1	35.4	6.2	3.8	1.1	5.7	18.4	4.8	2.4	3.1	7.5	423.6	8.3	7.6	3.3	8.2	3.6	7.0	8.7	0.0	6.7	4.4	7.4	0.0	2.7	83.7	18.1	1.3	17.6	3.2	3.0	2.8
LAMP5	"BAD-LAMP, C20orf103, dJ1119D9.3, UNC-46"	ENSG00000125869	"Lysosomal associated membrane protein family member 5"	Q9UJQ1	20	9514358-9530524	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 42.1;brain: 105.2"	"Cell type enriched"	"Detected in some"	7	"Horizontal cells: 57.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"basal ganglia: 105.2"	"Cell type enriched"	"Detected in some"	15	"plasmacytoid DC: 42.1"	"Lineage enriched"	"Detected in many"	30	"dendritic cells: 42.1"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 95.0;SH-SY5Y: 17.4;THP-1: 33.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA004802, HPA070765"	Enhanced		Uncertain	"Mitotic spindle,Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Mitotic spindle, Centriolar satellite"	"HPA004802: AB_10603682, HPA070765: AB_2686309"	"unprognostic (2.78e-2)"	"unprognostic (3.90e-3)"	"unprognostic (5.73e-4)"	"unprognostic (5.47e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (6.46e-6)"	"unprognostic (5.12e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.49e-3)"	0.5	4.1	21.6	1.5	105.2	2.0	1.0	2.3	28.6	9.1	1.3	0.6	1.8	1.3	4.6	6.0	0.6	9.7	2.9	0.6	18.7	4.1	0.9	0.5	1.1	4.8	4.5	7.7	21.2	1.3	0.3	2.0	0.4	23.2	2.3	1.4	2.6	1.4	3.6	0.3	0.5	1.4	3.8	6.7	1.4	1.6	1.1	4.8	0.0	1.1	0.0	4.7	1.2	0.6	1.4	42.1	0.9	0.5	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.1	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.9	0.5	0.0	0.0	0.1	0.0	1.4	0.0	0.0	2.8	0.1	0.0	0.0	0.1	0.0	0.0	42.1	0.0	0.7	21.6	105.2	2.3	19.1	18.7	4.1	4.5	7.7	23.2	4.8	0.0	1.4	2.2	0.0	0.1	7.5	0.2	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.6	5.8	0.1	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	1.1	57.2	0.0	0.0	1.2	5.6	0.6	0.2	3.3	8.2	0.0	4.0	0.2	0.0	0.0	0.0	4.9	0.0	1.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0
LRRC34	MGC27085	ENSG00000171757	"Leucine rich repeat containing 34"	Q8IZ02	3	169793428-169812986	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 13.7;testis: 23.8"	"Cell type enhanced"	"Detected in many"	16	"Ciliated cells: 144.6;Cone photoreceptor cells: 35.3;Early spermatids: 74.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 2.2;myeloid DC: 1.4;naive B-cell: 1.5;plasmacytoid DC: 4.6"	"Group enriched"	"Detected in many"	7	"B-cells: 2.2;dendritic cells: 4.6"	"Cell line enhanced"	"Detected in many"		"HEK 293: 7.4;HEL: 9.3;HL-60: 9.8;JURKAT: 8.1;NTERA-2: 9.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA035747	Approved		Approved	"Cell Junctions,Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			"Cell Junctions, Microtubules"	"Cytokinetic bridge, Mitotic spindle"	"HPA035747: AB_10670120"	"unprognostic (1.04e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (5.64e-2)"	"unprognostic (9.74e-3)"	"unprognostic (5.46e-2)"	"unprognostic (9.74e-2)"	"unprognostic (8.24e-2)"	"unprognostic (6.39e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.79e-1)"	2.8	1.1	4.8	1.2	9.6	2.7	2.3	1.1	4.0	2.3	0.9	4.2	1.4	1.0	1.9	3.9	1.0	13.7	1.1	2.0	4.1	3.8	2.1	0.9	3.4	1.9	3.5	5.6	2.2	0.5	1.0	7.9	0.9	11.8	2.0	0.7	2.6	1.3	2.4	0.9	1.0	1.1	2.0	3.6	1.8	1.1	23.8	4.8	1.7	2.7	0.5	1.2	1.0	0.9	2.2	4.6	0.1	0.3	0.0	0.5	0.4	2.7	0.4	0.8	0.0	1.1	4.1	0.0	1.2	2.4	2.8	2.7	0.1	0.0	1.6	0.0	0.7	3.8	0.0	2.5	0.0	1.0	0.4	7.4	9.3	0.1	0.0	0.7	9.8	2.4	1.4	0.4	1.1	0.0	0.1	1.7	8.1	0.2	0.0	1.0	0.0	0.9	1.9	9.9	0.0	3.1	4.9	0.0	0.5	2.3	0.2	4.9	3.8	0.8	0.1	0.0	0.3	0.0	4.7	0.4	0.6	0.0	0.3	0.0	0.0	0.0	2.3	4.5	0.1	2.6	0.0	0.2	0.0	0.0	0.3	0.2	2.2	0.0	0.0	1.4	1.5	0.0	0.0	0.1	0.0	0.0	4.6	0.5	0.4	4.8	9.6	1.1	4.0	4.1	3.8	3.5	5.6	11.8	4.8	3.0	1.6	0.0	0.9	0.3	5.3	2.8	0.0	144.6	15.9	5.2	35.3	0.2	1.7	0.5	74.2	1.5	0.0	0.0	0.2	0.2	3.2	0.7	1.1	0.0	2.2	11.1	4.1	11.1	0.3	23.5	9.8	1.7	0.0	6.4	0.5	6.0	0.2	0.0	9.9	3.2	18.6	0.0	1.7	29.6	8.6	0.3	0.5	0.7	0.1	0.3
MATK	"CHK, CTK, DKFZp434N1212, HHYLTK, HYL, HYLTK, Lsk, MGC1708, MGC2101"	ENSG00000007264	"Megakaryocyte-associated tyrosine kinase"	P42679	19	3777970-3802129	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.3;bone marrow: 19.1;brain: 27.4"	"Group enriched"	"Detected in many"	6	"granulocytes: 44.9;Hofbauer cells: 58.6;T-cells: 105.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 19.4;NK-cell: 29.3"	"Group enriched"	"Detected in many"	54	"NK-cells: 29.3;T-cells: 19.4"	"Cell line enhanced"	"Detected in some"		"HL-60: 41.6;HMC-1: 12.8;K-562: 18.5;MCF7: 13.5;NB-4: 29.0;SCLC-21H: 12.7;THP-1: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004847, HPA066547"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle,Centriolar satellite,Cytosol"		NA	NA			Microtubules	"Cytokinetic bridge, Mitotic spindle, Centriolar satellite, Cytosol"	"HPA004847: AB_1079316, HPA066547: "	"prognostic favorable (5.27e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.39e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.33e-2)"	11.2	1.6	22.1	6.8	18.1	19.1	2.2	1.5	27.4	1.5	2.3	1.7	0.0	7.0	1.2	0.4	1.1	4.7	5.1	1.7	25.1	10.0	1.1	2.8	7.3	9.6	7.0	11.0	1.0	1.6	0.1	1.4	1.4	6.1	1.2	1.4	0.6	3.8	1.0	0.8	1.6	6.7	1.1	2.8	14.8	4.1	2.1	1.3	3.5	0.9	0.0	4.5	2.4	0.7	0.4	0.3	0.4	0.0	29.3	19.4	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.4	4.2	5.5	0.1	0.0	0.0	7.2	4.6	0.5	1.1	0.0	41.6	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	18.5	0.0	0.0	13.5	0.1	29.0	3.4	3.5	0.1	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.4	0.0	10.9	1.3	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.0	13.2	0.0	2.5	12.2	0.3	0.4	1.2	7.1	0.4	29.3	0.0	0.1	0.1	2.7	22.1	18.1	1.5	27.4	25.1	10.0	7.0	11.0	6.1	1.3	0.0	1.4	2.4	0.0	0.3	1.7	1.1	0.0	1.4	0.0	0.0	11.8	0.2	0.0	0.0	1.5	1.4	0.0	0.0	0.0	0.3	0.5	0.1	44.9	0.8	58.6	0.0	6.8	11.6	3.5	4.0	0.0	7.2	1.7	1.0	0.0	0.5	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.3	2.7	1.0	0.2	105.8	0.1	0.0
MGAT5B	"FLJ25132, GnT-IX, GnT-VB"	ENSG00000167889	"Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B"	Q3V5L5	17	76868456-76950393	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 28.1"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 5.1;Early spermatids: 6.3;Extravillous trophoblasts: 2.8;Late spermatids: 6.8"	"Group enriched"	"Detected in many"	5	"glioma: 2.6;melanoma: 7.1;testis cancer: 2.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 21.8;SCLC-21H: 11.2;U-138 MG: 13.2;U-2 OS: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011082			Approved	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	No			"Nucleoplasm, Mitotic spindle"	"Cytokinetic bridge"	"HPA011082: AB_2668423"	"unprognostic (6.37e-2)"	"unprognostic (9.16e-3)"	"unprognostic (8.51e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.68e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.52e-3)"	"unprognostic (5.30e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.46e-7)"	"unprognostic (1.66e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.01e-1)"	1.1	1.2	9.3	1.1	13.4	1.0	0.9	4.4	28.1	1.0	0.9	1.1	0.0	0.8	1.1	0.7	0.9	1.0	0.9	0.8	5.5	2.8	0.9	0.7	1.0	0.9	2.3	8.1	1.2	0.8	1.0	0.6	1.1	2.6	0.8	0.8	1.1	0.8	0.8	0.7	0.9	0.9	0.8	0.7	1.4	1.0	2.3	1.7	0.0	0.8	0.0	0.9	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	21.8	4.4	2.2	0.0	0.0	2.3	0.3	0.9	8.0	4.7	0.0	0.5	0.0	1.7	1.0	9.4	0.1	1.0	0.2	2.1	0.0	0.3	0.0	1.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	1.3	3.6	1.4	0.4	0.1	0.0	0.0	1.0	0.0	0.0	1.2	0.5	2.3	3.0	3.9	4.5	6.2	0.0	11.2	4.3	3.8	1.7	3.4	0.2	0.1	0.1	4.0	13.2	14.3	0.2	4.1	0.0	0.0	0.5	0.4	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	13.4	4.4	27.4	5.5	2.8	2.3	8.1	2.6	1.7	0.0	0.0	0.0	0.1	0.1	5.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	2.8	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	6.8	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	2.1	0.0	0.2	0.9	2.2	0.0	0.1	0.0	0.0	0.0
NEXMIF	"KIAA2022, KIDLIA, MRX98, XPN"	ENSG00000050030	"Neurite extension and migration factor"	Q5QGS0	X	74732856-74925485	"Disease related genes, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.2;parathyroid gland: 9.0"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 2.2;Ciliated cells: 5.3;Club cells: 4.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HAP1: 6.7;Karpas-707: 10.8;SiHa: 9.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000407	Uncertain		Supported	"Nucleoplasm,Midbody,Mitotic spindle,Cytosol"		Yes	NA			Nucleoplasm	"Midbody, Mitotic spindle, Cytosol"	"HPA000407: AB_2665984"	"unprognostic (1.04e-3)"	"unprognostic (6.07e-5)"	"unprognostic (1.81e-2)"	"unprognostic (2.07e-5)"	"unprognostic (2.15e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.79e-4)"	"unprognostic (6.94e-4)"	0.6	3.0	5.4	0.7	6.2	0.4	1.3	10.2	9.4	1.7	1.9	0.7	1.0	0.6	1.7	0.9	1.8	1.3	0.5	0.3	5.0	6.2	2.4	0.2	0.9	0.5	1.8	5.0	1.7	4.4	9.0	7.5	0.5	1.9	3.2	1.1	1.1	2.5	2.5	0.4	1.8	1.1	2.6	1.2	0.6	1.6	0.9	1.5	0.0	1.5	0.0	0.5	0.7	2.8	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	10.8	0.0	0.2	0.3	0.1	0.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.4	0.0	9.5	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.2	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.4	6.2	10.2	6.8	5.0	6.2	1.8	5.0	1.9	1.5	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	5.3	4.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NUDCD2	"DKFZp686E10109, NudCL2"	ENSG00000170584	"NudC domain containing 2"	Q8WVJ2	5	163446526-163460140	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037384, HPA037385"	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		NA	NA			Microtubules	"Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA037384: AB_2675447, HPA037385: AB_10673630"	"unprognostic (3.96e-1)"	"unprognostic (3.69e-2)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.46e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.84e-1)"	"unprognostic (4.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.63e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.40e-2)"	"unprognostic (7.85e-2)"	18.3	17.3	19.1	17.4	20.2	14.0	16.6	10.4	21.8	8.5	15.1	23.2	12.7	20.2	12.5	9.7	15.0	14.3	9.9	10.1	19.9	15.1	16.2	20.1	11.8	18.9	27.0	14.5	13.4	24.4	9.6	13.2	14.5	19.3	12.7	9.1	9.3	19.4	10.6	25.7	11.7	18.0	14.1	30.5	16.6	15.9	12.5	20.9	16.9	14.6	11.0	13.4	12.8	11.5	34.3	30.3	14.1	21.6	28.5	36.5	24.4	23.5	12.2	9.3	14.6	5.7	4.2	12.3	9.5	2.8	3.4	5.5	10.9	18.1	13.4	23.0	1.5	15.9	11.9	4.9	5.4	4.1	26.7	13.7	12.4	15.5	9.9	6.2	13.9	14.1	1.5	3.2	3.3	4.8	4.9	3.8	15.3	13.0	16.8	3.5	9.6	20.6	30.7	10.2	7.0	13.5	17.4	15.5	23.8	3.1	5.5	23.7	13.4	15.0	9.7	24.7	5.8	18.6	14.4	8.5	11.8	17.7	13.0	21.8	13.9	23.2	22.6	13.7	24.2	12.3	14.1	18.9	11.8	23.8	21.6	30.3	34.3	34.0	28.4	25.4	24.4	36.5	31.9	2.4	28.5	17.9	30.3	30.0	24.4	19.1	20.2	10.4	18.1	19.9	15.1	27.0	14.5	19.3	20.9	26.8	18.4	48.4	46.7	52.8	29.3	36.7	30.6	41.5	31.8	36.6	21.6	97.0	126.0	54.7	60.9	45.6	19.3	23.3	55.7	43.8	50.3	51.1	30.1	51.3	61.4	9.5	42.1	31.9	41.1	11.4	47.8	38.8	47.2	40.5	42.0	35.3	54.2	28.1	48.1	89.3	36.4	38.8	41.9	69.5	42.8	59.1	47.5	42.4	61.0	48.8
NXPH3	NPH3	ENSG00000182575	"Neurexophilin 3"	O95157	17	49575858-49583827	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	10	"monocytes: 7.2;Muller glia cells: 8.9;Peritubular cells: 13.4;Smooth muscle cells: 12.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 18.1;BJ: 5.7"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"cerebellum: 61.3"	HPA073819			Approved	"Vesicles,Mitotic spindle"	"Secreted in brain"	NA	NA			Vesicles	"Mitotic spindle"	"HPA073819: "	"unprognostic (2.39e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.01e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.03e-2)"	"unprognostic (6.33e-2)"	"unprognostic (4.62e-4)"	"unprognostic (2.59e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.05e-3)"	4.5	2.4	3.2	2.9	7.4	0.3	3.9	23.5	16.4	18.9	8.9	3.4	0.0	1.2	11.3	3.8	4.5	8.0	4.0	5.0	4.7	3.4	0.8	0.4	5.1	1.3	2.7	7.7	9.2	1.6	0.7	7.2	4.1	5.1	11.2	1.6	6.8	6.0	12.3	2.6	2.1	1.7	11.0	1.7	1.2	3.6	3.5	3.2	0.0	1.4	3.9	1.2	15.9	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	18.1	5.7	0.6	0.4	0.2	0.9	0.0	0.0	0.3	0.1	1.2	0.1	0.6	0.2	0.1	0.0	0.4	0.0	0.1	0.6	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.6	0.0	0.1	0.2	0.1	0.5	0.0	0.0	2.0	0.1	0.0	0.0	0.4	0.3	0.1	0.0	1.9	0.1	0.0	0.0	0.0	0.7	1.8	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	7.4	23.5	11.4	4.7	3.4	2.7	7.7	5.1	3.2	0.0	2.2	0.0	0.2	0.3	2.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	1.9	2.5	0.3	0.0	0.0	0.2	0.0	0.0	1.8	0.3	0.0	4.0	0.0	1.7	7.2	0.0	8.9	0.0	0.0	13.4	0.0	1.1	0.0	12.5	0.1	0.6	1.0	0.1	0.0	0.0	0.1
OTUD7B	"CEZANNE, ZA20D1"	ENSG00000264522	"OTU deubiquitinase 7B"	Q6GQQ9	1	149937812-150010676	"Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 100.1"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"basophil: 4.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.7;NK-cells: 1.4;T-cells: 2.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027045, HPA076357"	Supported		Uncertain	"Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA027045: AB_1854847, HPA076357: "	"unprognostic (2.17e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.90e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.46e-2)"	"prognostic favorable (5.09e-5)"	"unprognostic (4.90e-2)"	"unprognostic (7.72e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.58e-2)"	8.8	6.2	5.8	2.6	12.3	0.3	6.2	8.5	8.9	8.6	6.3	20.6	4.0	4.6	8.5	4.1	6.1	7.6	4.3	5.3	6.0		4.5	8.6	5.6	0.9	12.7	5.1	9.2	4.5	12.5	4.3	5.3	11.6	5.3	5.6	7.4	5.4	6.3	13.2	4.3	5.1	8.9	8.5	2.3	5.2	9.6	12.5	0.0	8.3	2.3	2.1	6.3	7.1	0.6	0.6	4.7	0.3	1.4	2.3	0.2	11.5	9.3	6.5	10.9	8.6	8.1	6.2	8.2	12.0	9.8	6.8	6.8	9.4	0.1	5.3	14.8	4.4	9.2	9.2	9.0	10.4	11.1	4.7	4.4	12.9	4.6	9.2	5.0	4.9	8.9	7.0	16.6	14.6	7.7	8.0	1.4	12.1	12.6	7.0	11.8	0.9	1.4	8.3	8.7	9.1	1.2	9.0	2.9	3.8	15.9	4.2	8.0	14.4	10.6	12.9	8.9	8.8	2.7	9.5	10.2	9.5	6.8	9.5	13.5	13.0	1.3	9.1	1.5	16.7	4.7	0.3	1.3	2.3	0.2	1.7	0.6	1.0	1.4	0.1	0.6	0.9	1.0	1.2	1.4	0.3	0.6	0.6	0.2											32.8	9.4	2.2	22.0	14.2	25.3	16.2	12.7	12.0	15.9	10.4	100.1	16.8	6.6	11.5	56.6	14.7	19.3	23.3	9.6	7.6	13.6	16.9	0.0	29.3	2.8	22.3	16.7	12.3	0.6	57.7	13.6	2.5	35.4	7.2	12.2	25.5	16.8	21.0	21.5	10.3	66.3	0.0	11.3	10.7	6.4	14.4	17.7	6.7	9.2	21.0
PHLDB1	"FLJ00141, KIAA0638, LL5a"	ENSG00000019144	"Pleckstrin homology like domain family B member 1"	Q86UU1	11	118606440-118658038	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 87.0"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 68.1;Late spermatids: 60.6;Leydig cells: 62.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 39.2;ASC TERT1: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037959, HPA038448, HPA061506"	Approved		Approved	"Nucleoplasm,Mitotic spindle"		Yes	No			Nucleoplasm	"Mitotic spindle"	"HPA037959: AB_10673651, HPA038448: AB_10697390, HPA061506: AB_2684545"	"unprognostic (7.81e-2)"	"unprognostic (8.32e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.36e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.37e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (6.36e-6)"	"unprognostic (7.09e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.44e-1)"	40.5	7.4	19.6	9.5	52.2	0.9	19.0	4.6	30.8	25.0	10.7	87.0	3.6	8.1	22.0	9.6	8.2	18.7	18.5	20.8	22.4	11.8	9.6	2.8	13.7	4.0	47.0	19.9	21.4	18.9	4.9	4.5	20.8	26.9	9.4	5.9	8.0	7.1	14.6	10.0	9.2	8.8	16.0	27.6	10.2	7.9	7.0	51.0	0.0	10.7	5.4	2.3	10.8	11.6	0.5	0.4	2.1	0.3	1.9	0.7	0.1	1.6	2.6	10.5	5.1	39.2	39.8	3.7	7.8	9.6	4.6	2.7	3.9	11.4	0.0	14.7	15.6	6.2	6.6	2.3	16.0	0.7	0.2	1.5	3.0	1.9	1.9	10.1	0.0	5.7	20.7	3.5	6.4	4.4	10.4	13.1	0.2	2.6	0.1	5.9	1.2	0.0	0.1	3.7	0.1	1.3	0.4	2.7	0.2	4.6	2.4	2.4	5.2	19.9	1.7	5.5	4.2	7.3	0.9	16.0	9.5	8.6	4.8	6.2	0.0	0.0	0.0	2.7	0.5	10.7	0.5	0.3	0.4	0.2	0.0	0.3	0.2	0.3	0.7	0.0	0.5	0.7	0.5	2.1	1.9	0.2	0.4	0.2	0.1	19.6	52.2	4.6	30.8	22.4	11.8	47.0	19.9	26.9	51.0	6.0	13.6	0.9	8.3	16.4	3.5	3.9	0.0	0.0	10.3	29.6	0.0	0.9	0.0	9.1	68.1	25.1	16.5	0.0	3.9	1.3	32.9	5.0	1.1	0.6	5.0	3.2	8.1	31.3	3.5	60.6	62.2	7.0	11.8	3.6	21.4	6.7	15.4	28.1	41.8	5.7	1.8	38.8	45.5	7.4	5.8	8.0	1.3	2.2	13.5	2.1
PHLPP2	"KIAA0931, PHLPPL, PPM3B"	ENSG00000040199	"PH domain and leucine rich repeat protein phosphatase 2"	Q6ZVD8	16	71637835-71724701	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 29.9"	"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 98.2;Enterocytes: 51.9;Rod photoreceptor cells: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040761, HPA041837, HPA048598"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		NA	No			Cytosol	"Nucleoplasm, Cytokinetic bridge, Mitotic spindle"	"HPA040761: , HPA041837: , HPA048598: AB_2680459"	"unprognostic (5.67e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.97e-4)"	"unprognostic (3.08e-2)"	"unprognostic (8.85e-3)"	"unprognostic (6.41e-2)"	"unprognostic (4.92e-2)"	"unprognostic (8.46e-3)"	"unprognostic (8.27e-2)"	6.4	4.7	12.5	7.0	10.9	8.1	8.4	17.4	14.9	4.4	16.6	4.6	4.3	15.8	5.8	4.9	2.7	4.7	4.1	4.6	11.7	9.0	5.4	4.9	4.8	5.0	6.2	14.9	7.2	4.9	10.2	7.3	4.3	12.6	4.7	17.8	13.2	2.9	5.7	5.3	3.0	29.9	7.0	7.6	3.9	4.2	10.8	4.7	1.0	9.9	1.1	4.9	4.7	9.8	2.4	2.2	1.2	0.7	3.5	1.5	0.4	4.9	6.5	7.1	7.9	5.7	6.9	4.1	7.4	6.7	10.7	8.8	5.9	1.6	9.8	2.9	12.2	7.7	10.5	10.2	3.8	13.9	3.4	5.5	2.7	5.6	3.9	4.5	2.3	4.3	5.1	2.2	15.2	5.0	4.5	4.0	3.4	2.4	2.7	7.4	10.4	3.2	1.8	5.5	1.5	1.7	5.1	6.2	3.2	5.1	3.8	6.2	3.3	15.9	4.4	2.6	5.7	5.4	1.4	5.5	10.8	7.8	4.5	6.1	6.1	4.3	10.1	6.7	1.9	2.4	0.8	0.5	0.2	1.0	0.7	0.9	2.4	0.8	1.5	0.6	1.6	1.1	0.9	1.2	3.5	0.7	2.2	1.3	0.4	12.5	10.9	17.4	14.9	11.7	9.0	6.2	14.9	12.6	4.7	8.9	2.1	5.2	4.7	8.2	18.7	2.3	0.0	2.7	4.5	3.5	98.2	3.8	0.0	2.4	9.7	3.7	51.9	0.0	2.0	0.3	7.2	5.0	10.3	3.9	1.3	22.3	5.8	3.1	5.4	3.6	4.9	2.2	13.5	2.8	6.7	6.3	2.8	31.6	4.9	4.3	60.3	6.5	5.6	29.1	18.3	8.0	1.1	3.5	7.2	2.1
PPP1R3E	FLJ00089	ENSG00000235194	"Protein phosphatase 1 regulatory subunit 3E"	Q9H7J1	14	23295643-23302848	"Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 61.2;Early spermatids: 92.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 30.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA061600	Approved		Approved	"Microtubules,Mitotic spindle,Mitochondria"		Yes	No			"Microtubules, Mitochondria"	"Mitotic spindle"	"HPA061600: AB_2684566"	"unprognostic (3.45e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (6.89e-5)"	"unprognostic (4.05e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.12e-2)"	"prognostic favorable (3.10e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.41e-1)"	"unprognostic (8.67e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.88e-1)"	"unprognostic (8.12e-2)"	"unprognostic (5.46e-2)"	4.2	7.6	14.5	8.2	22.5	5.5	6.8	27.3	22.9	6.5	5.8	17.5	8.4	9.7	8.2	16.6	4.3	6.5	5.4	4.7	12.4	12.6	9.3	6.9	5.1	13.6	27.0	20.7	11.8	7.1	11.7	14.3	4.4	20.8	9.3	9.6	7.4	6.3	10.4	13.6	16.9	8.8	5.8	21.6	11.0	7.8	11.5	25.9	5.9	13.8	4.9	12.3	5.2	7.0	3.0	1.1	1.6	4.7	0.9	1.7	1.0	0.8	2.2	2.7	1.9	5.2	2.3	1.3	0.9	1.6	1.5	1.3	1.2	4.2	8.0	0.6	1.1	1.6	5.6	1.6	0.8	1.8	2.9	1.6	1.4	4.2	2.8	1.4	1.6	3.3	1.9	3.3	0.9	4.6	2.5	0.7	4.4	1.3	7.3	1.2	1.9	1.5	2.6	0.6	2.6	2.0	2.4	1.8	5.1	0.8	1.8	3.3	0.9	1.3	1.1	0.8	1.4	1.4	0.6	1.2	1.8	1.0	3.1	0.6	30.7	3.2	3.7	1.4	2.9	1.1	0.5	1.3	0.5	1.5	3.9	1.7	3.0	0.5	0.7	1.1	2.3	1.7	1.0	1.6	0.9	4.7	1.0	1.0	1.0	14.5	22.5	27.3	22.9	12.4	12.6	27.0	20.7	20.8	25.9	3.0	3.7	10.8	7.8	4.9	61.2	7.7	2.5	2.7	4.5	19.2	35.3	6.1	5.0	1.8	92.4	6.0	10.7	0.0	2.9	1.6	3.9	5.5	3.5	6.4	6.2	30.2	8.1	8.6	7.8	50.4	25.3	8.2	10.1	1.0	6.4	22.9	2.8	4.8	24.4	5.9	38.7	12.9	2.8	24.7	9.1	8.0	4.3	10.1	8.3	7.8
PRICKLE4	"C6orf49, DKFZp761H221, OEBT"	ENSG00000278224	"Prickle planar cell polarity protein 4"	Q2TBC4	6	41780762-41787372	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 2.6;Intestinal endocrine cells: 3.4;Rod photoreceptor cells: 3.4;Undifferentiated cells: 2.7"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 5.3;HeLa: 6.0;hTERT-RPE1: 15.2"									"HPA031240, HPA055593"	Approved		Approved	"Mitotic spindle,Centriolar satellite"		NA	NA			"Centriolar satellite"	"Mitotic spindle"	"HPA031240: AB_10600929, HPA055593: "	"unprognostic (1.16e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.56e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.47e-4)"	"unprognostic (4.25e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.56e-5)"	"unprognostic (3.64e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.17e-3)"	4.5	2.2	0.5	3.9	1.2	0.0	8.9	0.0	2.1	6.8	3.0	0.4	5.4	1.8	10.8	4.7	4.1	4.8	5.5	2.1	0.9		2.1	1.6	12.2	0.6	0.6	0.2	2.6	1.0	3.7	1.6	2.5	1.9	5.6	2.6	2.0	2.3	8.4	2.7	1.9	0.4	4.4	0.5	8.8	5.0	1.3	0.2	0.0	5.8	4.4	4.2	3.6	13.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	1.1	3.3	1.7	0.3	2.3	5.3	0.2	0.3	0.0	0.1	1.3	1.2	0.6	2.1	1.4	0.1	2.9	0.0	0.2	0.0	0.4	0.5	0.2	6.0	1.3	0.0	0.0	0.1	2.0	0.3	0.1	0.0	15.2	0.1	0.9	1.8	0.7	0.7	0.9	0.1	0.9	0.4	3.8	0.3	1.9	0.9	0.0	2.1	3.2	0.4	0.7	0.0	3.8	0.3	4.5	0.9	0.9	2.5	1.2	1.3	0.6	0.0	0.4	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	1.4	1.3	2.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	1.6	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.1	1.7	0.0	0.0	2.5	0.0	3.4	0.0	0.3	1.0	1.4	1.8	0.0	0.0	2.7	1.1
PRR23A		ENSG00000206260	"Proline rich 23A"	A6NEV1	3	139005468-139006268	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	8	"testis: 6.1"	"Cell type enriched"	"Detected in single"	6	"Spermatocytes: 1.1"	"Cancer enriched"	"Detected in single"	17	"testis cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 2.8"									HPA047473	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		NA	NA			"Nucleoplasm, Microtubules"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA047473: AB_2680062"															"unprognostic (1.48e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.7	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0
PRR23B	FLJ46116	ENSG00000184814	"Proline rich 23B"	Q6ZRT6	3	139019031-139020926	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	36	"testis: 4.7"	"Group enriched"	"Detected in some"	13	"Spermatocytes: 6.6;Spermatogonia: 4.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047473	Uncertain		Uncertain	"Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		NA	NA			"Nucleoplasm, Microtubules"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA047473: AB_2680062"															"unprognostic (7.57e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	4.1	0.0	0.0	0.0	0.0	0.1
PRR23C	FLJ46210	ENSG00000233701	"Proline rich 23C"	Q6ZRP0	3	139042102-139044892	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	9	"blood: 3.4;testis: 4.3"	"Cell type enhanced"	"Detected in some"	16	"Early spermatids: 3.0;Late spermatids: 1.5;Spermatocytes: 1.4;Spermatogonia: 2.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"HeLa: 1.2"									HPA047473	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		NA	NA			"Nucleoplasm, Microtubules"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA047473: AB_2680062"															"unprognostic (1.00e-1)"			0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.1	4.3			0.0		0.0	0.0	0.0	1.0	0.4	3.4	0.4	0.8	0.4	0.2	0.1	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.3	0.9	1.2	0.0	0.3	0.6	0.3	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.3	0.0	0.3	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.3	0.2	0.0	0.1	0.2	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.1	3.4	0.4	0.6	0.2	0.2	0.2	0.3	0.3	0.1	0.0	1.0	0.3	0.4	2.2	0.8	0.1	0.4	0.3	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.5	0.1	0.0	0.0	0.0	0.0
PTPN7	"HEPTP, LC-PTP"	ENSG00000143851	"Protein tyrosine phosphatase, non-receptor type 7"	P35236	1	202147013-202161588	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.5;lymphoid tissue: 63.7"	"Group enriched"	"Detected in many"	5	"B-cells: 40.6;granulocytes: 137.4;T-cells: 156.8"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basal ganglia: 9.4;thalamus: 2.9"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"granulocytes: 17.0;NK-cells: 9.9;T-cells: 10.6"	"Cell line enhanced"	"Detected in some"		"HEL: 16.7;HL-60: 36.3;HMC-1: 48.9;NB-4: 15.8;THP-1: 16.7;U-937: 26.2"	"Region enriched"	"Detected in single"	10	"basal ganglia: 5.5"	"Region enriched"	"Detected in all"	4	"basal ganglia: 10.9"	"CAB009530, HPA019118"	Approved		Supported	"Microtubules,Mitotic spindle,Cytosol"		NA	NA			Cytosol	"Microtubules, Mitotic spindle"	"CAB009530: AB_2173845, HPA019118: AB_1855755"	"unprognostic (4.19e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.09e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.91e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (3.01e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.42e-8)"	"unprognostic (1.46e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"	2.6	3.1	0.5	27.1	9.4	24.5	0.6	0.4	0.5	0.6	2.3	0.6	0.0	3.0	0.7	0.6	1.7	0.8	2.9	0.5	0.6	0.8	1.1	0.9	3.2	16.5	1.2	0.2	0.6	0.6	0.0	0.7	0.4	0.8	1.3	1.9	0.7	5.3	0.3	0.4	0.6	3.7	0.9	1.6	15.4	1.4	12.7	2.9	63.7	0.9	0.6	24.8	2.9	0.8	2.6	2.6	17.0	1.1	9.9	10.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	16.7	0.0	0.0	0.0	36.3	48.9	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.7	1.5	0.0	0.0	4.9	15.8	0.0	0.0	0.0	0.7	0.0	12.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.1	0.0	0.0	7.4	1.8	10.5	0.0	26.2	0.0	11.5	1.1	17.0	10.6	1.1	9.5	1.9	7.1	10.5	2.0	2.6	5.3	6.4	7.1	9.9	0.4	2.6	9.0	2.8	0.5	9.4	0.4	0.5	0.6	0.8	1.2	0.2	0.8	2.9	3.0	9.0	40.6	1.0	2.1	2.4	0.7	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.2	0.4	2.9	0.0	0.0	0.0	0.1	1.7	0.5	137.4	0.5	15.6	0.0	0.0	4.9	6.2	1.3	4.9	23.4	8.5	9.0	0.0	5.6	0.1	0.0	2.1	0.6	4.4	0.0	0.9	0.9	0.4	2.0	0.7	156.8	0.0	0.5
PYCR3	"FLJ13852, PYCRL"	ENSG00000104524	"Pyrroline-5-carboxylate reductase 3"	Q53H96	8	143603913-143609773	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	8	"Ciliated cells: 8.1;Collecting duct cells: 14.0;Ductal cells: 7.1;Exocrine glandular cells: 7.9;Extravillous trophoblasts: 10.5;Proximal tubular cells: 10.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053776, HPA063416, HPA069706"	Uncertain		Supported	"Cytokinetic bridge,Mitotic spindle,Cytosol"		NA	NA			Cytosol	"Cytokinetic bridge, Mitotic spindle"	"HPA053776: , HPA063416: AB_2685010, HPA069706: AB_2686178"	"unprognostic (2.12e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.85e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.54e-1)"	6.1	8.1	11.5	6.7	9.7	4.8	5.6	5.3	13.4	6.9	5.4	6.1	10.8	4.4	4.7	5.2	6.1	10.1	6.3	4.4	12.2	8.5	7.7	20.5	5.9	6.7	7.6	12.1	6.7	10.6	4.3	9.1	3.5	9.7	7.5	4.0	4.5	13.7	9.1	4.8	4.7	4.9	4.0	4.4	5.9	7.0	8.6	4.5	3.8	9.5	6.3	6.1	3.6	3.1	11.1	5.4	0.4	1.4	3.2	3.2	2.1	5.9	11.1	2.0	4.3	1.9	1.2	4.2	5.3	2.2	4.3	2.4	4.9	5.8	7.8	7.1	3.8	1.6	5.0	1.9	6.2	0.8	5.3	6.8	3.8	4.2	3.2	1.9	1.7	1.2	2.1	1.6	4.9	2.8	1.4	2.4	5.0	5.9	2.4	2.0	18.2	7.4	1.3	1.8	5.5	18.0	5.2	1.9	11.7	3.9	3.8	7.2	2.4	8.5	10.9	2.0	0.8	13.4	2.2	2.1	3.8	8.0	5.9	4.9	4.2	1.0	4.9	4.5	2.4	3.5	0.3	1.4	0.2	3.2	1.1	3.1	5.8	2.1	2.6	2.1	11.1	3.0	3.0	0.4	3.2	1.0	5.4	1.8	2.1	11.5	9.7	5.3	13.4	12.2	8.5	7.6	12.1	9.7	4.5	3.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	8.1	1.2	14.0	0.0	4.9	3.3	7.1	0.0	0.0	0.0	0.0	7.9	10.5	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	6.1	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0
RASSF4	"AD037, MGC44914"	ENSG00000107551	"Ras association domain family member 4"	Q9H2L5	10	44959407-44995891	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Hofbauer cells: 128.5;monocytes: 389.5;Muller glia cells: 247.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 28.3;intermediate monocyte: 21.7;myeloid DC: 28.5;non-classical monocyte: 11.5"	"Group enriched"	"Detected in many"	9	"dendritic cells: 28.5;monocytes: 28.3"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 21.5;RH-30: 54.6;RPMI-8226: 17.8;U-937: 27.9;WM-115: 18.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA038834, HPA077069"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli"	"Cell Junctions, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA038834: AB_10795576, HPA077069: "	"unprognostic (1.83e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.14e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.81e-2)"	"unprognostic (4.83e-2)"	"unprognostic (8.75e-3)"	"unprognostic (4.20e-1)"	"unprognostic (4.11e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.20e-2)"	23.4	5.9	16.7	17.0	25.5	6.0	8.4	12.5	36.5	3.6	8.2	26.7	12.1	11.2	2.6	14.9	4.3	3.3	9.0	29.1	16.6	15.1	37.2	10.5	9.7	14.1	34.5	9.7	3.0	11.5	2.2	8.4	10.4	19.4	4.5	5.3	8.4	14.0	9.9	7.6	2.9	10.8	7.0	21.8	12.6	4.3	5.7	31.5	1.2	23.0	2.9	7.4	8.3	3.9	0.0	28.5	0.9	28.3	2.2	3.0	13.8	0.4	0.1	2.0	3.9	6.1	0.3	1.4	0.2	0.3	0.6	1.2	1.6	0.2	0.0	0.7	0.2	1.3	0.0	0.8	0.9	0.9	12.2	0.0	0.0	0.0	12.7	6.5	0.8	0.0	4.5	0.0	0.6	0.0	3.7	0.9	0.5	0.0	21.5	0.9	0.0	0.9	13.9	0.4	0.0	0.4	2.6	54.6	17.8	0.1	0.3	0.3	0.3	0.0	0.1	0.6	3.7	0.3	10.6	0.2	0.1	1.2	1.0	2.1	0.2	0.2	0.0	6.4	27.9	18.1	0.0	28.3	0.0	3.0	21.7	0.0	0.0	0.2	1.3	28.5	0.0	0.2	1.0	0.9	2.2	11.5	0.7	0.1	13.8	16.7	25.5	12.5	18.2	16.6	15.1	34.5	9.7	19.4	31.5	17.9	15.0	4.7	1.2	3.3	17.2	38.7	38.2	6.7	10.3	15.7	3.9	0.9	14.9	40.8	1.2	4.7	11.8	0.0	3.4	1.1	7.0	1.3	1.1	15.5	128.5	35.0	11.1	8.0	63.6	3.2	9.8	81.9	8.5	389.5	8.7	247.8	4.1	14.0	2.1	98.2	13.3	25.8	17.6	0.3	0.9	1.5	2.2	6.4	16.6	0.5
RMDN2	"FAM82A, FAM82A1, FLJ32954, RMD2"	ENSG00000115841	"Regulator of microtubule dynamics 2"	Q96LZ7	2	37923187-38067142	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 38.4"	"Group enriched"	"Detected in many"	6	"Early spermatids: 207.9;Late spermatids: 131.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HSkMC: 17.7"									"HPA034705, HPA034706"	Enhanced		Supported	"Golgi apparatus,Mitotic spindle,Cytosol"		Yes	No			"Mitotic spindle, Cytosol"	"Golgi apparatus"	"HPA034705: AB_2674292, HPA034706: AB_10696362"	"unprognostic (1.34e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.06e-2)"	"prognostic favorable (2.63e-4)"	"unprognostic (7.85e-2)"	"unprognostic (9.96e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.08e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.34e-3)"	"unprognostic (3.34e-1)"	4.6	38.4	6.1	8.7	6.8	1.9	8.9	6.2	8.2	6.3	9.7	1.8	5.9	6.8	7.0	9.2	3.7	4.3	5.5	4.6	5.9	3.5	6.6	24.0	8.2	3.3	3.2	5.1	3.2	4.2	3.2	8.6	3.1	4.6	8.1	8.7	5.2	5.7	10.2	5.0	2.9	14.7	7.7	4.8	14.1	4.6	15.6	4.0	2.1	4.7	3.6	2.1	4.3	9.0	7.5	6.0	4.8	8.0	6.3	6.1	2.3	3.4	3.9	2.7	1.7	12.1	12.4	1.6	7.3	9.3	3.6	3.8	1.0	11.4	2.4	3.2	10.8	2.3	3.9	0.9	4.9	4.6	4.7	2.7	4.0	1.6	3.4	6.3	0.0	4.1	17.7	3.8	5.0	0.7	6.1	2.0	1.2	4.8	2.0	6.5	1.3	0.8	4.1	5.2	6.6	3.9	0.0	0.7	0.4	9.5	3.1	2.1	7.9	5.7	0.6	6.4	2.3	1.2	5.5	2.8	5.1	5.4	2.7	2.8	3.9	6.8	4.8	6.0	0.9	5.1	0.0	4.9	1.0	4.0	8.0	6.1	7.5	1.9	2.5	3.3	5.0	2.0	4.3	4.8	6.3	6.1	6.0	0.2	2.3	6.1	6.8	6.2	8.2	5.9	3.5	3.2	5.1	4.6	4.0	26.8	23.5	5.4	7.2	2.2	3.7	3.6	7.6	13.4	27.3	5.2	2.0	1.7	6.6	4.2	207.9	3.6	21.2	0.0	3.4	0.8	7.3	2.5	15.1	12.9	4.4	4.8	4.6	3.7	6.5	131.8	8.6	4.4	5.0	1.8	11.2	5.8	2.4	7.0	5.6	5.9	2.2	6.5	3.9	3.9	3.7	2.0	0.7	3.8	15.9	2.0
RNF167	DKFZP566H073	ENSG00000108523	"Ring finger protein 167"	Q9H6Y7	17	4940008-4945222	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA049810	Approved		Approved	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"		NA	NA			"Vesicles, Cytosol"	"Mitotic spindle, Centriolar satellite"	"HPA049810: AB_2680894"	"unprognostic (1.13e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.77e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.07e-2)"	"prognostic favorable (2.03e-6)"	"unprognostic (2.16e-1)"	"prognostic favorable (4.47e-4)"	"unprognostic (7.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.12e-1)"	30.5	45.9	45.8	32.1	47.0	40.7	38.3	37.9	67.9	44.3	43.5	54.6	49.2	42.7	43.1	55.8	51.6	44.0	47.4	40.1	43.1	39.9	44.1	84.1	35.6	38.7	43.7	43.6	42.6	52.4	52.8	40.7	49.0	41.2	43.6	46.7	38.5	49.1	51.7	56.5	51.6	51.1	42.4	46.4	47.1	42.7	42.0	33.1	53.9	55.1	47.3	47.6	48.1	40.7	25.6	18.2	54.4	26.7	27.6	53.0	37.9	24.2	35.2	15.3	18.8	37.8	18.9	22.9	15.0	21.0	31.7	25.1	24.5	11.2	17.9	29.2	24.8	15.8	37.3	26.6	29.2	23.7	17.3	42.8	30.6	44.4	24.1	28.6	14.4	64.6	22.1	46.1	33.0	31.4	19.9	20.4	26.7	11.9	61.3	25.3	17.3	22.7	17.9	18.3	25.7	22.6	15.7	15.3	22.3	36.5	20.4	12.1	15.0	13.8	23.7	20.0	22.4	22.6	14.7	12.5	19.0	12.6	17.0	28.5	20.4	20.6	5.9	26.1	20.8	19.8	22.4	21.4	54.4	53.0	22.6	41.1	25.6	40.6	52.7	18.2	24.0	28.5	42.3	52.1	27.6	26.7	18.0	37.7	37.9	45.8	47.0	37.9	67.9	43.1	39.9	43.7	43.6	41.2	33.1	0.0	3.8	37.8	33.1	60.9	40.7	13.4	66.2	2.7	2.3	47.1	19.6	101.9	48.0	68.5	41.4	35.8	73.2	46.7	58.4	102.1	39.8	31.4	13.9	83.9	52.2	17.5	30.5	38.1	36.1	68.6	45.1	42.0	37.1	57.7	40.4	45.0	52.7	40.3	50.5	53.1	25.5	38.8	27.8	111.1	83.5	72.8	104.7	90.0	54.4	39.3
SH3GL2	"CNSA2, EEN-B1, SH3D2A, SH3P4"	ENSG00000107295	"SH3 domain containing GRB2 like 2, endophilin A1"	Q99962	9	17579082-17797129	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 83.0"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 74.6;Cone photoreceptor cells: 21.6;Late spermatids: 36.0;Rod photoreceptor cells: 24.1"	"Cancer enhanced"	"Detected in many"		"glioma: 8.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 5.7;HeLa: 13.8;JURKAT: 12.1;RT4: 26.7;SCLC-21H: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010056, HPA026685, HPA063573"	Enhanced	Supported	Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	No			Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB010056: AB_628099, HPA026685: AB_1856817, HPA063573: AB_2685045"	"unprognostic (4.78e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.68e-2)"	"unprognostic (5.05e-5)"	"unprognostic (4.23e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.90e-1)"	"unprognostic (5.07e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.26e-1)"	"prognostic favorable (6.68e-12)"	"unprognostic (2.65e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.44e-2)"	1.1	1.2	16.7	1.1	17.3	1.0	1.1	68.4	83.0	3.1	1.5	1.6	0.0	1.2	2.8	2.1	1.4	2.6	1.1	4.1	17.1	11.3	13.7	1.1	1.9	1.0	9.1	22.2	2.5	3.4	1.2	6.6	1.0	12.8	2.5	1.6	1.6	1.0	1.1	1.1	1.1	1.5	2.4	6.3	1.1	4.5	5.8	2.2	0.0	2.2	0.0	1.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	4.8	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	5.7	0.0	13.8	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	1.5	0.0	0.0	0.0	0.0	26.7	17.3	0.0	0.2	0.0	0.5	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.9	0.0	0.2	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	17.3	68.4	41.1	17.1	11.3	9.1	22.2	12.8	2.2	0.0	0.0	0.0	0.3	0.1	74.6	1.6	0.0	0.0	0.0	7.0	21.6	0.0	10.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	12.7	5.1	0.0	0.0	36.0	1.1	0.0	0.0	0.0	0.7	6.5	0.3	0.0	0.4	18.3	24.1	0.0	0.1	2.1	2.5	0.0	0.1	0.0	0.2	0.4
SHCBP1	"FLJ22009, PAL"	ENSG00000171241	"SHC binding and spindle associated 1"	Q8NEM2	16	46580554-46621626	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.9;lymphoid tissue: 22.9;testis: 14.1"	"Cell type enhanced"	"Detected in many"	11	"Extravillous trophoblasts: 24.1;Spermatocytes: 27.0;Spermatogonia: 30.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA048876	Uncertain		Approved	"Nuclear bodies,Microtubules,Midbody,Mitotic spindle"		Yes	Yes			"Nuclear bodies"	"Microtubules, Midbody, Mitotic spindle"	"HPA048876: AB_2680542"	"unprognostic (2.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.96e-4)"	"unprognostic (2.26e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.47e-5)"	"unprognostic (4.81e-2)"	"unprognostic (2.22e-16)"	"unprognostic (3.59e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.66e-1)"	1.5	0.8	1.0	17.3	3.0	18.9	0.9	2.4	1.3	0.8	2.2	0.6	0.3	1.3	1.5	2.0	5.7	0.4	1.1	1.5	1.0	0.7	5.0	0.3	1.7	11.2	0.7	0.7	1.2	0.3	0.2	0.8	2.8	0.7	0.9	2.5	0.3	2.6	0.3	1.4	3.8	2.3	1.9	1.1	9.9	1.4	14.1	0.9	22.9	0.6	3.0	12.9	2.0	1.6	4.6	2.0	1.8	5.4	0.3	3.4	2.1	15.3	16.4	6.2	7.5	1.3	3.2	8.6	31.4	12.4	30.7	14.3	7.8	10.1	13.5	14.2	14.3	12.4	10.2	13.6	10.2	38.0	8.6	9.1	14.8	12.4	13.2	0.0	13.0	18.9	0.6	0.6	22.5	9.2	3.0	16.0	7.1	6.1	14.3	33.3	10.2	11.6	10.8	4.8	7.2	17.5	21.2	41.6	21.6	6.3	4.8	2.6	3.4	21.7	11.5	4.9	5.6	6.3	10.7	9.2	22.5	14.6	21.7	24.9	11.3	14.9	21.6	10.3	14.0	22.6	0.3	0.8	1.8	0.5	1.3	0.1	4.6	0.8	0.4	1.2	1.9	0.1	0.3	0.8	0.3	5.4	2.0	3.4	2.1	1.0	3.0	2.4	1.3	1.0	0.7	0.7	0.7	0.7	0.9	0.0	1.4	0.0	0.5	1.4	0.2	1.4	2.5	0.0	2.3	0.0	0.0	3.1	0.0	0.3	6.4	0.3	0.4	0.0	0.0	24.1	1.0	0.4	0.0	0.0	10.7	0.0	0.0	2.5	2.9	1.5	0.6	3.9	1.7	2.8	0.2	1.0	0.1	0.0	0.4	0.0	0.3	0.0	0.5	27.0	30.1	0.5	3.1	0.7	0.6	0.9
SKA3	"C13orf3, MGC4832, RAMA1"	ENSG00000165480	"Spindle and kinetochore associated complex subunit 3"	Q8IX90	13	21153595-21176602	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 41.6;testis: 12.6"	"Cell type enhanced"	"Detected in many"	10	"Extravillous trophoblasts: 19.6;Spermatocytes: 18.7;Spermatogonia: 13.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.3"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.9;T-cells: 2.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039272, HPA039356, HPA061534"	Approved		Supported	"Mitotic spindle,Centrosome,Cytosol"		Yes	Yes			"Mitotic spindle, Centrosome"	Cytosol	"HPA039272: AB_10805359, HPA039356: AB_10805475, HPA061534: "	"unprognostic (3.46e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (9.73e-6)"	"unprognostic (2.03e-3)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.39e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.24e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-1)"	0.8	0.6	0.6	6.4	0.6	6.2	0.9	0.4	1.6	0.8	2.8	0.3	0.0	1.1	1.0	0.8	5.1	0.2	0.3	0.4	0.8	0.5	0.8	0.5	1.0	6.1	0.6	0.3	0.5	0.4	0.0	0.6	2.6	0.8	0.4	4.0	0.2	0.9	0.0	0.5	2.4	3.1	1.1	0.5	2.6	1.4	12.6	0.3	41.6	0.3	5.7	6.4	0.5	1.4	0.4	0.2	0.3	0.3	1.9	2.3	0.6	11.3	6.0	10.8	9.1	0.0	2.3	8.5	15.3	6.5	19.4	13.2	9.8	12.2	15.5	4.6	8.4	8.3	10.7	14.4	6.2	21.2	13.3	7.4	20.6	3.9	5.6	0.0	16.0	8.0	0.4	0.4	15.5	5.2	1.8	9.4	13.2	10.7	6.6	12.8	8.8	24.3	14.4	12.5	17.2	11.2	16.0	23.2	7.2	4.3	4.4	13.8	5.1	5.1	8.0	3.2	7.5	7.1	12.3	3.8	7.7	11.1	7.1	18.4	4.0	8.5	15.6	1.9	12.5	22.0	0.0	0.0	0.3	0.4	0.0	0.0	0.4	0.8	1.4	0.2	0.0	0.8	0.3	0.0	1.9	0.3	0.0	2.3	0.6	0.6	0.6	0.4	1.6	0.8	0.5	0.6	0.3	0.8	0.3	0.0	0.0	2.2	0.5	1.8	0.0	0.6	0.0	2.7	2.3	0.0	0.0	1.3	0.0	0.9	5.1	0.8	0.2	0.0	1.2	19.6	0.8	0.4	0.0	0.2	4.6	0.0	0.0	2.5	1.9	6.0	1.4	2.2	0.0	1.0	0.3	0.2	0.6	0.9	1.1	0.3	0.0	0.0	0.9	18.7	13.5	2.5	1.8	1.0	2.7	0.1
SKIV2L	"170A, DDX13, HLP, SKI2W, SKIV2, SKIV2L1"	ENSG00000204351	"Ski2 like RNA helicase"	Q15477	6	31959080-31969755	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 19.2"	"Low region specificity"	"Detected in all"							"HPA047122, HPA051959, HPA054419"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Mitotic spindle,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Mitotic spindle, Cytosol"	"HPA047122: , HPA051959: AB_2681672, HPA054419: AB_2682482"	"unprognostic (1.43e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.66e-2)"	"unprognostic (6.43e-2)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.53e-3)"	"prognostic unfavorable (3.02e-7)"	"unprognostic (6.77e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.06e-2)"	14.5	32.8	12.4	19.4	15.2	19.0	11.3	15.4	20.2	11.6	12.6	16.0	10.6	36.7	12.5	37.4	14.8	11.7	10.3	12.3	10.7	8.2	12.6	27.8	17.9	13.9	12.3	10.1	13.6	13.1	3.8	21.6	11.3	12.7	17.2	11.1	14.6	11.5	14.3	17.1	14.3	15.7	17.8	10.6	21.7	22.7	10.7	13.7	17.4	14.9	7.5	15.0	13.6	10.7	2.2	2.3	1.1	4.3	0.4	3.2	1.2	0.3	8.1	7.2	0.7	2.1	4.1	8.3	5.8	3.4	4.4	7.6	0.4	0.1	0.3	12.6	8.6	6.9	5.8	0.0	10.0	3.5	8.3	15.9	0.0	0.5	0.7	0.0	0.3	0.4	10.3	8.8	0.1	0.1	6.0	0.0	9.7	0.1	7.2	0.0	0.5	0.5	0.7	10.2	0.0	0.1	1.1	0.1	0.5	2.3	0.1	0.3	0.4	9.3	0.1	5.0	6.3	0.4	7.8	6.6	8.6	2.9	10.3	0.2	16.0	19.2	3.4	12.3	0.4	0.3	1.0	1.3	0.3	2.4	4.3	1.6	1.5	2.2	1.6	2.3	2.2	3.2	2.6	1.1	0.4	2.9	0.6	0.2	1.2	12.4	15.2	15.4	20.2	10.7	8.2	12.3	10.1	12.7	13.7	14.9	9.9	13.0	4.1	2.5	5.7	6.7	2.5	10.7	4.5	7.0	7.9	10.4	1.7	8.8	2.3	5.8	20.0	0.0	7.4	6.8	3.9	7.1	8.1	15.3	8.2	0.0	12.1	9.2	4.7	1.6	8.6	4.6	6.8	8.2	12.1	6.3	7.9	14.0	5.6	5.1	7.8	0.0	5.0	3.9	8.3	3.1	10.4	7.7	9.0	4.2
SLC34A1	"NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2"	ENSG00000131183	"Solute carrier family 34 member 1"	Q06495	5	177379235-177398848	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	79	"kidney: 94.5"	"Cell type enriched"	"Detected in some"	16	"Proximal tubular cells: 128.7"	"Cancer enriched"	"Detected in single"	12	"renal cancer: 1.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Group enriched"	"Detected in some"	12	"HEL: 6.7;U-937: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051255, HPA077175"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol"		Yes	NA			"Nuclear speckles, Plasma membrane"	"Nucleoplasm, Mitotic spindle, Cytosol"	"HPA051255: AB_2681409, HPA077175: "	"unprognostic (1.17e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.49e-2)"		"unprognostic (1.56e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.66e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.2	0.0	6.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	7.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	128.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0
SP6	"Epfn, KLF14"	ENSG00000189120	"Sp6 transcription factor"	Q3SY56	17	47844908-47855874	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 33.7;placenta: 24.7;seminal vesicle: 26.2"	"Group enriched"	"Detected in some"	9	"Cytotrophoblasts: 45.5;Syncytiotrophoblasts: 82.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebellum: 1.3;pons and medulla: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"BEWO: 45.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA024516, HPA044469"			Supported	"Nucleoplasm,Mitotic spindle,Centrosome"		Yes	No			Nucleoplasm	"Mitotic spindle, Centrosome"	"HPA024516: AB_10960551, HPA044469: AB_10966430"	"unprognostic (3.06e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.55e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (1.22e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.59e-3)"	"prognostic favorable (6.39e-4)"	"unprognostic (3.33e-1)"	"unprognostic (9.93e-2)"	"prognostic favorable (5.72e-4)"	0.9	1.0	0.1	0.5	0.0	0.0	3.8	1.3	0.2	1.7	1.8	0.1	33.7	1.5	0.4	4.1	5.8	1.1	0.4	0.4	0.1	0.1	0.9	0.1	3.6	0.5	0.1	0.0	3.6	0.4	2.0	0.2	24.7	1.1	6.9	0.7	0.2	1.0	26.2	0.1	14.9	5.3	0.3	0.3	0.9	0.3	0.4	0.0	0.8	1.3	5.6	3.6	5.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.2	0.4	0.0	0.0	0.0	0.0	45.4	0.2	0.2	0.9	0.2	9.5	0.9	0.0	0.3	0.0	0.6	1.3	0.0	1.6	0.2	0.1	0.3	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.9	0.1	0.1	0.1	2.2	0.0	0.0	0.8	0.0	0.0	0.0	3.9	0.8	0.0	0.0	0.0	0.2	5.7	1.4	0.0	0.0	5.8	0.0	8.7	2.3	0.0	3.0	0.2	1.3	0.0	0.2	0.4	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.3	0.2	0.1	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.3	0.0	0.0	0.0	1.8	0.0	45.5	0.0	0.7	0.0	0.3	6.9	0.0	0.7	1.6	0.3	1.6	0.0	0.0	3.6	0.0	1.7	1.3	0.0	0.0	0.3	0.0	0.0	0.0	2.4	0.0	1.3	2.9	0.0	0.0	0.0	0.0	0.3	0.2	0.6	0.6	82.6	0.0	2.7	5.1
SPAG5	"DEEPEST, hMAP126, MAP126"	ENSG00000076382	"Sperm associated antigen 5"	Q96R06	17	28577565-28599279	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.3;testis: 94.2"	"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 101.5;Spermatocytes: 43.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 10.1;T-reg: 6.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 10.1;T-cells: 6.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA022008, HPA022479, HPA024418"	Approved		Supported	"Nuclear bodies,Mitotic spindle,Cytosol"		NA	Yes			"Nuclear bodies, Mitotic spindle"	Cytosol	"HPA022008: AB_1853519, HPA022479: AB_1853521, HPA024418: "	"unprognostic (4.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.32e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (5.43e-5)"	"unprognostic (3.37e-3)"	"unprognostic (4.84e-3)"	"unprognostic (5.97e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (3.49e-2)"	"prognostic unfavorable (5.43e-13)"	"unprognostic (2.64e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.01e-1)"	2.1	1.1	2.3	7.6	3.8	16.5	1.7	2.7	3.4	1.7	5.1	0.8	0.5	3.9	2.0	1.9	3.8	0.5	1.8	1.7	1.8	3.7	12.7	9.5	2.6	6.5	1.5	0.7	1.4	1.9	0.4	1.9	3.3	1.3	1.3	5.3	1.3	1.4	0.9	0.8	2.5	7.1	1.5	1.9	5.8	1.7	94.2	1.0	27.3	3.9	5.5	11.2	1.8	1.3	1.2	0.4	10.1	0.7	1.0	6.2	1.2	23.8	25.3	30.3	23.5	1.5	2.5	12.4	19.3	12.2	28.7	23.2	19.7	7.3	16.8	10.5	13.4	27.0	20.8	32.9	12.2	30.7	30.2	21.1	17.8	25.2	23.9	0.2	23.1	22.5	0.8	1.1	23.1	12.0	4.2	15.0	26.2	19.2	29.7	23.3	15.7	30.4	27.5	16.3	19.2	12.8	20.3	42.2	20.0	8.6	12.7	23.0	13.5	27.7	33.4	9.6	26.1	23.8	21.2	7.4	16.6	27.9	13.7	32.9	13.8	21.1	25.9	11.2	17.7	26.4	10.1	0.0	0.3	0.6	0.7	1.1	0.9	1.8	1.3	0.1	1.2	1.5	1.4	0.6	1.0	0.4	0.4	6.2	1.2	2.3	3.8	2.7	3.4	1.8	3.7	1.5	0.7	1.3	1.0	3.0	1.7	2.2	1.1	1.8	4.7	0.4	0.0	10.7	2.3	0.0	0.0	1.7	1.7	0.5	101.5	1.0	6.2	23.3	0.3	10.6	1.1	0.6	1.1	3.9	5.3	3.2	12.5	4.3	1.8	14.4	0.9	3.6	0.0	1.0	2.3	0.6	0.3	0.8	0.0	10.9	3.3	6.5	1.7	43.6	23.0	0.9	3.2	2.5	2.7	0.5
TACC3	ERIC1	ENSG00000013810	"Transforming acidic coiled-coil containing protein 3"	Q9Y6A5	4	1721490-1745176	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 54.8;bone marrow: 26.0;lymphoid tissue: 64.3;testis: 58.1"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 43.8;Late spermatids: 49.1;Spermatocytes: 69.6;Spermatogonia: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 54.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA005781, HPA006050, CAB010111, HPA022039"	Enhanced		Enhanced	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	Yes			"Mitotic spindle, Centriolar satellite, Cytosol"	Vesicles	"CAB010111: AB_628323, HPA005781: AB_1857724, HPA006050: AB_2667505, HPA022039: AB_1857725"	"unprognostic (2.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.10e-3)"	"unprognostic (4.61e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.26e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.44e-3)"	"unprognostic (9.75e-2)"	3.8	2.7	1.1	39.1	1.1	26.0	3.4	2.1	1.4	1.9	4.4	1.1	0.8	4.5	1.8	2.7	8.8	1.6	3.5	2.0	1.4	1.3	2.5	2.4	4.3	20.1	1.3	0.7	1.6	1.0	0.5	1.8	5.7	1.1	1.6	4.9	1.6	3.0	1.2	2.0	2.6	7.7	2.5	1.8	15.6	3.4	58.1	0.9	64.3	1.6	7.3	27.9	3.2	3.0	4.0	10.4	54.8	19.9	3.8	17.9	16.1	25.4	21.2	32.5	18.6	1.7	3.6	18.3	28.9	15.5	33.2	22.0	23.5	30.8	32.5	12.3	15.7	38.6	17.2	34.3	21.0	33.8	14.3	18.6	27.5	17.6	21.6	1.6	37.2	23.4	1.5	1.4	20.9	12.1	7.3	25.2	26.8	24.8	25.7	31.4	20.8	49.0	53.3	35.1	21.8	27.9	34.8	23.0	13.0	18.8	38.6	25.3	15.9	17.4	11.0	8.1	25.5	21.6	21.6	14.7	19.4	23.2	17.5	43.5	18.0	23.9	52.1	11.2	36.0	27.4	24.7	19.9	17.9	5.5	9.0	6.0	4.0	12.3	7.6	10.4	3.8	17.9	9.8	54.8	3.8	5.5	3.1	17.5	16.1	1.1	1.1	2.1	1.4	1.4	1.3	1.3	0.7	1.1	0.9	0.0	7.9	16.0	0.5	1.9	1.0	2.2	0.0	0.0	4.5	8.7	7.9	3.3	0.0	2.1	43.8	2.5	2.0	23.3	0.6	16.5	2.6	1.0	4.7	4.3	35.7	4.8	1.2	4.9	20.5	49.1	2.6	21.9	0.0	12.6	3.1	1.4	1.9	3.5	2.5	1.8	3.2	6.5	1.0	69.6	47.8	1.3	3.3	15.3	5.7	1.3
TAF1D	"JOSD3, MGC5306, TAF(I)41"	ENSG00000166012	"TATA-box binding protein associated factor, RNA polymerase I subunit D"	Q9H5J8	11	93729948-93784391	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA030703, HPA055935, HPA060385"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Mitotic spindle,Centriolar satellite"		Yes	No			Nucleoplasm	"Nucleoli, Mitotic spindle, Centriolar satellite"	"HPA030703: , HPA055935: AB_2682974, HPA060385: AB_2684271"	"unprognostic (9.91e-3)"	"unprognostic (4.38e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.40e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.68e-3)"	"unprognostic (9.70e-2)"	"unprognostic (5.24e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (3.17e-7)"	"unprognostic (1.95e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.37e-2)"	13.9	10.6	12.5	19.9	18.4	14.2	12.9	17.3	20.1	15.1	14.7	4.3	17.3	16.8	15.2	9.7	16.0	11.5	18.1	11.1	12.0	7.6	13.6	18.7	15.8	19.0	14.4	13.6	20.9	30.5	9.3	24.3	18.5	13.6	16.4	13.4	3.9	12.3	11.4	31.5	14.5	17.8	18.1	22.1	18.4	13.0	8.0	13.6	13.1	13.2	12.9	12.2	28.1	17.1	24.1	14.3	22.3	9.2	9.0	16.3	2.7	3.9	3.1	4.2	4.2	4.1	16.2	7.6	4.4	3.3	5.7	4.1	10.6	10.7	9.5	8.5	4.3	1.9	11.7	4.9	6.9	6.3	2.6	2.0	9.7	17.5	6.3	4.1	8.8	5.2	4.5	7.5	4.5	7.4	9.0	7.1	5.0	6.6	18.8	7.8	1.2	7.4	17.0	3.2	2.9	2.4	3.5	4.7	8.1	6.5	6.3	3.0	6.3	2.6	9.6	3.0	6.1	11.9	2.2	6.9	8.6	5.7	12.9	6.5	8.4	9.5	8.0	3.1	9.4	2.9	17.4	9.2	14.8	10.0	6.5	10.0	19.5	13.8	10.9	6.2	24.1	16.3	13.6	22.3	9.0	5.2	14.3	9.4	2.7	12.5	18.4	17.3	20.1	12.0	7.6	14.4	13.6	13.6	13.6	83.4	80.4	125.3	241.5	216.9	84.2	23.0	129.9	91.0	139.9	27.9	37.3	149.3	38.1	80.3	12.9	79.2	61.0	0.0	125.2	151.7	105.8	205.9	100.6	46.5	62.1	65.2	105.6	52.2	91.2	12.3	119.0	105.3	75.9	66.7	101.9	39.6	109.2	66.6	63.6	64.8	75.6	71.1	94.7	37.0	70.9	177.4	134.6	106.5	115.9	265.8
TDRD6	"bA446F17.4, CT41.2, NY-CO-45, SPATA36"	ENSG00000180113	"Tudor domain containing 6"	O60522	6	46687875-46704319	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 37.9"	"Cell type enhanced"	"Detected in many"	23	"Early spermatids: 172.1;Spermatocytes: 66.0;Spermatogonia: 30.6"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.1"	"Region enriched"	"Detected in many"	6	"cerebellum: 8.2"	"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4;intermediate monocyte: 1.4"	"Lineage enhanced"	"Detected in single"		"monocytes: 2.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.6;HeLa: 4.0;hTCEpi: 2.3;PC-3: 3.4;SCLC-21H: 1.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA075923, HPA077353"	Enhanced		Approved	"Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			"Microtubules, Cytokinetic bridge, Mitotic spindle"	Vesicles	"HPA075923: , HPA077353: "	"unprognostic (2.01e-1)"	"unprognostic (7.41e-3)"	"unprognostic (7.25e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.54e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.32e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.20e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-2)"	"unprognostic (4.38e-3)"	0.7	1.4	0.7	2.6	1.3	0.0	0.7	8.2	1.3	0.7	0.7	0.7	0.7	0.3	0.7	2.9	0.7	0.3	1.7	0.7	1.0	0.8	0.7	1.3	0.7	3.0	1.1	0.7	0.7	0.7	0.4	1.8	1.1	0.7	1.6	0.0	0.9	0.9	0.7	1.5	2.9	0.7	0.7	0.9	1.9	0.3	37.9	0.7	0.7	5.2	0.7	0.7	1.6	0.7	0.0	0.7	0.1	2.4	0.0	0.0	0.4	0.0	0.0	0.2	1.5	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.0	0.4	0.0	0.0	0.0	1.6	0.0	4.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.1	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	3.4	0.0	0.0	0.0	0.9	0.7	1.7	0.0	0.1	0.0	0.1	0.9	0.0	0.0	0.0	0.3	0.6	0.1	0.0	1.1	0.0	0.4	0.0	0.0	0.7	0.0	2.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.7	1.3	8.2	0.9	1.0	0.8	1.1	0.7	0.7	0.7	8.9	0.3	0.0	0.4	0.5	8.3	2.9	0.0	0.0	6.8	7.0	5.9	0.0	1.7	0.1	172.1	0.6	0.0	0.0	0.2	0.0	0.5	0.5	0.0	1.6	0.1	4.8	4.1	0.0	0.3	17.5	3.7	0.0	3.3	0.0	0.0	1.4	0.1	0.0	4.2	0.0	6.2	12.9	0.5	66.0	30.6	1.4	0.0	0.0	0.5	0.1
TFDP2	Dp-2	ENSG00000114126	"Transcription factor Dp-2"	Q14188	3	141944428-142149544	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 140.3"	"Cell type enhanced"	"Detected in all"	12	"Early spermatids: 731.6;Late spermatids: 294.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 42.8;MOLT-4: 80.4;REH: 42.9;U-698: 70.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018396, HPA070399"	Supported		Supported	"Nucleoplasm,Vesicles,Mitotic spindle"		Yes	No			Nucleoplasm	"Vesicles, Mitotic spindle"	"CAB018396: AB_2287284, HPA070399: "	"unprognostic (1.35e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (8.08e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.60e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (9.84e-4)"	"unprognostic (6.04e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.08e-1)"	8.4	8.4	6.1	6.3	8.7	20.7	9.3	9.9	8.6	8.9	11.1	6.5	6.5	10.4	9.9	8.6	8.3	7.2	11.6	12.0	7.5	4.9	14.3	9.5	6.8	5.3	6.0	5.0	11.6	8.8	10.4	19.4	13.5	8.0	9.9	6.6	8.8	7.9	6.9	14.5	8.0	14.6	11.8	8.5	5.3	8.6	51.9	5.4	140.3	10.6	4.8	6.4	9.7	8.0	9.3	16.5	24.6	4.5	18.0	14.7	5.7	6.3	2.9	12.3	9.8	4.1	4.5	27.1	3.2	3.7	5.1	8.3	3.7	6.3	22.5	15.0	3.6	9.0	3.8	3.1	6.1	7.2	9.0	5.6	27.1	4.4	4.9	4.0	8.2	9.6	4.2	4.3	5.6	5.4	4.8	3.5	42.8	10.1	1.2	8.8	4.8	80.4	3.1	9.9	3.3	4.0	42.9	8.5	5.2	5.9	3.3	5.4	5.0	10.8	4.0	5.5	9.6	9.3	4.2	2.3	4.9	4.5	3.9	4.0	4.2	3.8	70.6	3.9	2.2	2.3	24.6	2.1	22.3	14.7	3.4	5.7	6.6	6.7	7.6	4.8	9.3	10.1	11.8	2.4	18.0	4.5	16.5	6.1	5.7	6.1	8.7	9.9	8.6	7.5	4.9	6.0	5.0	8.0	5.4	29.8	20.4	15.7	43.3	22.2	30.3	70.0	38.2	54.9	33.0	45.4	31.4	191.4	79.6	29.5	731.6	22.4	31.6	116.8	23.1	95.8	33.4	41.8	31.3	35.9	24.4	35.0	37.2	20.9	9.2	294.5	71.4	15.0	5.0	17.2	32.3	24.6	24.5	32.3	70.7	74.6	34.6	25.8	21.4	52.6	55.1	17.6	83.0	35.5	42.3	22.7
TMEM9	TMEM9A	ENSG00000116857	"Transmembrane protein 9"	Q9P0T7	1	201134772-201171574	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008483			Approved	"Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			Vesicles	"Microtubules, Cytokinetic bridge, Mitotic spindle"	"HPA008483: "	"unprognostic (1.88e-1)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (2.95e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.17e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.90e-2)"	12.4	33.4	32.3	8.4	33.3	10.1	20.4	19.9	43.5	31.3	13.1	23.0	20.1	10.9	24.4	30.4	12.0	34.5	17.2	18.4	31.2	35.9	25.7	21.8	18.2	13.4	24.2	29.4	32.8	36.0	20.2	19.0	12.3	23.0	25.9	11.3	28.3	26.3	22.0	15.9	11.0	9.5	16.6	17.0	9.4	15.2	22.2	12.2	7.8	30.7	7.0	10.8	17.6	14.9	28.0	29.3	21.2	32.7	15.1	36.8	37.2	15.0	28.5	18.1	41.8	9.8	14.0	32.1	11.9	12.7	19.0	17.2	27.9	24.5	8.0	17.4	17.8	17.6	30.2	18.9	19.5	9.4	5.1	32.5	13.9	46.0	18.2	18.9	6.6	13.0	16.6	21.7	17.7	10.8	23.0	11.7	11.3	24.8	8.8	16.3	19.3	8.0	10.9	27.6	13.8	70.5	14.5	27.0	10.4	21.8	11.7	16.9	34.5	21.2	36.4	21.9	28.2	44.7	11.7	8.7	21.4	17.8	17.0	14.3	36.2	31.1	6.1	16.2	7.2	10.3	19.1	32.7	16.9	25.5	20.9	28.7	28.0	24.8	20.9	26.9	27.0	36.8	24.2	21.2	15.1	18.9	29.3	21.5	37.2	32.3	33.3	19.9	43.5	31.2	35.9	24.2	29.4	23.0	12.2	47.6	38.0	4.5	30.3	11.4	64.1	33.1	48.4	54.9	40.9	34.9	29.5	35.6	14.9	74.6	47.8	25.3	7.4	0.0	65.8	41.2	50.3	37.0	12.7	32.1	24.1	7.9	30.6	29.4	15.0	47.1	65.6	14.5	21.9	11.8	25.4	102.0	41.4	18.2	49.8	48.1	26.0	12.9	32.0	44.2	81.2	12.2	10.9	12.8	28.5	22.0
TPX2	"C20orf1, C20orf2, DIL-2, p100"	ENSG00000088325	"TPX2, microtubule nucleation factor"	Q9ULW0	20	31739271-31801805	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 92.7"	"Group enriched"	"Detected in many"	5	"Erythroid cells: 70.0;Extravillous trophoblasts: 57.2;Spermatocytes: 121.8;Spermatogonia: 68.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 4.0;NK-cells: 4.8;T-cells: 10.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005487	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	Yes			Nucleoplasm	"Cytokinetic bridge, Mitotic spindle"	"HPA005487: AB_1858223"	"unprognostic (2.18e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.43e-6)"	"unprognostic (2.99e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (8.07e-7)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (3.70e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.68e-5)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.56e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.39e-1)"	1.8	1.7	1.0	13.4	2.0	21.7	1.2	2.2	1.7	2.2	5.7	0.5	0.3	4.6	1.2	2.3	13.3	0.5	1.9	1.5	0.8	0.7	1.2	2.7	2.6	12.9	0.7	1.1	0.8	0.5	0.0	0.7	6.6	0.9	0.7	7.4	0.5	2.3	0.5	2.2	5.9	4.7	3.2	0.9	5.9	3.2	22.0	0.6	92.7	0.7	11.0	16.2	2.2	3.8	1.0	1.4	4.0	0.1	4.8	10.4	1.3	70.8	23.8	28.8	22.5	2.3	4.2	27.8	29.8	16.9	43.3	32.7	50.5	30.7	33.4	17.6	16.6	32.4	37.5	32.8	27.0	49.5	14.4	12.7	65.4	22.8	34.4	0.7	25.1	16.8	1.4	1.5	27.1	19.8	6.2	23.3	25.3	48.3	30.5	33.9	29.1	41.9	19.5	32.1	27.4	25.8	23.9	77.8	20.2	11.6	11.6	20.9	14.1	45.6	17.3	13.5	20.7	30.0	15.3	15.7	48.6	29.9	22.2	45.7	12.2	21.1	29.9	15.2	89.5	31.6	4.0	0.0	0.5	0.6	0.0	0.3	1.0	1.9	2.3	0.6	0.4	0.4	0.7	0.4	4.8	0.1	1.4	10.4	1.3	1.0	2.0	2.2	1.7	0.8	0.7	0.7	1.1	0.9	0.6	0.0	6.2	16.2	0.8	6.2	0.8	0.8	7.6	0.0	5.7	0.0	0.0	4.4	0.0	1.0	6.4	0.3	0.6	70.0	0.4	57.2	2.9	0.6	0.0	2.5	15.9	1.6	1.2	9.8	5.3	10.6	0.9	5.1	0.0	3.6	2.6	0.3	1.2	0.6	0.0	0.0	0.3	0.0	2.1	121.8	68.8	5.4	3.9	6.9	7.3	1.4
TRAT1	"HSPC062, TCRIM, TRIM"	ENSG00000163519	"T cell receptor associated transmembrane adaptor 1"	Q6PIZ9	3	108822698-108855005	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	17	"blood: 57.9;lymphoid tissue: 128.9"	"Cell type enriched"	"Detected in some"	10	"T-cells: 74.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 57.9"	"Group enriched"	"Detected in many"	160	"granulocytes: 53.1;T-cells: 57.9"	"Group enriched"	"Detected in some"	23	"JURKAT: 16.4;MOLT-4: 38.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002356, CAB026130, HPA072760"	Enhanced		Enhanced	"Plasma membrane,Mitotic spindle,Centriolar satellite"		NA	NA			"Plasma membrane"	"Mitotic spindle, Centriolar satellite"	"CAB026130: , HPA002356: AB_1080375, HPA072760: "	"unprognostic (1.54e-4)"	"unprognostic (1.41e-3)"	"unprognostic (6.82e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.87e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.21e-3)"	"unprognostic (8.96e-3)"	"unprognostic (8.03e-2)"	"unprognostic (4.32e-1)"	"unprognostic (2.86e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.90e-4)"	"unprognostic (4.36e-2)"	2.6	0.3	0.2	8.2	0.2	1.8	1.3	0.2	0.3	0.8	1.0	0.1	0.1	0.9	0.7	0.3	0.9	0.8	1.9	0.7	0.2	0.2	1.1	1.0	4.0	17.8	0.2	0.2	0.5	0.5	0.0	0.4	0.3	0.3	1.1	1.0	0.1	1.9	0.3	0.4	1.0	5.5	0.2	0.3	9.0	1.6	0.5	0.1	128.9	1.1	1.0	9.8	2.8	1.1	0.1	0.1	53.1	0.1	0.3	57.9	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	1.1	0.0	0.0	38.6	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.1	0.1	0.0	10.5	0.0	21.2	0.1	42.1	21.6	0.0	0.0	57.9	14.2	0.6	0.3	0.1	0.1	17.9	22.9	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.3	0.1	0.0	5.6	0.9	0.1	7.4	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	2.3	0.6	0.2	0.0	0.0	1.8	0.0	1.4	0.0	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	6.9	0.1	74.0	0.0	0.0
TUBB	"M40, MGC16435, OK/SW-cl.56, Tubb5"	ENSG00000196230	"Tubulin beta class I"	P07437	6	30720201-30725426	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 198.7"	"Cell type enhanced"	"Detected in all"	6	"Extravillous trophoblasts: 1893.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005417, CAB012406, HPA043640, HPA046280"	Enhanced		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	Yes		510000000	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB005417: AB_2241191, CAB012406: AB_2210370, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (1.01e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (2.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (2.62e-8)"	"unprognostic (8.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.50e-1)"	51.6	27.7	30.0	31.8	33.2	78.8	30.0	30.9	57.2	43.3	37.0	24.3	18.7	10.8	58.5	39.7	39.9	41.0	29.6	33.1	23.7	48.2	31.4	74.1	32.7	62.1	27.8	24.0	81.5	27.0	15.3	16.3	41.1	39.9	32.2	34.2	30.6	27.9	24.3	29.6	37.6	24.3	37.6	27.4	47.7	29.1	19.7	14.4	198.7	26.9	36.8	91.5	39.7	34.3	15.4	17.5	8.6	15.4	12.3	18.2	19.8	42.4	15.7	61.3	26.6	17.4	30.0	0.5	0.0	0.0	0.0	0.0	29.9	16.2	21.2	26.3	19.6	16.4	14.7	49.5	44.5	0.0	11.9	31.3	0.5	0.0	17.2	8.3	57.8	28.5	22.3	10.4	0.0	0.5	13.5	21.6	46.9	16.7	0.0	27.0	30.7	41.8	0.2	0.0	13.5	18.5	0.0	0.6	12.5	35.8	24.2	10.7	35.9	23.1	10.2	0.4	39.9	26.7	5.3	13.3	64.5	28.7	0.0	0.2	19.8	38.1	49.2	12.7	57.5	81.6	4.9	7.7	8.6	15.5	12.2	18.2	15.4	12.1	17.6	6.2	10.0	12.3	12.2	4.3	12.3	15.4	17.5	14.2	19.8	30.0	33.2	30.9	57.2	23.7	48.2	27.8	24.0	39.9	14.4	122.1	48.4	184.6	261.7	511.8	64.2	96.8	186.0	50.9	100.1	162.3	37.3	493.5	263.6	1083.5	6.9	247.2	97.2	700.8	929.9	1893.7	657.3	117.4	203.1	240.5	829.2	103.3	156.9	268.2	310.8	15.4	372.8	361.3	305.4	1224.5	123.1	172.7	843.8	91.2	223.1	178.3	51.0	116.4	444.0	46.2	42.8	376.4	184.3	200.5	178.2	168.9
TUBB1	dJ543J19.4	ENSG00000101162	"Tubulin beta 1 class VI"	Q9H4B7	20	59019254-59026654	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 58.6;lymphoid tissue: 28.2"	"Cell type enhanced"	"Detected in some"	23	"Early spermatids: 11.5;Erythroid cells: 23.3;Late spermatids: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"basophil: 8.7;neutrophil: 6.5"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 8.7"	"Cell line enriched"	"Detected in some"	19	"HEL: 25.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004286, HPA043640, HPA046280"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA		480000000	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB004286: AB_2288090, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (3.76e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.10e-4)"	"unprognostic (1.02e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.86e-2)"	"unprognostic (7.51e-4)"	"unprognostic (1.90e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.80e-5)"	"unprognostic (3.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.00e-1)"	0.6	0.3	0.2	0.4	0.6	12.2	0.2	0.7	0.7	0.2	0.2	0.1	0.0	0.2	0.2	0.9	0.2	0.5	0.6	10.8	0.2	0.2	0.2	1.0	8.3	0.4	0.2	0.4	0.8	0.4	0.0	0.7	3.2	0.6	0.3	0.0	0.5	0.2	0.6	0.6	0.2	0.5	0.0	0.6	28.2	0.3	1.8	0.0	0.0	0.5	0.3	0.2	0.4	1.8	0.1	0.6	8.7	0.5	0.0	0.1	58.6	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.3	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	25.0	0.6	1.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.1	0.3	0.2	0.0	0.1	0.3	0.2	0.1	0.2	0.0	0.3	0.3	0.2	0.1	0.5	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.1	0.2	0.3	8.7	0.5	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.0	6.5	0.0	0.0	0.6	0.1	58.6	0.2	0.6	0.7	0.7	0.2	0.2	0.2	0.4	0.6	0.0	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.2	0.0	3.9	0.0	0.0	0.0	11.5	0.0	0.0	23.3	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.6	0.0	4.9	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0
TUBB2A	"dJ40E16.7, TUBB, TUBB2"	ENSG00000137267	"Tubulin beta 2A class IIa"	Q13885	6	3153669-3157526	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 158.3"	"Cell type enhanced"	"Detected in all"	7	"Horizontal cells: 487.8;Suprabasal keratinocytes: 322.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 6.0;monocytes: 2.6;T-cells: 5.5"	"Cell line enhanced"	"Detected in many"		"AF22: 49.5;CACO-2: 50.0;SuSa: 77.3;WM-115: 55.3"	"Low region specificity"	"Detected in all"							"CAB015339, HPA043640, HPA046280"	Supported		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB015339: AB_2210539, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (2.57e-1)"	"unprognostic (9.86e-3)"	"unprognostic (5.90e-3)"	"unprognostic (7.98e-3)"	"unprognostic (4.02e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.53e-2)"	"unprognostic (1.48e-3)"	"unprognostic (9.99e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.42e-2)"	"prognostic favorable (4.65e-4)"	"unprognostic (2.39e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (1.61e-4)"	19.6	9.1	59.4	8.7	46.9	26.8	7.9	46.5	158.3	5.4	8.7	9.1	1.2	11.1	6.7	13.5	17.2	4.8	10.9	6.1	56.5	76.0	7.7	16.9	4.1	5.4	58.4	43.3	2.6	14.3	1.6	6.9	11.0	78.6	6.1	4.5	4.6	5.8	8.0	7.3	24.7	13.8	17.7	24.3	2.3	17.6	2.9	5.4	0.1	1.9	10.4	4.7	5.4	5.8	6.0	0.9	0.7	2.6	0.6	5.5	1.8	10.6	9.0	49.5	11.1	6.3	7.0	2.9	23.7	8.9	16.2	23.6	50.0	3.6	5.3	14.6	22.4	16.1	5.1	17.5	5.3	5.6	25.6	11.6	1.8	2.6	15.1	6.5	0.2	1.8	7.3	6.3	17.0	1.1	5.9	7.5	2.2	6.3	1.8	14.5	4.7	2.8	0.5	42.4	3.1	11.6	2.4	4.6	4.0	5.5	5.4	12.4	11.3	5.9	1.8	33.9	77.3	3.8	0.3	14.9	11.0	12.0	23.7	12.7	0.7	0.8	3.6	4.0	1.4	55.3	0.0	1.9	0.0	4.0	2.6	4.4	6.0	3.9	5.5	0.9	1.2	2.1	3.7	0.7	0.6	2.0	0.3	5.3	1.8	59.4	46.9	46.5	89.2	56.5	76.0	58.4	43.3	78.6	5.4	14.9	16.2	11.3	50.6	276.6	98.5	16.7	48.4	24.1	15.9	12.2	15.7	2.1	184.1	43.1	50.4	30.8	111.0	70.0	155.6	48.0	118.0	26.1	34.6	48.9	44.2	487.8	70.0	11.1	6.5	18.3	19.2	38.9	123.2	125.4	69.8	243.3	112.9	105.2	14.5	26.4	58.8	6.5	107.2	21.2	12.6	322.2	5.1	10.7	23.3	53.3
TUBB2B	"bA506K6.1, DKFZp566F223, MGC8685"	ENSG00000137285	"Tubulin beta 2B class IIb"	Q9BVA1	6	3224261-3231730	"Disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 125.4"	"Group enriched"	"Detected in many"	6	"Distal tubular cells: 351.5;Horizontal cells: 406.8;Muller glia cells: 726.9"	"Cancer enriched"	"Detected in many"	9	"glioma: 216.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	21	"memory B-cell: 2.0"	"Lineage enriched"	"Detected in single"	21	"B-cells: 2.0"	"Cell line enhanced"	"Detected in some"		"AF22: 73.9;CACO-2: 54.3;NTERA-2: 36.2;RPMI-8226: 37.2;SCLC-21H: 110.9;SH-SY5Y: 53.8;SuSa: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043640, HPA046280"	Supported		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (2.66e-2)"	"unprognostic (3.41e-1)"	"unprognostic (5.92e-3)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (6.81e-2)"	"unprognostic (3.26e-2)"	"unprognostic (9.03e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.78e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.24e-3)"	"unprognostic (6.04e-2)"	"unprognostic (3.58e-4)"	"unprognostic (2.30e-3)"	3.8	5.9	53.6	5.9	63.1	1.5	4.4	23.2	125.4	4.7	4.6	22.6	0.0	2.8	4.0	29.7	2.5	2.0	3.6	2.1	34.3	48.6	6.6	1.4	1.6	6.0	56.7	18.6	1.5	2.9	1.4	4.8	3.9	36.1	2.1	3.1	2.3	3.6	4.3	4.5	3.0	4.7	5.5	80.5	1.8	3.3	1.7	16.2	0.0	1.6	0.0	4.6	2.1	0.6	2.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	73.9	22.3	0.0	0.0	0.0	0.4	0.9	2.7	6.0	54.3	0.2	0.0	0.7	0.5	0.0	0.0	28.9	0.0	1.6	0.0	13.2	0.0	0.0	4.2	0.2	0.0	0.8	0.4	0.0	0.3	0.0	0.9	0.0	0.0	0.8	0.1	0.7	0.0	0.1	0.0	36.2	0.0	2.3	0.0	3.5	37.2	0.3	0.0	110.9	53.8	0.0	0.2	0.3	35.3	0.4	0.0	0.0	0.0	12.6	0.6	0.0	7.3	0.0	0.0	0.1	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	53.6	63.1	23.2	39.2	34.3	48.6	56.7	18.6	36.1	16.2	0.0	0.0	1.5	2.5	7.7	30.9	33.1	10.2	0.0	0.0	7.0	15.7	0.1	351.5	10.8	3.0	6.0	0.2	0.0	3.0	0.4	24.0	2.8	0.0	0.8	2.5	406.8	64.0	1.3	0.0	4.1	0.3	0.0	87.7	6.4	0.5	726.9	19.6	0.0	0.0	1.4	34.7	0.0	27.8	1.2	6.8	2.4	0.7	0.0	0.4	0.7
TUBB3	"beta-4, CFEOM3, CFEOM3A, FEOM3"	ENSG00000258947	"Tubulin beta 3 class III"	Q13509	16	89921392-89938761	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 85.1"	"Cell type enhanced"	"Detected in some"	20	"Ductal cells: 22.7;Exocrine glandular cells: 18.4;Late spermatids: 9.5;Pancreatic endocrine cells: 44.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"naive B-cell: 5.2"	"Lineage enriched"	"Detected in single"	7	"B-cells: 5.2"	"Cell line enhanced"	"Detected in many"		"A549: 66.2;SCLC-21H: 67.5;SH-SY5Y: 68.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043640, HPA046280"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA		250000000	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (7.08e-2)"	"unprognostic (3.37e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.12e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.27e-3)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.91e-2)"	5.1	19.4	23.9	8.9	23.3	3.2	1.2	24.1	85.1	2.4	4.1	7.8	0.0	3.6	7.9	1.1	2.2	1.0	7.3	1.8	25.0	66.5	1.1	1.1	1.6	5.7	44.5	15.9	1.1	2.5	1.0	9.9	2.2	60.9	1.6	2.8	5.5	1.9	1.3	1.0	4.1	4.8	9.3	12.9	1.1	2.5	11.2	3.3	0.0	1.0	1.7	4.4	5.3	0.6	5.2	0.7	0.2	0.3	0.0	0.2	0.2	4.6	66.2	24.7	28.1	2.9	28.5	1.0	28.4	4.8	17.1	7.8	9.0	8.6	14.0	14.8	21.4	12.0	17.5	23.8	4.2	4.3	3.4	2.3	0.1	5.6	58.7	0.9	0.0	11.0	16.3	1.2	26.2	2.3	22.3	14.1	0.9	1.4	0.5	19.5	44.1	0.1	4.7	43.3	1.7	36.4	0.0	8.7	1.5	21.3	1.3	67.5	68.2	39.9	0.7	19.4	4.7	2.2	0.2	17.6	23.5	25.3	31.4	28.7	0.2	2.8	5.3	24.3	1.8	41.5	0.2	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.2	0.0	5.2	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.2	23.9	23.3	24.1	51.0	25.0	66.5	44.5	15.9	60.9	3.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	22.7	5.3	0.0	0.0	0.0	18.4	0.3	0.0	0.0	0.0	0.0	0.2	4.8	4.7	0.0	0.0	9.5	0.3	0.0	0.0	0.0	0.0	0.2	44.3	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0
TUBB4A	"beta-5, DYT4, TUBB4"	ENSG00000104833	"Tubulin beta 4A class IVa"	P04350	19	6494319-6502848	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Dystonia, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 62.6;brain: 197.8"	"Cell type enhanced"	"Detected in many"	15	"Horizontal cells: 9.5;Melanocytes: 13.5;Muller glia cells: 31.5"	"Group enriched"	"Detected in many"	9	"glioma: 50.1;melanoma: 83.2;testis cancer: 49.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	12	"B-cells: 5.3;T-cells: 6.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 36.3;HAP1: 20.8;HEL: 30.5;PC-3: 15.1;REH: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010768, HPA043640, HPA046280"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA		360000000	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB010768: AB_261775, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.05e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (8.42e-7)"	"unprognostic (3.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.08e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.30e-1)"	2.3	62.6	41.3	2.9	52.4	2.2	2.3	115.3	197.8	2.2	2.9	115.2	0.0	2.7	2.3	2.3	2.5	2.3	2.4	2.3	56.8	36.9	2.8	2.2	2.3	2.6	73.7	34.5	2.6	2.8	2.1	0.2	2.5	72.0	2.2	2.5	2.7	2.7	2.3	3.9	4.6	3.2	2.5	73.2	4.8	2.2	31.3	43.0	0.0	2.1	0.0	2.4	2.3	0.1	5.3	0.1	0.2	0.0	0.4	6.5	1.6	0.0	10.7	0.0	36.3	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.1	0.0	10.6	0.0	1.3	0.3	20.8	0.0	0.2	0.0	3.4	30.5	0.7	0.3	0.0	0.0	2.0	0.0	0.0	0.8	0.0	0.3	0.0	6.0	2.9	0.2	0.0	1.0	6.1	1.3	2.7	0.0	15.1	15.0	0.0	7.1	3.9	0.0	0.1	12.1	0.1	0.1	10.6	1.0	0.3	0.7	0.0	0.0	4.5	0.0	0.1	0.8	0.5	4.1	0.4	0.0	0.2	0.0	0.0	0.0	6.3	0.0	4.6	5.3	1.0	6.5	0.0	1.6	2.2	4.7	0.2	0.4	0.0	0.1	0.0	1.6	41.3	52.4	115.3	79.7	56.8	36.9	73.7	34.5	72.0	43.0	0.0	0.0	0.5	0.5	1.6	2.6	8.1	0.0	0.0	0.0	0.0	0.0	0.1	5.0	1.6	2.5	0.6	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.0	0.3	9.5	0.0	0.6	0.0	5.6	4.9	0.0	13.5	0.0	0.0	31.5	0.2	0.0	0.4	1.6	1.7	6.5	1.7	1.4	1.1	1.4	0.1	0.0	0.0	0.1
TUBB4B	"Beta2, TUBB2C"	ENSG00000188229	"Tubulin beta 4B class IVb"	P68371	9	137241213-137243707	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease mutation, FDA approved drug targets, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 207.7"	"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 1754.5;Late spermatids: 2132.3;Spermatocytes: 1761.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010880, HPA043640, HPA046280"	Enhanced		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	Yes			Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB010880: AB_609915, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.50e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (1.29e-2)"	"unprognostic (8.93e-2)"	"prognostic unfavorable (9.98e-4)"	"unprognostic (9.92e-3)"	"unprognostic (2.90e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.47e-3)"	"unprognostic (6.37e-2)"	"unprognostic (1.36e-2)"	"prognostic favorable (6.36e-6)"	"unprognostic (1.69e-1)"	31.1	22.1	33.0	22.1	32.7	87.5	24.4	22.3	67.2	23.0	44.0	35.9	25.2	33.4	22.7	52.7	65.7	122.5	32.1	66.4	35.2	55.5	46.6	49.7	28.4	21.0	33.8	46.6	33.7	33.0	13.4	25.3	31.9	48.4	29.8	27.3	40.9	41.8	31.8	37.1	55.9	38.9	28.4	21.5	21.0	30.5	207.7	12.2	61.1	40.1	56.7	40.1	21.8	25.7	17.2	18.3	37.0	14.6	11.2	21.7	14.4	59.3	89.0	38.1	27.4	19.2	20.3	53.1	55.8	47.0	77.2	53.4	94.0	73.1	36.4	42.7	54.1	75.3	113.0	47.1	89.8	29.4	25.9	39.8	26.4	70.9	73.8	12.1	31.0	29.4	13.0	25.5	58.9	16.2	19.2	55.1	26.1	36.8	21.0	63.6	163.2	28.1	42.3	40.2	105.3	155.3	35.8	72.7	33.7	58.0	55.6	26.7	28.7	73.9	42.6	14.8	22.6	61.3	33.8	42.7	55.2	61.5	62.5	73.3	8.1	22.5	40.2	45.0	24.3	47.8	37.0	14.1	20.5	21.4	14.6	20.6	17.2	16.7	18.2	17.5	14.1	10.7	14.3	28.6	11.2	14.6	18.3	21.7	14.4	33.0	32.7	22.3	67.2	35.2	55.5	33.8	46.6	48.4	12.2	205.4	139.7	150.7	842.9	289.7	457.2	82.3	132.5	1026.5	175.1	136.1	282.7	235.6	187.3	348.8	1754.5	152.3	547.1	490.6	391.5	458.3	161.8	365.4	188.9	114.3	228.8	230.4	375.8	129.5	67.2	2132.3	235.3	111.2	131.6	359.7	292.5	271.2	343.5	375.2	143.9	259.6	647.3	109.9	245.2	1761.9	564.6	260.1	268.5	97.8	359.3	575.4
TUBB6	"HsT1601, MGC4083"	ENSG00000176014	"Tubulin beta 6 class V"	Q9BUF5	18	12307669-12344320	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Extravillous trophoblasts: 423.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 46.7"	"Group enriched"	"Detected in many"	5	"B-cells: 14.8;dendritic cells: 46.7"	"Cell line enhanced"	"Detected in many"		"TIME: 94.1"	"Region enriched"	"Detected in single"	10	"olfactory region: 24.5"	"Low region specificity"	"Detected in all"			"HPA043640, HPA046280"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	Yes		150000000	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.40e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.20e-3)"	"unprognostic (8.42e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"prognostic unfavorable (1.22e-7)"	"unprognostic (5.83e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (9.69e-4)"	63.0	7.2	4.2	24.0	7.6	7.9	46.6	3.2	3.9	47.4	38.7	5.6	14.7	8.9	62.8	36.3	83.3	28.6	35.9	39.5	5.1	5.5	13.6	8.2	23.6	28.4	6.1	2.5	42.3	18.0	0.9	7.3	27.3	11.9	34.7	8.3	15.6	14.9	27.1	17.4	21.6	16.2	84.4	7.1	15.3	22.0	15.0	4.7	4.2	14.5	47.4	32.8	62.1	26.1	14.8	46.7	0.5	5.8	0.3	0.1	3.5	23.2	16.0	17.1	8.8	17.6	24.5	12.2	72.5	48.3	56.0	52.3	12.0	7.6	0.1	33.7	48.2	17.2	11.3	9.2	71.6	43.0	0.2	5.0	3.7	18.4	8.0	17.8	0.3	6.9	25.5	16.6	47.9	25.9	17.5	40.6	1.4	17.4	0.3	47.6	23.6	0.1	17.6	9.1	0.4	7.7	0.1	29.7	0.2	10.9	0.6	2.3	3.1	42.1	4.1	12.4	18.1	8.9	23.3	94.1	71.8	59.0	66.2	67.2	1.3	0.4	0.4	55.2	5.2	25.5	0.5	5.8	0.0	0.1	2.2	0.1	11.7	0.0	0.0	7.6	14.8	0.0	0.1	0.1	0.3	2.0	46.7	0.0	3.5	4.2	7.6	3.2	3.9	5.1	5.5	6.1	2.5	11.9	4.7	77.4	9.3	11.5	34.7	61.8	1.0	45.2	10.2	13.4	23.9	7.0	0.0	49.8	1.7	133.5	171.4	65.5	0.0	0.0	92.9	423.0	106.7	14.4	43.9	0.4	67.7	0.0	0.0	79.2	11.7	98.9	65.0	55.0	32.1	111.0	0.1	0.0	147.5	0.0	85.9	0.6	1.6	25.8	106.6	5.0	4.3	58.5	18.5	2.5	0.2	49.6
TUBB8	bA631M21.2	ENSG00000261456	"Tubulin beta 8 class VIII"	Q3ZCM7	10	46892-74163	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 2.2;parathyroid gland: 2.3;testis: 2.5"	"Cell type enhanced"	"Detected in some"	18	"Early spermatids: 9.6;Spermatocytes: 13.5;Spermatogonia: 8.7"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.0"					"Cell type enhanced"	"Detected in some"		"eosinophil: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.8;MCF7: 5.4;NTERA-2: 1.9"									"HPA043640, HPA046280"	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.75e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.74e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.50e-1)"	"unprognostic (4.15e-3)"	"unprognostic (7.17e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.33e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.86e-3)"	0.0	0.0		0.5		0.0	1.1		0.1	0.0	0.0			0.0	0.4	0.1	0.0	1.2	0.0	0.1			0.1	0.0	0.0	0.4			0.0	0.0	2.3		0.4		0.0	0.0		0.0	0.0	0.0	0.1	0.1	0.0		0.0	0.0	2.5			0.3		0.1	0.5		1.0	0.1	2.2	0.3	0.2	0.5	0.1	0.5	0.0	0.0	0.3	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	5.4	0.1	0.0	1.9	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.6	0.2	0.7	0.2	0.4	1.0	0.4	0.0	0.0	0.0	0.8	0.0	0.3	0.1	0.4	0.1	0.0	0.0	0.2	0.1	2.2	0.5	0.2	0.2	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.7	0.2	0.3	0.1	0.1	0.1											0.0	0.0	0.0	0.6	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	13.5	8.7	0.0	0.0	0.0	0.0	0.7
TUBB8P12		ENSG00000173213	"Tubulin beta 8 pseudogene 12"	A6NNZ2	18	47390-49557	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 7.4"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"testis cancer: 1.7"					"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.3;neutrophil: 1.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.3;Hep G2: 2.2;MCF7: 1.7;T-47d: 2.3;U-266/70: 1.8;U-266/84: 1.9"									"HPA043640, HPA046280"	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.46e-2)"	"unprognostic (7.42e-4)"	"unprognostic (3.96e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.88e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.78e-1)"	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0			0.0	0.0	0.5	0.5	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.2	0.0		1.3	0.1	0.3	0.5	0.8		0.3	0.0		0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.3	7.4			0.1		0.1	0.6	0.1	0.4	0.0	1.1	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	2.2	0.0	0.0	1.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.0	0.7	0.2	0.5	2.3	0.0	0.0	0.0	0.0	0.6	0.0	1.8	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UNC119B	"MGC5139, POC7B"	ENSG00000175970	"Unc-119 lipid binding chaperone B"	A6NIH7	12	120710435-120723640	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077812	Enhanced		Approved	"Cytokinetic bridge,Mitotic spindle,Mitochondria,Cytosol"		Yes	No			"Cytokinetic bridge, Mitotic spindle"	"Mitochondria, Cytosol"	"HPA077812: "	"unprognostic (1.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.86e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.26e-4)"	"unprognostic (9.35e-2)"	"prognostic favorable (6.69e-10)"	"unprognostic (2.52e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.42e-2)"	12.7	33.5	18.1	9.2	18.6	9.5	16.3	17.0	17.2	16.0	12.1	15.0	18.7	8.6	20.7	15.0	11.6	42.8	14.9	13.2	18.9	19.7	27.1	14.7	14.0	9.3	14.2	16.0	33.7	17.1	40.8	25.8	13.4	20.4	18.4	12.3	14.6	14.1	23.8	6.7	13.6	11.4	17.5	15.5	13.4	14.5	21.9	15.2	16.1	38.6	7.3	13.7	12.1	16.3	2.1	2.5	2.1	5.8	2.5	4.0	1.4	11.5	11.2	23.4	20.0	23.5	17.5	19.9	14.4	16.8	16.4	7.4	13.4	4.8	11.7	5.7	16.0	7.9	12.3	24.7	16.1	17.0	9.1	12.5	5.4	8.3	8.3	15.9	14.8	8.6	13.7	16.6	12.2	18.9	26.5	18.4	17.8	13.1	1.3	13.8	10.2	13.5	12.2	28.9	13.2	13.9	16.3	15.6	6.0	19.6	24.3	14.1	17.8	34.4	6.8	11.8	17.3	26.8	10.2	11.5	15.3	10.5	6.5	9.6	9.5	8.2	7.2	18.1	7.5	16.5	0.2	1.1	1.3	3.3	0.6	2.1	1.8	3.0	3.8	1.2	2.1	4.0	3.2	2.1	2.5	5.8	2.5	2.8	1.4	18.1	18.6	17.0	17.2	18.9	19.7	14.2	16.0	20.4	15.2	3.0	6.9	2.9	6.5	2.6	8.1	3.5	5.1	18.7	5.7	17.4	9.8	9.1	13.3	6.6	11.8	6.3	3.5	0.0	6.7	4.0	6.2	10.2	2.3	5.5	2.7	7.9	13.7	8.6	3.7	2.2	12.0	1.8	5.0	0.0	6.1	11.2	6.9	5.8	15.2	11.8	9.8	12.9	5.0	11.4	14.5	2.9	4.3	9.2	8.0	6.4
WAPL	"FOE, KIAA0261, WAPAL"	ENSG00000062650	"WAPL cohesin release factor"	Q7Z5K2	10	86435256-86521815	"Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037874, HPA037875, HPA066141"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytokinetic bridge,Mitotic spindle,Centrosome,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytokinetic bridge, Mitotic spindle, Centrosome, Cytosol"	"HPA037874: AB_10697086, HPA037875: AB_10672396, HPA066141: "	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.91e-2)"	"unprognostic (6.63e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.78e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	15.3	15.4	16.0	15.5	16.9	19.8	15.6	23.6	15.0	13.4	14.0	12.1	6.8	12.5	16.0	8.7	20.4	12.6	11.2	13.3	15.3	8.2	14.5	23.1	17.5	19.3	14.8	11.5	14.8	13.6	18.1	18.2	19.0	13.4	13.9	13.1	9.4	14.9	10.6	34.4	20.4	16.0	16.0	16.4	18.2	13.5	28.1	16.4	39.2	15.9	9.4	22.4	15.1	15.9	5.2	6.2	14.3	8.7	3.9	7.7	3.1	20.2	9.5	16.7	22.0	13.3	14.2	14.7	17.8	22.0	15.2	16.6	20.6	17.9	30.8	12.1	15.9	13.4	19.1	18.9	15.3	23.4	20.0	12.4	18.6	15.2	22.6	15.2	37.6	21.5	11.1	17.9	19.4	32.7	17.3	16.9	18.0	19.5	18.6	17.3	17.3	23.4	14.1	14.8	12.7	9.6	16.7	13.5	12.2	13.1	18.0	6.5	12.6	15.7	10.6	19.3	17.3	23.2	20.1	16.2	14.6	17.4	12.8	23.3	18.3	25.4	32.6	13.4	26.9	10.3	14.3	4.7	9.4	4.7	5.3	7.0	5.2	6.3	6.5	6.2	4.8	7.2	5.7	7.3	3.9	8.7	4.7	7.7	3.1	16.0	16.9	23.6	15.0	15.3	8.2	14.8	11.5	13.4	16.4	77.4	51.5	21.9	40.4	0.0	47.2	0.0	12.7	25.4	38.7	15.7	19.6	36.2	18.3	52.5	61.6	29.2	15.6	70.0	46.0	25.0	22.4	50.1	23.3	41.2	35.6	52.4	17.5	28.8	48.6	27.3	29.7	49.5	0.0	56.9	31.7	45.3	46.8	37.1	30.4	26.7	127.3	64.7	0.0	125.1	82.8	0.0	63.6	38.9	32.2	54.7
ZNF263	"FPM315, ZKSCAN12, ZSCAN44"	ENSG00000006194	"Zinc finger protein 263"	O14978	16	3263800-3301401	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 41.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035085, HPA035086"	Approved		Supported	"Nucleoplasm,Mitotic spindle,Cytosol"		Yes	No			Cytosol	"Nucleoplasm, Mitotic spindle"	"HPA035085: AB_10671099, HPA035086: AB_10603244"	"unprognostic (2.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.98e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.66e-1)"	28.3	17.8	21.5	16.9	25.7	15.0	23.3	26.4	23.5	21.9	19.2	18.1	14.0	13.8	30.4	23.4	15.4	24.2	17.6	14.6	15.7	14.2	16.9	17.1	18.5	20.4	20.3	18.1	30.7	23.0	36.4	24.8	20.1	16.8	21.8	16.8	20.2	19.5	21.1	15.8	22.7	18.2	18.6	14.0	23.6	20.5	17.3	16.5	18.9	20.1	14.5	28.8	20.2	27.6	6.6	5.5	9.6	5.0	6.7	9.2	3.3	8.6	11.2	13.4	19.4	10.7	14.1	17.4	11.9	18.3	14.3	15.6	12.2	13.6	31.9	12.4	15.3	13.3	11.0	18.2	12.1	14.4	17.5	18.2	14.5	15.0	11.7	12.5	21.4	17.8	16.2	25.4	13.0	19.2	16.1	12.2	20.6	16.3	21.7	11.7	11.9	19.7	16.5	24.9	10.2	9.6	32.1	13.6	25.1	10.0	8.7	19.4	20.3	13.0	14.1	14.5	16.3	15.6	25.6	12.6	15.2	14.6	11.2	11.1	23.3	24.7	38.5	5.9	10.8	10.7	2.1	3.9	9.6	6.0	4.2	6.9	4.5	7.3	8.0	5.5	6.6	9.2	6.8	5.0	6.7	5.0	4.6	4.9	3.3	21.5	25.7	26.4	23.5	15.7	14.2	20.3	18.1	16.8	16.5	0.0	14.4	9.1	14.5	15.5	10.2	3.6	12.7	4.0	4.5	1.8	0.0	9.7	6.6	8.9	41.6	11.1	6.0	0.0	8.6	8.9	10.8	11.4	6.9	5.8	8.0	3.2	12.7	5.5	8.9	26.2	7.5	8.0	15.1	8.2	9.2	10.1	8.2	3.5	7.4	5.0	9.0	12.9	18.6	11.4	10.4	18.1	9.3	10.0	11.7	11.9
ZNF654	"FLJ10997, FLJ21142"	ENSG00000175105	"Zinc finger protein 654"	Q8IZM8	3	88059274-88144665	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 35.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036172, HPA036173, HPA049262, HPA077939"	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			Microtubules	"Nucleoplasm, Cytokinetic bridge, Mitotic spindle"	"HPA036172: AB_10672081, HPA036173: AB_2674987, HPA049262: , HPA077939: AB_2732364"	"unprognostic (2.54e-2)"	"unprognostic (2.28e-1)"	"unprognostic (6.89e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.74e-2)"	"unprognostic (3.45e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.72e-3)"	"prognostic unfavorable (9.97e-6)"	"unprognostic (1.29e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.50e-2)"	18.2	8.9	10.9	13.2	11.6	15.1	12.6	18.6	13.3	13.5	11.8	9.8	13.5	9.7	14.0	12.1	14.4	9.5	10.8	10.4	11.3	8.5	11.0	15.4	11.8	12.3	13.9	10.3	14.7	9.5	12.8	21.8	11.9	11.1	12.8	9.8	10.7	12.5	10.2	13.9	14.9	13.4	13.1	15.8	10.1	10.0	12.3	14.8	22.2	13.4	9.4	12.0	16.6	14.6	2.6	2.3	10.0	2.0	6.5	4.0	1.7	4.7	2.0	3.4	4.8	7.6	6.3	3.1	6.3	5.7	4.2	6.0	3.0	2.9	7.5	4.3	5.4	3.0	3.2	3.7	5.8	8.5	4.6	2.0	4.7	2.7	2.2	5.7	5.3	5.3	6.2	5.8	4.7	5.6	9.0	5.7	4.4	3.1	6.2	9.5	3.6	5.3	4.9	1.8	3.9	3.2	3.7	2.3	3.6	4.1	6.2	2.6	2.3	4.5	3.7	11.9	4.6	5.0	4.2	6.4	9.4	6.2	35.2	4.5	7.0	4.8	5.3	7.6	5.1	6.0	10.0	1.9	2.7	2.9	2.0	3.3	1.8	3.2	4.0	2.3	2.6	3.9	2.6	2.7	6.5	1.4	1.1	2.2	1.7	10.9	11.6	18.6	13.3	11.3	8.5	13.9	10.3	11.1	14.8	8.9	13.3	6.9	8.9	19.9	12.3	10.9	7.6	9.4	11.4	5.2	11.8	3.7	1.7	5.6	0.8	11.3	8.7	0.0	4.5	2.9	14.1	9.3	15.1	11.3	5.3	15.9	5.1	9.2	11.7	1.1	6.9	13.3	8.5	1.8	9.2	9.5	7.0	7.0	11.7	4.8	13.3	6.5	6.2	10.4	7.9	16.3	6.9	11.7	7.1	11.5
